TITLE 32: ENERGY CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION PART 330 LICENSING OF RADIOACTIVE MATERIAL
SUBPART A: GENERAL PROVISIONS
Section 330.10 Purpose and Scope
Section 330.15 Incorporations by Reference
Section 330.20 Definitions
Section 330.30 License Exemption - Source Material
Section 330.40 License Exemption - Radioactive Materials Other Than Source Material
SUBPART B: TYPES OF LICENSES
Section 330.200 Types of Licenses
Section 330.210 General Licenses – Source Material
Section 330.220 General Licenses - Radioactive Material Other Than Source Material
SUBPART C: SPECIFIC AND GENERAL LICENSES
Section 330.240 Filing Applications for Specific Licenses
Section 330.250 General Requirements for the Issuance of Specific Licenses
Section 330.260 Special Requirements for Issuance of Certain Specific Licenses for Radioactive Materials
Section 330.270 Special Requirements for Specific Licenses of Broad Scope
Section 330.280 Special Requirements for a Specific License to Manufacture, Assemble, Repair, or Distribute Commodities, Products, or Devices that Contain Radioactive Material
Section 330.290 Requirements for Emergency Plans
Section 330.300 Issuance of Specific Licenses
Section 330.310 Terms and Conditions of Specific and General Licenses
Section 330.320 Renewal Requirements for Specific Licenses
Section 330.325 Termination Requirements for Specific Licenses and Locations of Use
Section 330.330 Renewal of Licenses (Repealed)
Section 330.340 Amendment of Licenses at Request of Licensee
Section 330.350 Agency Action on Application to Renew and Amend
Section 330.360 Persons Possessing a License for Source, Byproduct, or Special Nuclear Material in Quantities Not Sufficient to Form a Critical Mass on Effective Date of This Part (Repealed)
Section 330.370 Persons Possessing Accelerator-Produced or Naturally-Occurring Radioactive Material on Effective Date of This Part (Repealed)
Section 330.400 Transfer of Material
Section 330.500 Modification and Revocation of Licenses
Section 330.900 Reciprocal Recognition of Licenses
Section 330.950 Nationally Tracked Sources
SUBPART D: TRANSPORTATION (Repealed)
Section 330.1000 Transportation of Radioactive Material (Repealed)
Section 330.APPENDIX A Exempt Concentrations
Section 330.APPENDIX A Exempt Concentrations
Section 330.APPENDIX B Exempt Quantities
Section 330.APPENDIX C Quantities of Radioactive Materials Requiring Consideration of the Need for an Emergency Plan for Responding to a Release
Section 330.TABLE A Group I (Repealed)
Section 330.TABLE B Group II (Repealed)
Section 330.TABLE C Group III (Repealed)
Section 330.TABLE D Group IV (Repealed)
Section 330.TABLE E Group V (Repealed)
Section 330.TABLE F Group VI (Repealed)
Section 330.APPENDIX D Limits for Licenses of Broad Scope (Section 330.270)
Section 330.APPENDIX D Limits for Licenses of Broad Scope (Section 330.270)
Section 330.APPENDIX E List of Specialty Board Certifications Recognized by the Agency Until October 24, 2007 (Repealed)
Section 330.APPENDIX F Nationally Tracked Source Thresholds
Section 330.APPENDIX G Financial Surety Arrangements (Section 330.250(c)(1)(D)) (Repealed)
Section 330.APPENDIX H Wording of Financial Surety Arrangements (Section 330.250(c)(1)(E)) (Repealed)
SUBPART A: GENERAL PROVISIONS
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.10 PURPOSE AND SCOPE
Section 330.10 Purpose and
Scope
a) This Part provides for the licensing of radioactive material.
No person shall receive, possess, use, manufacture, distribute, transfer, own
or acquire radioactive material or devices or equipment utilizing or producing
such materials except as authorized in a specific or general license issued
pursuant to this Part or as otherwise provided in 32 Ill. Adm. Code: Chapter
II, Subchapters b and d. These requirements provide for the protection of
health, safety and the environment.
b) The requirements of this Part are in addition to, and not in
substitution for, others in 32 Ill. Adm. Code: Chapter II, Subchapters b and d.
Additional specific requirements for certain types of licenses are found in
different Parts of 32 Ill. Adm. Code.
(Source: Amended at 24 Ill. Reg. 8042, effective June 1, 2000)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.15 INCORPORATIONS BY REFERENCE
Section 330.15
Incorporations by Reference
All rules, standards and
guidelines of agencies of the United States or nationally recognized
organizations or associations that are incorporated by reference in this Part
are incorporated as of the date specified in the reference and do not include
any later amendments or editions. Copies of these rules, standards and
guidelines that have been incorporated by reference are available for public
inspection and copying at the Illinois Emergency Management Agency, 1035 Outer
Park Drive, Springfield, Illinois.
(Source: Amended at 30 Ill.
Reg. 8928, effective April 28, 2006)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.20 DEFINITIONS
Section 330.20 Definitions
"Associate
Radiation Safety Officer" means an individual, who for this Part only:
Meets the requirements in Sections
330.260(c)(17) and (c)(21); and
Is currently identified as an
Associate Radiation Safety Officer for the types of use of radioactive material
for which the individual has been assigned duties and tasks by the Radiation
Safety Officer on a specific license that authorizes medical use or the
practice of nuclear pharmacy issued by the Agency, the U.S. Nuclear Regulatory
Commission, or an Agreement State; or a permit that authorizes medical use or
the practice of nuclear pharmacy issued by a U.S. Nuclear Regulatory Commission
master material licensee.
"Authorized nuclear pharmacist" means
a pharmacist who:
Meets the requirements in Section
330.260(c)(18)(A) and (21); or
Is identified as
an authorized nuclear pharmacist on:
A specific license issued by the
Nuclear Regulatory Commission or Agreement State that authorizes medical use or
the practice of nuclear pharmacy; or
A permit issued by a Nuclear
Regulatory Commission master material licensee that authorizes medical use or
the practice of nuclear pharmacy; or
A permit issued by a Nuclear
Regulatory Commission or Agreement State broad scope medical use licensee that
authorizes medical use or the practice of nuclear pharmacy; or
A permit issued by a Nuclear
Regulatory Commission master material license broad scope medical use permittee
that authorizes medical use or the practice of nuclear pharmacy; or
Is identified as an authorized
nuclear pharmacist by a commercial nuclear pharmacy that has been authorized to
identify authorized nuclear pharmacists; or
Is designated as an authorized
nuclear pharmacist in accordance with Section 330.260(c)(16).
"Consortium" means an
association of medical use licensees and a PET radionuclide production facility
in the same geographical area that jointly own or share in the operation and
maintenance cost of the PET radionuclide production facility that produces PET
radionuclides for use in producing radioactive drugs within the consortium for
noncommercial distributions among its associated members for medical use. The
PET radionuclide production facility within the consortium must be located at
an educational institution or a medical facility.
"General
license" means a license, as set forth in this Part and 32 Ill.
Adm. Code 341, which is effective without the filing of an application to
transfer, acquire, own, possess or use quantities of, or devices or equipment
utilizing, radioactive material [420 ILCS 40/4(d)], although the filing of
a certificate with the Agency may be required by the particular general
license. The general licensee is subject to all other applicable portions of
32 Ill. Adm. Code: Chapter II and any limitations of the general license.
"Nationally
tracked source" is a sealed source containing a quantity equal to or
greater than Category 1 or Category 2 levels of any radioactive material listed
in Appendix F. In this context, a sealed source is defined as radioactive
material that is sealed in a capsule or closely bonded in a solid form and is
not exempt from regulatory control. It does not mean material encapsulated
solely for disposal, or nuclear material contained in any fuel assembly,
subassembly, fuel rod, or fuel pellet. Category 1 nationally tracked sources
are those containing radioactive material at a quantity equal to or greater
than the Category 1 threshold. Category 2 nationally tracked sources are those
containing radioactive material at a quantity equal to or greater than the
Category 2 threshold but less than the Category 1 threshold.
"Preceptor"
means an individual who provides, directs or verifies training and experience
required for an individual to become an authorized user, an authorized medical
physicist, an authorized nuclear pharmacist, a Radiation Safety Officer, or an
Associate Radiation Safety Officer.
"Protective
actions" means actions taken by members of the public to protect
themselves from radiation from an incident involving radioactive material,
which may include sheltering, evacuation, relocation, control of access,
administration of radiation-protective drugs, decontamination of persons,
decontamination of land or property, or control of food or water.
"Specific license"
means a license, issued after application, to use, manufacture, produce,
transfer, receive, acquire, own, or possess quantities of, or devices or
equipment utilizing, radioactive materials [420 ILCS 40/4(m)]. The
licensee is subject to all applicable portions of 32 Ill. Adm. Code: Chapter II,
as well as any limitations specified in the licensing document.
(Source: Amended at 48 Ill.
Reg. 13634, effective August 29, 2024)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.30 LICENSE EXEMPTION - SOURCE MATERIAL
Section 330.30 License
Exemption − Source Material
a) Any person is exempt from this Part to the extent that the
person receives, possesses, uses, owns or transfers source material in any
chemical mixture, compound, solution or alloy in which the source material is
by weight less than one-twentieth of one percent (0.05 percent) of the mixture,
compound, solution or alloy.
b) Any person is exempt from this Part to the extent that the
person receives, possesses, uses or transfers unrefined and unprocessed ore
containing source material; provided that, except as authorized in a specific
license, the person shall not refine or process that ore.
c) Any person is exempt from the requirements for a license set
forth in section 62 of the Atomic Energy Act of 1954, as amended, this Part and
32 Ill. Adm. Code 340 and 400 to the extent that the person receives,
possesses, uses or transfers:
1) Any quantities of thorium contained in:
A) Incandescent gas mantles;
B) Vacuum tubes;
C) Welding rods;
D) Electric lamps for illuminating purposes provided that each
lamp does not contain more than 50 milligrams of thorium;
E) Germicidal lamps, sunlamps and lamps for outdoor or industrial
lighting provided that each lamp does not contain more than 2 grams of thorium;
F) Rare earth metals and compounds, mixtures and products
containing not more than 0.25 percent by weight thorium, uranium or any
combination of these; or
G) Personnel neutron dosimeters, provided that each dosimeter does
not contain more than 50 milligrams of thorium.
2) Source material contained in the following products:
A) Glazed ceramic tableware, manufactured before August 27, 2016, provided
that the glaze contains not more than 20 percent by weight source material;
B) Piezoelectric ceramic containing not more than two percent by
weight source material;
C) Glassware containing not more than two percent by weight source
material or, for glassware manufactured before August 27, 2016, not more than
ten percent by weight source material, but not including commercially
manufactured glass brick, pane glass, ceramic tile or other glass or ceramic
used in construction; and
D) Glass enamel or glass enamel frit containing not more than ten
percent by weight source material imported or ordered for importation into the
United States, or initially distributed by manufacturers in the United States,
before July 25, 1983.
3) Photographic film, negatives and prints containing uranium or
thorium.
4) Any finished product or part fabricated of, or containing,
tungsten-thorium or magnesium-thorium alloys, provided that the thorium content
of the alloy does not exceed four percent by weight and that this exemption
shall not be deemed to authorize the chemical, physical or metallurgical
treatment or processing of the product or part.
5) Uranium contained in counterweights installed in aircraft,
rockets, projectiles and missiles, or stored or handled in connection with
installation or removal of those counterweights, provided that:
A) Each counterweight has been impressed with the following legend
clearly legible through any plating or other covering: "DEPLETED
URANIUM";
AGENCY NOTE: The requirement specified in subsection
(c)(5)(B) does not need to be met by counterweights manufactured prior to
December 31, 1969; provided that the counterweights were manufactured under a
specific license issued by the Atomic Energy Commission and were impressed with
the legend, "CAUTION − RADIOACTIVE MATERIAL − URANIUM",
as previously required by 10 CFR 40.13(c)(5)(ii), as in effect on June 30,
1969, exclusive of subsequent amendments or editions.
B) Each counterweight is durably and legibly labeled or marked
with the identification of the manufacturer and the statement:
"UNAUTHORIZED ALTERATIONS PROHIBITED"; and
AGENCY NOTE: The requirement specified in subsections (c)(5)(A)
and (B) do not need to be met by counterweights manufactured prior to December
31, 1969; provided that the counterweights were manufactured under a specific
license issued by the Atomic Energy Commission and were impressed with the
legend, "CAUTION − RADIOACTIVE MATERIAL − URANIUM", as
previously required by 10 CFR 40.13(c)(5)(ii), as in effect on June 30, 1969,
exclusive of subsequent amendments or editions.
C) This exemption shall not be deemed to authorize the chemical,
physical or metallurgical treatment or processing of any such counterweights
other than repair or restoration of any plating or covering.
6) Natural or depleted uranium metal used as shielding
constituting part of any shipping container, provided that:
A) The shipping container is conspicuously and legibly impressed
with the legend, "CAUTION − RADIOACTIVE SHIELDING − URANIUM";
and
B) The uranium metal is encased in mild steel or equally fire
resistant metal of minimum wall thickness of 3.2 millimeters (⅛ inch).
7) Thorium or uranium contained in or on finished optical lenses
and mirrors, provided that each lens or mirror does not contain more than ten
percent by weight thorium or uranium or, for lenses manufactured before August
27, 2016, 30 percent by weight of thorium and that this exemption shall not be
deemed to authorize either:
A) The shaping, grinding or polishing of the lens or mirror or
manufacturing processes other than the assembly of the lens or mirror into
optical systems and devices without any alteration of the lens or mirror; or
B) The receipt, possession, use or transfer of uranium or thorium
contained in contact lenses, or in spectacles, or in eyepieces in binoculars or
other optical instruments.
8) Thorium contained in any finished aircraft engine part
containing nickel-thoria alloy, provided that:
A) The thorium is dispersed in the nickel-thoria alloy in the form
of finely divided thoria (thorium dioxide); and
B) The thorium content in the nickel-thoria alloy does not exceed
four percent by weight.
9) No
person may initially transfer for sale or distribution a product containing
source material to persons exempt under this subsection (c) unless authorized
by an NRC license issued under 10 CFR 40.52 to initially transfer such products
for sale or distribution.
A) Persons
initially distributing source material in products covered by the exemptions in
subsection (c) before August 27, 2016 without specific authorization may
continue distribution for one year beyond this date. Initial distribution may
also be continued until NRC takes final action on a pending application for
license or license amendment to specifically authorize distribution submitted
no later than one year beyond this date.
B) Persons
authorized to manufacture, process or produce these materials or products
containing source material under a specific license issued by the Agency and
persons who import finished products or parts, for sale or distribution, must
be authorized by an NRC license issued under 10 CFR 40.52 for distribution only
and are exempt from the requirements of 10 CFR 19, 20 and 40.32(b) and (c).
d) The exemptions in subsection (c) do not authorize the
manufacture of any of the products described.
e) Any licensee is exempt from the requirements of this Part to
the extent that its activities are subject to the requirements of 32 Ill. Adm.
Code 601, except as specifically provided for in 32 Ill. Adm. Code 601.
(Source: Amended at 40 Ill. Reg. 12971, effective August 25, 2016)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.40 LICENSE EXEMPTION - RADIOACTIVE MATERIALS OTHER THAN SOURCE MATERIAL
Section 330.40 License
Exemption − Radioactive Materials Other Than Source Material
a) Exempt Concentrations
1) Any person is exempt from this Part to the extent that person
receives, possesses, uses, transfers, owns or acquires products containing
radioactive material introduced in concentrations not in excess of those listed
in Appendix A provided they have been introduced or transferred as described in
subsection (a)(2) or (3). This Section shall not be deemed to authorize the
import of radioactive materials or products containing radioactive materials.
2) No person may introduce radioactive material into a product or
material knowing or having reason to believe that it will be transferred to
persons exempt under subsection (a)(1) or equivalent regulations of the U.S.
Nuclear Regulatory Commission (NRC) (10 CFR 30.14) or an Agreement State,
except in accordance with a specific license issued pursuant to Section
330.280(a).
3) A manufacturer, processor or producer of a product or material
is exempt from the requirements for a license set forth in this Part to the
extent that person transfers radioactive material contained in a product or
material in concentrations not in excess of those specified in Appendix A and
introduced into the product or material by a licensee holding a specific
license issued by the Agency expressly authorizing that introduction. This exemption
does not apply to the transfer of radioactive material contained in any food,
beverage, cosmetic, drug or other commodity or product designed for ingestion
or inhalation by, or application to, a human being.
b) Exempt Quantities
1) Except as restricted by subsections (b)(2) through (4), any
person is exempt from this Part to the extent that person receives, possesses,
uses, transfers, owns or acquires radioactive material in individual quantities
each of which does not exceed the applicable quantity set forth in Appendix B. Furthermore,
any person is exempt from this Part to the extent that person possesses, uses,
transfers or owns radioactive material that was received or acquired before
September 25, 1971 under the general license then provided by the regulations
of the U.S. Atomic Energy Commission (10 CFR 31.4) or the equivalent
regulations of an Agreement State.
AGENCY NOTE:
Capsules distributed pursuant to 10 CFR 32.21 that contain carbon-14 urea are
only authorized for "in-vivo" diagnostic use for humans. Any person
who desires to use the capsules for research involving human subjects shall
apply for and receive a specific license from the Agency. Nothing in this
Section relieves persons from complying with applicable federal and State requirements
governing receipt, administration and use of drugs.
2) This subsection (b) does not authorize the production,
packaging or repackaging of radioactive material for purposes of commercial
distribution, or the incorporation of radioactive material into products
intended for commercial distribution.
3) No person may, for purposes of commercial distribution,
transfer radioactive material in the individual quantities set forth in
Appendix B, knowing or having reason to believe that such quantities of
radioactive material will be transferred to persons exempt under this
subsection (b) or equivalent regulations of NRC or an Agreement State, except
in accordance with a specific license issued by NRC pursuant to 10 CFR 32.18 or
32.21, or by the Agency pursuant to Section 330.280(b), which states that the
radioactive material may be transferred by the licensee to persons exempt under
this subsection (b) or the equivalent regulations of the NRC or an Agreement
State.
4) No person shall, for purposes of producing an increased
radiation level, combine quantities of radioactive material covered by the
exemption in subsection (b)(1) so that the aggregate quantity exceeds the
limits set forth in Appendix B, except for radioactive material combined within
a device placed in use before May 3, 1999, or as otherwise permitted by this
Part.
AGENCY NOTE:
Authority to transfer possession or control by the manufacturer, processor, or
producer of any equipment, device, commodity, or other product containing
byproduct material whose subsequent possession, use, transfer and disposal by
all other persons are exempted from regulatory requirements may be obtained
only from the U.S. Nuclear Regulatory Commission, Washington DC 20555.
c) Exempt Items
1) Certain Items Containing Radioactive Material. Except for
persons who apply radioactive material to, or persons who incorporate
radioactive material into, the following products or persons who initially
transfer for sale or distribution the following products, any person is exempt
from this Part to the extent that the person receives, possesses, uses,
transfers, owns or acquires the following products:
AGENCY NOTE:
Authority to transfer possession or control by the manufacturer, processor, or
producer of any equipment, device, commodity, or other product containing
byproduct material whose subsequent possession, use, transfer and disposal by
all other persons are exempted from regulatory requirements may be obtained
only from the U.S. Nuclear Regulatory Commission, Washington DC 20555.
A) Timepieces or hands or dials containing not more than the
following specified quantities of radioactive material and not exceeding the
following specified radiation dose rate:
i) 925 MBq (25 mCi) of tritium per timepiece;
ii) 185 MBq (5 mCi) of tritium per hand;
iii) 555 MBq (15 mCi) of tritium per dial (bezels when used shall
be considered as part of the dial);
iv) 3.7 MBq (100 microCi) of promethium-147 per watch or 7.4 MBq
(200 microCi) of promethium-147 per any other timepiece;
v) 740 kBq (20 microCi) of promethium-147 per watch hand or 1.48
MBq (40 microCi) of promethium-147 per other timepiece hand;
vi) 2.22 MBq (60 microCi) of promethium-147 per watch dial or 4.44
MBq (120 microCi) of promethium-147 per other timepiece dial (bezels when used
shall be considered as part of the dial);
vii) The radiation dose rate from hands and dials containing
promethium-147 will not exceed, when measured through 50 milligrams/square
centimeter of absorber: for wrist watches, 1 microGy (100 microrad)/hour at 10
centimeters from any surface; for pocket watches, 1 microGy (100 microrad)/hour
at 1 centimeter from any surface; for any other timepiece, 2 microGy (200
microrad)/hour at 10 centimeters from any surface; or
viii) 37 kBq (1 microCi) of radium-226 per timepiece in intact timepieces
manufactured prior to November 30, 2007.
B) Precision balances containing not more than 37 MBq (1 mCi) of
tritium per balance or not more than 18.5 MBq (500 microCi) of tritium per
balance part manufactured before December 17, 2007.
C) Marine compasses containing not more than 27.8 GBq (750 mCi) of
tritium gas and other marine navigational instruments containing not more than
9.25 GBq (250 mCi) of tritium gas manufactured before December 17, 2007.
D) Electron tubes; provided that:
i) Each tube does not contain more than one of the following
specified quantities of radioactive material:
• 5.55 GBq (150 mCi) of tritium per microwave receiver
protector tube or 370 MBq (10 mCi) of tritium per any other electron tube;
• 37
kBq (1 microCi) of cobalt-60;
• 185
kBq (5 microCi) of nickel-63;
• 1.11
MBq (30 microCi) of krypton-85;
• 185
kBq (5 microCi) of cesium-137; or
• 1.11
MBq (30 microCi) of promethium-147; and
ii) The radiation dose rate from each electron tube containing
radioactive material will not exceed 10 microGy (1 mrad)/hour at 1 centimeter
from any surface when measured through 7 milligrams/square centimeter of
absorber.
AGENCY NOTE:
For purposes of subsection (c)(1)(D), "electron tubes" include spark
gap tubes, power tubes, gas tubes including glow lamps, receiving tubes, microwave
tubes, indicator tubes, pick-up tubes, radiation detection tubes and any other
completely sealed tube that is designed to conduct or control electrical
currents.
E) Ionizing radiation measuring instruments containing, for
purposes of internal calibration or standardization, one or more sources of
radioactive material, provided that:
i) Each source contains no more than one exempt quantity set
forth in Appendix B; and
ii) Each instrument contains no more than 10 exempt quantities.
For purposes of this requirement, an instrument's sources may contain one or
more radionuclides and an individual exempt quantity may be composed of
fractional parts of one or more of the exempt quantities in Appendix B,
provided that the sum of the fractions shall not exceed unity.
AGENCY NOTE:
For purposes of subsection (c)(1)(E), 1.85 kBq (50 nCi) of americium-241 is
considered an exempt quantity.
F) Ionization chamber smoke detectors containing not more than 37
kBq (1 microCi) of americium-241 per detector in the form of a foil and
designed to protect life and property from fires.
G) Static
elimination devices designed for use as static eliminators that contain, as a
sealed source or sources, radioactive material consisting of a total of not
more than 18.5 MBq (500 microCi) of polonium-210 per device.
H) Ion
generating tubes designed for ionization of air that contain, as a sealed
source or sources, byproduct material consisting of a total of not more than
18.5 MBq (500 μCi) of polonium-210 per device or of a total of not more
than 1.85 GBq (50 mCi) of hydrogen-3 (tritium) per device.
I) Devices described in subsections (c)(1)(G) and (H) authorized before
October 23, 2015 for use under the general license then provided in Section 330.220(a)
and manufactured, tested and labeled by the manufacturer in accordance with the
specifications contained in a specific license issued by the Agency or the
equivalent regulations of NRC or of an Agreement State.
2) Self-Luminous Products Containing Radioactive Material
A) Tritium, Krypton-85 or Promethium-147. Except for persons who
manufacture, process or produce self-luminous products containing tritium,
krypton-85 or promethium-147, any person is exempt from this Part to the extent
that person receives, possesses, uses, transfers, owns or acquires tritium,
krypton-85 or promethium-147 in self-luminous products manufactured, processed,
produced, imported or transferred in accordance with a specific license, issued
by NRC pursuant to 10 CFR 32.22, which authorizes the transfer of the product
to persons who are exempt from regulatory requirements. The exemption in this
subsection (c)(2)(A) does not apply to tritium, krypton-85 or promethium-147
used in products for frivolous purposes or in toys or adornments. NRC shall
make this determination of exemption.
B) Any person who desires to manufacture, process, produce or
initially transfer for sale or distribution self-luminous products containing
tritium, krypton-85 or promethium-147 for use under subsection (c)(2)(A) should
apply for a license under 10 CFR 32.22 and for a certificate of registration
pursuant to 10 CFR 32.210 with NRC.
C) Radium-226. Any person is exempt from this Part to the extent
that person receives, possesses, uses, transfers or owns articles containing
less than 3.7 kBq (100 nCi) of radium-226 that were acquired prior to May 1,
1974.
3) Gas and Aerosol Detectors Containing Radioactive Material
A) Except for persons who manufacture, process, produce or
initially transfer for sale and distribution gas and aerosol detectors
containing radioactive material, any person is exempt from 32 Ill. Adm. Code: Chapter
II, Subchapters b and d to the extent that person receives, possesses, uses,
transfers, owns or acquires radioactive material in gas and aerosol detectors
designed to protect life or property from fires and airborne hazards. The
detectors shall be manufactured, processed, produced or initially transferred
in accordance with a specific license issued by NRC pursuant to 10 CFR 32.26
that authorizes transfer of the detectors to persons who are exempt from
regulatory requirements and who have been issued a certificate of registration
in accordance with 10 CFR 32.210 from NRC.
B) Gas and aerosol detectors previously manufactured and
distributed to general licensees in accordance with a specific license issued
by an Agreement State or a former Licensing State shall be considered exempt
under subsection (c)(3)(A), provided that the device is labeled in accordance
with the specific license and provided further that it meets the requirements
of 10 CFR 32.26 in effect at the time of distribution. This exemption also
covers gas and aerosol detectors manufactured or distributed before November
30, 2007, in accordance with a specific license issued by an Agreement State
under comparable provisions to 10 CFR 32.26 authorizing distribution to persons
exempt from regulatory requirements.
4) Certain Industrial
Devices
A) Except
for persons who manufacture, process, produce or initially transfer for sale or
distribution industrial devices containing byproduct material designed and
manufactured for the purpose of detecting, measuring, gauging or controlling
thickness, density, level, interface location, radiation, leakage or
qualitative or quantitative chemical composition, or for producing an ionized
atmosphere, any person is exempt from the requirements for a license set forth
in Section 81 of the Act and from 32 Ill. Adm. Code: Chapter II, Subchapters b
and d to the extent that person receives, possesses, uses, transfers, owns or
acquires byproduct material, in these certain detecting, measuring, gauging or
controlling devices and certain devices for producing an ionized atmosphere,
and manufactured, processed, produced or initially transferred in accordance
with a specific license issued under 10 CFR 32.30, which license authorized the
initial transfer of the device for use under this Section. This exemption does
not cover sources not incorporated into a device, such as calibration and
reference sources.
B) Any
person who desires to manufacture, process, produce or initially transfer for
sale or distribution industrial devices containing byproduct material for use
under subsection (c)(4)(A), should apply for a license under 10 CFR 32.30 and
for a certificate of registration in accordance with 10 CFR 32.210.
AGENCY NOTE: Authority to
transfer possession or control by the manufacturer, processor or producer of
any equipment, device, commodity or other product containing byproduct material
whose subsequent possession, use, transfer and disposal by all other persons
are exempted from regulatory requirements may be obtained only from the U.S.
Nuclear Regulatory Commission, Washington DC 20555.
(Source: Amended at 49 Ill.
Reg. 1196, effective January 8, 2025)
SUBPART B: TYPES OF LICENSES
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.200 TYPES OF LICENSES
Section 330.200 Types of
Licenses
Licenses for radioactive
materials are of two types: general and specific.
(Source: Amended at 30 Ill.
Reg. 8928, effective April 28, 2006)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.210 GENERAL LICENSES SOURCE MATERIAL
Section 330.210 General
Licenses – Source Material
a) A general license is hereby issued authorizing commercial and
industrial firms; research, educational and medical institutions; and federal,
State and local government agencies to receive, possess, use and transfer
uranium and thorium, in their natural isotopic concentrations and in the form
of depleted uranium, for research, development, educational, commercial or
operational purposes in the following forms and quantities:
1) No
more than 1.5 kilograms (3.3 pounds) of uranium and thorium in dispersible forms
(e.g., gaseous, liquid, powder, etc.) at any one time. Any material processed
by the general licensee that alters the chemical or physical form of the
material containing source material must be accounted for as a dispersible
form. A person authorized to possess, use and transfer source material under
this subsection (a) may not receive more than a total of 7 kilograms (15.4
pounds) of uranium and thorium in any one calendar year. Persons possessing
source material in excess of these limits as of August 27, 2016, may continue
to possess up to 7 kilograms (15.4 pounds) of uranium and thorium at any one
time for one year beyond this date, or until the Agency takes final action on a
pending application submitted on or before August 27, 2017, for a specific license
for that material and may receive up to 70 kilograms (154 pounds) of uranium or
thorium in any one calendar year until December 31, 2017, or until the Agency
takes final action on a pending application submitted on or before August 27,
2017, for a specific license for that material; and
2) No
more than:
A) a
total of 7 kilograms (15.4 pounds) of uranium and thorium at any one time. A
person authorized to possess, use and transfer source material under this
subsection (a)(2)(A) may not receive more than a total of 70 kilograms (154
pounds) of uranium and thorium in any one calendar year. A person may not alter
the chemical or physical form of the source material possessed under this
subsection (a)(2)(A) unless it is accounted for under the limits of subsection
(a)(1); or
B) 7
kilograms (15.4 pounds) of uranium, removed during the treatment of drinking
water, at any one time. A person may not remove more than 70 kilograms (154
pounds) of uranium from drinking water during a calendar year under this
subsection (a)(2)(B); or
C) 7 kilograms (15.4 pounds) of uranium and thorium
at laboratories for the purpose of determining the concentration of uranium and
thorium contained within the material being analyzed at any one time. A person
authorized to possess, use and transfer source material under this subsection (a)(2)(C)
may not receive more than a total of 70 kilograms (154 pounds) of source
material in any one calendar year.
b) Any person who receives, possesses, uses or transfers source material
in accordance with the general license in subsection (a):
1) Is
prohibited from administering source material, or the radiation therefrom,
either externally or internally, to human beings, except as may be authorized
by the Agency in a specific license;
2) Shall
not abandon such source material. Source material may be disposed of as
follows:
A) A
cumulative total of 0.5 kilograms (1.1 pounds) of source material in a solid,
nondispersible form may be transferred each calendar year, by a person
authorized to receive, possess, use and transfer source material under the
general license to persons receiving the material for permanent disposal. The
recipient of source material transferred under the provisions of this
subsection (b)(2)(A) is exempt from the requirement to obtain a license under
this Part to the extent the source material is permanently disposed. This
provision does not apply to any person who is in possession of source material
under a specific license issued under this Subchapter b; or
B) In
accordance with 32 Ill. Adm. Code 340.1010;
3) Is
subject to the provisions in 32 Ill. Adm. Code 310, 330.310(a) through (c),
330.400, 330.500 and 340.1220(a) through (d);
4) Shall
respond to written requests from the Agency to provide information relating to
the general license within 30 calendar days after the date of the request, or
other time specified in the request. If the person cannot provide the requested
information within the allotted time, the person shall, within that same time
period, request a longer period to supply the information by providing the
Agency a written justification for the request; and
5) Shall not export such source material except in
accordance with 10 CFR 110.
c) Any
person who receives, possesses, uses or transfers source material in accordance
with subsection (a) shall conduct activities to minimize contamination of the
facility and the environment. When activities involving the source material are
permanently ceased at any site, if evidence of significant contamination is
identified, the general licensee shall notify the Agencyabout such contamination and may consult with the Agency as to the
appropriateness of sampling and restoration activities to ensure that any
contamination or residual source material remaining at the site where source
material was used under this general license is not likely to result in
exposures that exceed the limits in Section 330.325(b)(1)(B)(ii).
d) Any
person who receives, possesses, uses or transfers source material in accordance
with the general license granted in subsection (a) is exempt from the
provisions of 32 Ill. Adm. Code 340 and 400 to the extent
that such receipt, possession, use and transfer are within the terms of this
general license, except that person shall comply with the provisions of Section
330.325(b)(1)(B)(ii) and 32 Ill. Adm. Code 340.1010 to the extent necessary to
meet the provisions of subsections (b)(2) and (c) of this Section. However, this
exemption does not apply to any person who also holds a specific license issued
under Subchapter b.
e) No person may initially transfer or distribute
source material to persons generally licensed under subsection (a)(1) or (2)
unless authorized by a specific license issued in accordance with Section
330.280(o). This prohibition does not apply to analytical laboratories
returning processed samples to the client who initially provided the sample.
Initial distribution of source material to persons generally licensed by
subsection (a) before August 27, 2016, without specific authorization, may
continue for one year beyond that date. Distribution may also be continued
until the Agency takes final action on a pending application for license or
license amendment to specifically authorize distribution submitted on or before
August 27, 2017.
f) A general license is hereby issued authorizing the receipt of
title to source material without regard to quantity. This general license does
not authorize any person to receive, possess, use or transfer source material.
g) Depleted Uranium in Industrial Products and Devices
1) A general license is hereby issued to receive, acquire,
possess, use or transfer, in accordance with this subsection (g), depleted
uranium contained in industrial products or devices for the purpose of
providing a concentrated mass in a small volume of the product or device.
2) The general license in subsection (g)(1) applies only to
industrial products or devices that have been manufactured either in accordance
with a specific license issued to the manufacturer of the products or devices
pursuant to Section 330.280(l) or in accordance with a specific license issued
to the manufacturer by NRC or an Agreement State that authorizes manufacture of
the products or devices for distribution to persons generally licensed by NRC
or an Agreement State.
3) Persons who receive, acquire, possess or use depleted uranium
pursuant to the general license established by subsection (g)(1) shall:
A) File the form "Registration Certificate − Use of
Depleted Uranium Under General License," with the Agency. The form shall
be submitted within 30 days after the first receipt or acquisition of depleted
uranium. The registrant shall furnish the following information on the form:
i) Name and address of the registrant;
ii) A statement that the registrant has developed and will
maintain procedures designed to establish physical control over the depleted
uranium described in subsection (g)(1) and designed to prevent transfer of the
depleted uranium in any form, including metal scrap, to persons not authorized
to receive the depleted uranium; and
iii) Name and/or title, address and telephone number of the
individual duly authorized to act for and on behalf of the registrant in
supervising the procedures identified in subsection (g)(3)(A)(ii).
B) Report in writing to the Agency any changes in information
furnished by the registrant in the form. The report shall be submitted within
30 days after the effective date of the change.
4) A person who receives, acquires, possesses or uses depleted
uranium pursuant to the general license established by subsection (g)(1):
A) Shall not introduce the depleted uranium, in any form, into a
chemical, physical or metallurgical treatment or process, except a treatment or
process for repair or restoration of any plating or other covering of the
depleted uranium;
B) Shall not abandon the depleted uranium;
C) Shall transfer or dispose of the depleted uranium only in
accordance with Section 330.400. When the transferee receives the depleted
uranium pursuant to the general license established by subsection (g)(1), the
transferor shall furnish the transferee a copy of this Part and a copy of the
form, "Registration Certificate – Use of Depleted Uranium Under General
License". When the transferee receives the depleted uranium pursuant to a
general license contained in NRC's regulation 10 CFR 40.25(a) or Agreement
State's regulation equivalent to subsection (g)(1), the transferor shall
furnish the transferee a copy of this Part and a copy of the form, accompanied
by a note explaining that use of the product or device is regulated by NRC or an
Agreement State under requirements substantially the same as those in this
Part;
D) Within 30 days after any transfer, shall report in writing to
the Agency the name and address of the person receiving the depleted uranium through
that transfer; and
E) Shall not export the depleted uranium except in accordance with
a license issued by NRC pursuant to 10 CFR 110.
5) Any person receiving, acquiring, possessing, using or
transferring depleted uranium pursuant to the general license established by
subsection (g)(1) is exempt from the requirements of 32 Ill. Adm. Code 340 and
400 with respect to the depleted uranium covered by that general license.
(Source: Amended at 40 Ill.
Reg. 12971, effective August 25, 2016)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.220 GENERAL LICENSES - RADIOACTIVE MATERIAL OTHER THAN SOURCE MATERIAL
Section 330.220 General
Licenses − Radioactive Material Other Than Source Material
a) Certain Measuring, Gauging or Controlling Devices and Certain
Devices for Producing Light or an Ionized Atmosphere
1) A general license is hereby issued to commercial and
industrial firms and to research, educational and medical institutions,
individuals in the conduct of their business and State or local government
agencies to receive, acquire, possess, use or transfer, in accordance with the
provisions of subsections (a)(2) through (9), radioactive material, excluding
special nuclear material, contained in devices designed and manufactured for
the purpose of detecting, measuring, gauging or controlling thickness, density,
level, interface location, radiation, leakage, or qualitative or quantitative
chemical composition, or for producing light or an ionized atmosphere.
2) The general license provided by subsection (a)(1) applies only
to radioactive material contained in devices that have been manufactured or
initially transferred and labeled in accordance with the specifications
contained in a specific license issued by the Agency pursuant to Section
330.280(d) or in accordance with the specifications contained in an equivalent
specific license issued by the U.S. Nuclear Regulatory Commission, an Agreement
State or a Licensing State that authorizes distribution of devices to persons
generally licensed by NRC, an Agreement State or a former Licensing State. The
devices shall have been received from a specific licensee described in this subsection
(a)(2) or through a transfer made under subsection (a)(3)(L).
AGENCY NOTE:
Regulations under the Federal Food, Drug and Cosmetic Act authorizing the use
of radioactive control devices in food production require certain additional
labeling that is found in 21 CFR 179.21.
3) Any person who receives, acquires, possesses, uses or
transfers radioactive material in a device pursuant to the general license described
in subsection (a)(1):
A) Shall assure that all labels affixed to the device at the time
of receipt, and bearing a statement that removal of the label is prohibited,
are maintained on the device and shall comply with all instructions and
precautions provided by such labels;
B) Shall assure that the device is tested for leakage of, or
contamination by, radioactive material and proper operation of the on-off
mechanism and indicator, if any, at no longer than 6-month intervals or at such
other intervals as are specified on the device labels; however:
i) A device containing only krypton need not be tested for
leakage of, or contamination by, radioactive material; and
ii) A device containing only tritium or not more than 3.7 MBq
(100 µCi) of other beta and/or gamma emitting material or 370 kBq (10 µCi) of
alpha emitting material or a device held in storage in the original shipping
container prior to initial installation need not be tested for any purpose;
C) Shall assure that the tests required by subsection (a)(3)(B)
and other testing, installation, servicing and removal from installation
involving the radioactive material, its shielding or containment is
performed:
i) In accordance with the instructions provided by the labels;
or
ii) By a person holding an applicable specific license from the Agency,
NRC or an Agreement State to perform such activities;
D) Shall maintain records showing compliance with the requirements
of subsections (a)(3)(B), (C), (H) and, as applicable, (a)(6)(B). The records
shall show the results of tests. The records shall also show the dates of
performance of, and the names of persons performing, physical inventories,
testing, installation, servicing and removal from installation of radioactive
material or its shielding or containment. Any person who receives, acquires,
possesses, uses or transfers radioactive material in a device pursuant to the
general license provided by subsection (a)(1) shall retain these records as
follows:
i) A
record of a test of an on-off mechanism and indicator or a test for leakage or
contamination performed in accordance with subsection (a)(3)(B) shall be
retained for 5 years after the next required test is performed or until the
device is transferred or disposed of; and
ii) A
record of testing, installation, servicing or removal from installation
performed in accordance with subsection (a)(3)(C) shall be retained for 5 years
from the date of the recorded event or until the device is transferred or
disposed of; and
iii) A
record of transfer or disposal of a device in accordance with subsection (a)(3)(H)
shall be retained for 5 years from the date of the recorded event; and
AGENCY NOTE: Note that this
record must be retained after transfer of the device.
iv) A
record of a quarterly physical inventory, performed for those devices in
storage and not in use in accordance with subsection (a)(6)(B), shall be
retained for 5 years after the next required test is performed or until the
device is transferred or disposed of;
E) Shall immediately suspend operation of the device if there is a
failure of or damage to, or any indication of a possible failure of or damage
to, the shielding of the radioactive material or the on-off mechanism or
indicator, or upon the detection of 185 Bq (5 nCi) or more removable
radioactive material. The device shall not be operated until it has been
repaired by the manufacturer or other person holding an applicable specific
license from the Agency, NRC or an Agreement State to repair such devices. The
device and any radioactive material from the device shall be disposed of only by
transfer to a person authorized by an applicable specific license to receive
the radioactive material in the device or as otherwise approved by the Agency.
A report containing a brief description of the event and the remedial action
taken shall be furnished to the Agency within 30 days. As applicable, the
following shall also be furnished to the Agency:
i) A report within 5 days (as required by 32 Ill. Adm. Code
340.1260) if detection of 185 Bq (5 nCi) or more removable radioactive material
indicates that a sealed source is leaking or contaminated; and
ii) A
plan within 30 days for ensuring that the person's premises and environs are
acceptable for unrestricted use if 185 Bq (5 nCi) or more removable radioactive
material is detected on the device or failure of or damage to a source is
likely to result in contamination of the premises or the environs;
F) Shall not abandon the device containing radioactive material;
G) Shall not export the device containing radioactive material
except in accordance with 10 CFR 110, published at 73 Fed. Reg. 78615, December
23, 2008, exclusive of subsequent amendments or editions;
H) Shall transfer or dispose of the device containing radioactive
material only:
i) By export as provided by subsection (a)(3)(G);
ii) By transfer to another general licensee as provided by
subsection (a)(3)(L);
iii) By
transfer to a person authorized to receive the device by a specific license
issued by the Agency pursuant to Section 330.280(d) or an equivalent specific
license issued by NRC or an Agreement State;
iv) By
transfer to a person authorized to perform waste collection by a specific
license issued by the Agency, NRC or an Agreement State; or
v) As
approved under subsection (a)(3)(K);
I) Shall furnish a written report to the Agency within 30 days
after transferring or disposing of the device containing radioactive material.
The notification shall include:
i) The identification of the device by manufacturer's (or
initial transferor's) name, model and serial number;
ii) The name, address and license number of the transferee
(license number not applicable if exported);
iii) The date of the transfer;
iv) A receipt from the transferee showing the serial number of the
device and the date that it was received (not applicable if exported);
J) Shall respond to written requests from the Agency to provide
information relating to the general license within 30 calendar days of the date
of the request, or other time specified in the request. If the general licensee
cannot provide the requested information within the allotted time, it shall,
within that same time period, request a longer period to supply the information
to the Agency, by an appropriate method listed in 32 Ill. Adm. Code 310.110.;
K) Shall obtain
written approval from the Agency before transferring the device to any other
specific licensee not authorized in subsections (a)(3)(H)(i) through (iv); however,
a holder of a specific license may transfer a device for possession and use
under its own specific license without prior approval, if, the holder:
i) Verifies
that the specific license authorizes the possession and use, or applies for and
obtains an amendment to the license authorizing the possession and use;
ii) Removes,
alters, covers, or clearly and unambiguously augments the existing label
(otherwise required by subsection (a)(3)(A)) so that the device is labeled in
compliance with 32 Ill. Adm. Code 340.940; however the manufacturer, model
number, and serial number must be retained;
iii) Obtains
the manufacturer's or initial transferor's information concerning maintenance
that would be applicable under the specific license (such as leak testing
procedures); and
iv) Reports
the transfer under subsection (a)(3)(I).
L) Shall
transfer the device to another general licensee only if:
i) The
device remains in use at a particular location. In such case the transferor
shall give the transferee a copy of subsection (a), a copy of 32 Ill. Adm. Code
310.40, 330.310, 330.500, 340.1210, 340.1220, 340.1260 and any safety documents
identified in the device labels; or
ii) The
device is held in storage by an intermediate person in the original shipping
container at its intended location of use prior to initial use by a general
licensee;
M) Shall
furnish a report to the Agency within 30 days after transferring a device
containing radioactive material as provided by subsection (a)(3)(L)(i). The
notification shall include:
i) The
identification of the device by manufacturer's (or initial transferor's) name,
model and serial number;
ii) The
transferee's name and mailing address;
iii) The
address of the transferee's location of use or storage of the device; and
iv) The
name, title and phone number of the responsible individual identified by the
transferee in accordance with subsection (a)(3)(N) to have knowledge of, and
authority to take actions to ensure compliance with, the appropriate
regulations and requirements;
N) Shall
appoint an individual responsible for having knowledge of the appropriate
regulations and requirements and the authority for taking required actions to
comply with appropriate regulations and requirements. The general licensee,
through this individual, shall ensure day-to-day compliance with appropriate
regulations and requirements. This appointment does not relieve the general
licensee of any of its responsibility in this regard.
4) Any
person who receives, acquires, possesses or uses a device identified in
subsection (a)(4)(A) shall register with the Agency in accordance with
subsection (a)(4)(B):
A) A
person shall register devices (i.e., an electron capture detector, gauge, x-ray
fluorescence analyzer, or other measuring, gauging or controlling device)
containing at least 370 MBq (10 mCi) of cesium-137, 3.7 MBq (0.1 mCi) of
strontium-90, 37 MBq (1 mCi) of cobalt-60, 3.7 MBq (0.1 mCi) of radium-226, or
37 MBq (1 mCi) of americium-241, or any other transuranic (i.e., element with
atomic number greater than uranium (92)), based on the activity indicated on
the label;
B) A
person shall register with the Agency no later than 30 days after receiving a
device identified in subsection (a)(4)(A). Registration information shall be
in a format prescribed by the Agency and furnished in accordance with
subsection (a)(4)(C);
C) When
registering with the Agency, a person shall furnish the following and any other
information requested by the Agency to track the location and use of a device:
i) The
name and mailing address of the general licensee;
ii) The
name, title and phone number of the responsible individual designated as a
representative of the general licensee in accordance with subsection (a)(3)(N);
iii) Information
about each device meeting the criteria of subsection (a)(4)(A). This
information shall include the manufacturer (or initial transferor), model,
serial number, radionuclide and activity as indicated on the labels, and the
calendar quarter and year the person received the device;
iv) The
address or locations at which the devices are used or stored;
AGENCY NOTE: For portable
devices, these are the addresses of the primary places of storage.
v) Certification
by the responsible individual that the information about devices was verified
through a physical inventory and examination of label information; and
vi) Certification
by the responsible individual that the general licensee is aware of the
requirements of the general license;
AGENCY NOTE: Fee requirements
for general licenses are in 32 Ill. Adm. Code 331. Reporting requirements are
in Section 330.310(b), and bankruptcy notification requirements are in Section
330.310(j).
D) Any person who is required by subsection (a)(4) to register
with the Agency shall report a change in mailing address or address of location
of use or storage. This report shall be furnished to the Agency within 30 days
after the change.
AGENCY NOTE: For portable
devices, this is the address of the primary place of storage.
5) A
person from out of state who is generally licensed by NRC or an Agreement State
with respect to a device identified in subsection (a)(4)(A) is exempt from the
registration requirement in subsection (a)(4) if the device is used in areas
subject to Agency jurisdiction for a period less than 180 days in any calendar
year.
6) Any
person who receives, acquires, possesses or uses radioactive material in a
device under the general license described in subsection (a)(1) shall limit
storage of a device that is not in use to a maximum of 2 years.
A) If
a device with a shutter is not being used, the shutter shall be locked in the
closed position. Testing for leakage of, or contamination by, radioactive
material and for proper operation of the on-off mechanism and indicator is not
required during the storage period. However, the testing required in
subsection (a)(3)(B) shall be conducted before the device is returned to
service if the device has not been tested within the required test interval.
B) A
device kept in standby for future use is exempt from the 2-year storage limit
if the person performs a quarterly physical inventory of the device while it is
in standby. The requirements and exemption of subsection (a)(6)(A) shall
apply.
AGENCY
NOTE: Record keeping requirements are contained in subsection (a)(3)(D).
7) Failure
of any person to comply with the requirements of this subsection (a) may cause
the Agency to impose civil penalties in accordance with 420 ILCS 40/36 and 32
Ill. Adm. Code 200.
8) The general license described in subsection (a)(1) does not
authorize the manufacture or import of devices containing radioactive material.
9) The general license described in subsection (a)(1) is subject
to the provisions of 32 Ill. Adm. Code 310, 326, 331, 340.1210, 340.1220,
340.1260, and 341 and Sections 330.310 and 330.500. Any person who receives,
acquires, possesses, uses or transfers radioactive material in a device
pursuant to the general license described in subsection (a)(1) is exempt from
the requirements of 32 Ill. Adm. Code 400 and 340 except for the Sections of 32
Ill. Adm. Code 340 specifically identified in subsections (a)(3)(E) and (a)(9).
b) Luminous Safety Devices for Aircraft
1) A general license is hereby issued to receive, acquire,
possess and use tritium or promethium-147 contained in luminous safety devices
for use in aircraft, provided:
A) Each device contains not more than 370 GBq (10 Ci) of tritium
or 11.1 GBq (300 mCi) of promethium-147; and
B) Each device has been manufactured, assembled or initially transferred
in accordance with a specific license issued under the provisions of Section
330.280(e) or manufactured or assembled in accordance with a specific license
issued by NRC or an Agreement State which authorizes manufacture or assembly of
the device for distribution to persons generally licensed by the Agency.
2) Persons who receive, acquire, possess or use luminous safety
devices pursuant to the general license in subsection (b)(1) are exempt from
the requirements of 32 Ill. Adm. Code 340 and 400, except that they shall
comply with the provisions of 32 Ill. Adm. Code 340.1210 and 340.1220.
3) This general license does not authorize the manufacture,
assembly, repair, or import of luminous safety devices containing tritium or
promethium-147.
4) This general license does not authorize the receipt,
acquisition, possession or use of promethium-147 contained in instrument dials.
5) This general license is subject to the provisions of 32 Ill.
Adm. Code 310 and 341 and Sections 330.310, 330.400 and 330.500.
c) Ownership of Radioactive Material. A general license is
hereby issued to own radioactive material without regard to quantity.
Notwithstanding any other provisions of this Part, this general license does
not authorize the manufacture, production, transfer, receipt, possession, use,
import, or export of byproduct material.
d) Calibration and References Sources
1) A general license is hereby issued to those persons listed
below to receive, acquire, possess, use and transfer, in accordance with the
provisions of subsections (d)(4) and (5), americium-241 in the form of
calibration or reference sources:
A) Any person who holds a specific license issued by the Agency that
authorizes the licensee to receive, possess, use and transfer radioactive
material; and
B) Any person who holds a specific license issued by NRC that
authorizes the licensee to receive, possess, use and transfer special nuclear
material.
2) A general license is hereby issued to receive, possess, use
and transfer plutonium in the form of calibration or reference sources in
accordance with the provisions of subsections (d)(4) and (5) to any person who
holds a specific license issued by the Agency that authorizes the licensee to
receive, possess, use and transfer radioactive material.
3) A general license is hereby issued to receive, possess, use
and transfer radium-226 in the form of calibration or reference sources in
accordance with the provisions of subsections (d)(4) and (5) to any person who
holds a specific license issued by the Agency that authorizes the licensee to
receive, possess, use and transfer radioactive material.
4) The general licenses in subsections (d)(1) through (3) apply
only to calibration or reference sources that have been manufactured or
initially transferred in accordance with the specifications contained in a
specific license issued to the manufacturer or importer of the sources by NRC
pursuant to 10 CFR 32.57 or 70.39, or that have been manufactured in
accordance with the specifications contained in a specific license issued by
the Agency, or an Agreement State pursuant to licensing requirements equivalent
to those contained in 10 CFR 32.57 or 70.39.
5) The general licenses provided in subsections (d)(1) through
(3) are subject to the provisions of 32 Ill. Adm. Code 310, 340, 341 and 400
and Sections 330.310, 330.400 and 330.500. In addition, persons who receive,
acquire, possess, use or transfer one or more calibration or reference sources
pursuant to these general licenses:
A) Shall not possess at any one time, at any one location of
storage or use, more than 185 kBq (5 µCi) of americium-241, 185 kBq (5 µCi) of
plutonium or 185 kBq (5 µCi) of radium-226 in such sources;
B) Shall not receive, possess, use or transfer such source unless
the source or the storage container bears a label that includes the following statement
or a statement that contains the information called for in this statement:
The receipt,
possession, use and transfer of this source, Model , Serial No. ,
are subject to a general license and the regulations of the U.S. Nuclear
Regulatory Commission or of a state with which the Commission has entered into
an agreement for the exercise of regulatory authority. Do not remove this
label.
CAUTION –
RADIOACTIVE MATERIAL – THIS SOURCE CONTAINS (AMERICIUM-241) (PLUTONIUM) (RADIUM-226).
DO NOT TOUCH RADIOACTIVE PORTION OF THIS SOURCE.
Name of Manufacturer or Importer
AGENCY NOTE:
Showing only the name of the appropriate material.
C) Shall not transfer, abandon or dispose of the source except by
transfer to a person authorized by a license from the Agency, NRC or an
Agreement State to receive the source;
D) Shall store the source, except when the source is being used,
in a closed container adequately designed and constructed to contain
americium-241, plutonium or radium-226 that might otherwise escape during
storage; and
E) Shall not use the source for any purpose other than the
calibration of radiation detectors or the standardization of other sources.
6) These general licenses do not authorize the manufacture,
import, or export of calibration or reference sources containing americium-241,
plutonium or radium-226.
e) General License for Use of Radioactive Material for Certain In
Vitro Clinical or Laboratory Testing
AGENCY NOTE:
The New Drug provisions of the Federal Food, Drug and Cosmetic Act also govern
the availability and use of any specific diagnostic drugs in interstate
commerce.
1) A general license is hereby issued to any physician,
veterinarian, clinical laboratory or hospital to receive, acquire, possess,
transfer or use, for any of the following stated tests, in accordance with the
provisions of subsections (e)(2) through (6), the following radioactive
materials in prepackaged units for use in in vitro clinical or laboratory tests
not involving internal or external administration of radioactive material, or
the radiation therefrom, to human beings or animals:
A) Carbon-14, in units not exceeding 370 kBq (10 µCi) each.
B) Cobalt-57, in units not exceeding 370 kBq (10 µCi) each.
C) Hydrogen-3 (tritium), in units not exceeding 1.85 MBq (50 µCi)
each.
D) Iodine-125, in units not exceeding 370 kBq (10 µCi) each.
E) Mock iodine-125 reference or calibration sources, in units not
exceeding 1.85 kBq (50 nCi) of iodine-129 and 185 Bq (5 nCi) of americium-241
each.
F) Iodine-131, in units not exceeding 370 kBq (10 µCi) each.
G) Iron-59, in units not exceeding 740 kBq (20 µCi) each.
H) Selenium-75, in units not exceeding 370 kBq (10 µCi) each.
2) No person shall receive, acquire, possess, use or transfer
radioactive material pursuant to the general license established by subsection
(e)(1) until he or she has filed the Agency form entitled "Certificate –
In Vitro Testing with Radioactive Material Under General License", with
the Agency and received from the Agency a validated copy of the form with
certification number assigned. No person shall transfer a validated copy of the
form to another person without prior written consent of the Agency. The
following information shall be furnished to the Agency on the form entitled
"Certificate – In Vitro Testing with Radioactive Material Under General
License":
A) Name and address of the physician, veterinarian, clinical
laboratory or hospital;
B) The location of use; and
C) A statement that the physician, veterinarian, clinical
laboratory or hospital has appropriate radiation measuring instruments to carry
out in vitro clinical or laboratory tests with radioactive material as
authorized under the general license in subsection (e)(1) and that the tests
will be performed only by personnel competent in the use of such instruments
and in the handling of the radioactive material.
3) A person who receives, acquires, possesses or uses radioactive
material pursuant to the general license established by subsection (e)(1) shall
comply with the following:
A) The general licensee shall not possess at any one time,
pursuant to the general license in subsection (e)(1), at any one location of
storage, or use a total amount of iodine-125, iodine-131, selenium‑75,
iron-59 and/or cobalt-57 in excess of 7.4 MBq (200 µCi).
B) The general licensee shall store the radioactive material,
until used, in the original shipping container or in a container providing
equivalent radiation protection.
C) The general licensee shall use the radioactive material only
for the uses authorized by subsection (e)(1).
D) The general licensee shall not transfer the radioactive
material to a person who is not authorized to receive it pursuant to a license
issued by the Agency, NRC or an Agreement State, nor transfer the radioactive
material in any manner other than in the unopened, labeled shipping container
as received from the supplier.
E) The general licensee shall dispose of the mock iodine-125
reference or calibration sources described in subsection (e)(1)(E) as required
by 32 Ill. Adm. Code 340.1010(a).
4) The general licensee shall not receive, acquire, possess or
use radioactive material pursuant to subsection (e)(1):
A) Except as prepackaged units that are labeled in accordance with
the provisions of an applicable specific license issued pursuant to Section
330.280(g) or in accordance with the provisions of a specific license issued by
NRC or an Agreement State that authorizes the manufacture and distribution of
iodine-125, iodine‑131, carbon-14, hydrogen-3 (tritium), iron-59,
selenium-75, cobalt‑57 or mock iodine-125 to persons generally licensed
under this subsection (e) or its equivalent; and
B) Unless one of the following statements, as appropriate, or a
statement that contains the information called for in one of the following
statements, appears on a label affixed to each prepackaged unit or appears in a
leaflet or brochure that accompanies the package:
This
radioactive material shall be received, acquired, possessed and used only by
physicians, veterinarians, clinical laboratories or hospitals and only for in
vitro clinical or laboratory tests not involving internal or external
administration of the material, or the radiation therefrom, to human beings or
animals. Its receipt, acquisition, possession, use and transfer are subject to
the regulations and a general license of the U.S. Nuclear Regulatory Commission
or of a state with which the Commission has entered into an agreement for the
exercise of regulatory authority.
Name of Manufacturer or
Importer
5) The physician, veterinarian, clinical laboratory or hospital
possessing or using radioactive material under the general license of
subsection (e)(1) shall report in writing to the Agency, any changes in the
information furnished by the licensee in the "Certificate – In Vitro
Testing with Radioactive Material Under General License", Agency Form
KLM.006. The report shall be furnished within 30 days after the effective date
of the change.
6) Any person using radioactive material pursuant to the general
license of subsection (e)(1) is exempt from the requirements of 32 Ill. Adm.
Code 400 and 340, with respect to byproduct materials covered by that general
license, except that such persons using the Mock Iodine-125 described in
subsection (e)(1)(E) shall comply with the provisions of Sections 340.1010,
340.1210, and 340.1220.
f) Ice Detection Devices
1) A general license is hereby issued to receive, acquire,
possess, use and transfer strontium-90 contained in ice detection devices,
provided each device contains not more than 1.85 MBq (50 µCi) of strontium-90
and each device has been manufactured or initially transferred in accordance
with a specific license issued by NRC or each device has been manufactured or
initially transferred in accordance with the specifications contained in a
specific license issued by the Agency or an Agreement State to the manufacturer
of the device pursuant to licensing requirements equivalent to those in 10 CFR
32.61.
2) Persons who receive, acquire, possess, use or transfer
strontium-90 contained in ice detection devices pursuant to the general license
in subsection (f)(1):
A) Shall, upon occurrence of visually observable damage, such as a
bend or crack or discoloration from overheating to the device, discontinue use
of the device until it has been inspected, tested for leakage or contamination
and repaired by a person holding a specific license from NRC or an Agreement
State to manufacture or service those devices; or shall dispose of the device
pursuant to the provisions of 32 Ill. Adm. Code 340.1010(a);
B) Shall assure that all labels affixed to the device at the time
of receipt, and that bear a statement that prohibits removal of the labels, are
maintained on the device; and
C) Are exempt from the requirements of 32 Ill. Adm. Code 340 and
400 except that such persons shall comply with the provisions of 32 Ill. Adm.
Code 340.1010(a), 340.1210, 340.1220 and 340.1260.
3) This general license does not authorize the manufacture,
assembly, disassembly, repair, or import of strontium-90 in ice detection
devices.
4) This general license is subject to the provisions of 32 Ill.
Adm. Code 310 and 341 and Sections 330.310, 330.400 and 330.500.
g) Certain Items and
Self-Luminous Products Containing Radium-226
1) A
general license is hereby issued to any person to acquire, receive, possess,
use or transfer, in accordance with the provisions of this subsection (g),
radium-226 contained in the following products manufactured prior to November
30, 2007:
A) Antiquities
originally intended for use by the general public. For the purposes of this
subsection (g)(1)(A), antiquities means products originally intended for use by
the general public and distributed in the late 19th and early 20th
centuries, such as radium emanator jars, revigators, radium water jars, radon generators,
refrigerator cards, radium bath salts and healing pads;
B) Intact
timepieces containing greater than 37 kBq (1 µCi), nonintact timepieces and
timepiece hands and dials no longer installed in timepieces;
C) Luminous items installed
in air, marine or land vehicles;
D) All
other luminous products, provided that no more than 100 items are used or
stored at the same location at any one time; and
E) Small
radium sources containing no more than 37 kBq (1 µCi) of radium-226. For the
purposes of this subsection (g)(1)(E), "small radium sources" means
discrete survey instrument check sources, sources contained in radiation
measuring instruments, sources such as cloud chambers and spinthariscopes used
in educational demonstrations, electron tubes, lightning rods, ionization sources,
static eliminators or sources otherwise designated by the Agency.
2) Any
person who acquires, receives, possesses, uses or transfers radioactive
material under the general license in subsection (g)(1) is exempt from the
provisions of 32 Ill. Adm. Code 340 and 400 to the extent that the receipt,
possession, use or transfer of radioactive material is within the terms of the
general license. This exemption does not apply to any person specifically
licensed under this Part.
3) Any
person who acquires, receives, possesses, uses or transfers radioactive
material in accordance with the general license in subsection (g)(1):
A) Shall
notify the Agency within 30 days if there is any indication of possible damage
to a product that could result in loss of radioactive material. The report
shall provide a brief description of the event and the remedial action taken;
B) Shall
not abandon a product containing radium-226. The product and any radioactive
material from the product shall only be disposed of in accordance with
subsection (g)(3)(D);
C) Shall
not export a product containing radium-226, except in accordance with 10 CFR
110, published at 73 Fed. Reg. 78615, December 23, 2008, exclusive of
subsequent amendments or editions; and
D) Shall
dispose of a product containing radium-226 only in accordance with 32 Ill. Adm.
Code 340.1010(a), or by transfer to a person specifically licensed under this
Part to receive the radium-226 in the product, or as otherwise approved by the
Agency in writing.
4) The
general license in subsection (g)(1) does not authorize the manufacture,
assembly, disassembly, repair or import of a product containing radium-226,
except that timepieces may be disassembled and repaired.
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
SUBPART C: SPECIFIC AND GENERAL LICENSES
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.240 FILING APPLICATIONS FOR SPECIFIC LICENSES
Section 330.240 Filing
Applications for Specific Licenses
a) Application requirements:
1) Applications for the issuance, renewal or amendment of
specific licenses shall be submitted in English.
AGENCY NOTE:
Applications involving Agency evaluation of a sealed source or device
containing radioactive material shall be in accordance with the requirements of
this Section.
2) Applications for initial issuance, amendment and renewal of specific licenses shall be in the format prescribed by the
Agency. Each application filed shall be complete with all requested
information submitted, including all applicable attachments. The Agency may at
any time after the filing of the original application, and before the
expiration or termination of the license, require further statements from the
applicant or licensee to enable the Agency to determine whether the application
should be granted or denied or whether an existing license should be modified
or revoked in accordance with Section 330.500.
3) Each application shall include all information required by
this Part and any other Parts of 32 Ill. Adm. Code: Chapter II, Subchapters b
and d, applicable to the requested authorizations.
4) An application may incorporate by reference information
contained in previous applications, statements or reports filed with the
Agency, provided the references are clear and specific.
5) Each application and each request for amendment shall be
signed by the applicant, licensee, or a person duly authorized in writing to
act for and on the licensee or applicant's behalf.
6) Each
application shall identify the Radiation Safety Officer. The proposed
activities shall be under the same administrative control for radiation safety
purposes and the same radiation protection program.
7) An application may request authority to receive, possess,
utilize, manufacture, distribute, transfer, own or acquire radioactive material
or devices or equipment utilizing or producing radioactive materials. The
request can include one or more of these activities.
8) An application for a specific license to authorize receipt,
possession or use of radioactive material in the form of a sealed source or in
a device that contains a sealed source:
A) Shall identify the sealed source or device that contains a
sealed source by manufacturer and model as registered with the U.S. Nuclear
Regulatory Commission under 10 CFR 32.210, or with an Agreement State or, for a
source or device containing naturally occurring or accelerator-produced
material, with a state under provisions comparable to 10 CFR 32.210; or
B) Shall contain the information identified in Section
330.280(m); or
C) Shall
describe, for a sealed source or device containing radioactive material
manufactured prior to October 23, 2015, that is not registered with NRC in
accordance with 10 CFR 32.210 or with an Agreement State and for which the
applicant is unable to provide the information described in Section
330.280(m)(3):
i) The
information required by Section 330.280(m)(3) concerning the source and, if
applicable, the device; and
ii) Sufficient
additional information to demonstrate that the radiation safety properties of
the source or device are adequate to protect health and minimize danger to life
and property. The information shall include a description of the source or
device, a description of radiation safety features, the intended use and
associated operating experience, and the results of a recent leak test; or
D) For
sealed sources and devices allowed to be distributed without
registration of safety information
in accordance with Section 330.280(m)(7), may describe only the manufacturer,
model number, radionuclide and quantity; or
E) If it
is not feasible to identify each sealed source and device individually, may
propose constraints on the number and type of sealed sources and devices to be
used and the conditions under which they will be used, in lieu of identifying
each sealed source and device.
9) For
each location to be listed on the license as an authorized use location, the
applicant shall submit:
A) A statement that the applicant owns the facility where
radioactive material is used or stored; or
B) A signed acknowledgement from the facility owner or
authorized representative of the owner that the owner is aware radioactive
material is being or will be used or stored at the facility; or
C) A copy of a letter or statement from the facility owner or
authorized representative of the owner indicating that the owner is aware that
radioactive material is being used or will be used or stored at the facility.
AGENCY NOTE: Subsection
10(11) of the Radiation Protection Act of 1990, 420 ILCS 40, requires the
Agency to provide written notice of an application for a new license for a
fixed location facility or a license amendment for a new location for a
facility to the municipality, or county where appropriate, where the facility
is located.
10) The
applicant shall ensure that all applicable fees specified in 32 Ill. Adm. Code
331 are paid in full when due.
11) The applicant
shall address the Emergency Plan requirements of Section 330.250(e), when
applicable.
b) Review
of application or amendment request. When evaluating an application or an
amendment request, the Agency shall consider:
1) The completeness of the application or amendment request;
2) The complexity, similarity and proximity of the proposed
activities;
3) The
radiation protection program proposed by the applicant to ensure the protection
of the licensee's personnel, the public and the environment;
4) The
qualifications and experience of the applicant's proposed Radiation Safety
Officer and authorized users; and
5) The applicant's history of compliance.
c) Public access to information. Public inspection of
applications and other documents submitted to the Agency pursuant to this
Section shall be in accordance with 2 Ill. Adm. Code 1800 and the requirements
of the Freedom of Information Act [5 ILCS 140].
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.250 GENERAL REQUIREMENTS FOR THE ISSUANCE OF SPECIFIC LICENSES
Section 330.250 General
Requirements for the Issuance of Specific Licenses
a) A license application or a request for an amendment to an
existing license will be approved only if the Agency determines that:
1) The applicant's Radiation Safety Officer and authorized users
are qualified by reason of training and experience to use the material in
question for the purpose requested in such a manner as to minimize danger to
health and safety or property;
2) The applicant's proposed equipment, facilities and procedures
are adequate to minimize danger to health and safety or property;
3) The issuance of the license will not be inimical to the health
and safety of the public; and
4) The applicant satisfies any applicable special requirements in
32 Ill. Adm. Code: Chapter II, Subchapters b and d.
b) Environmental Report, Commencement of Construction
1) In the case of an application for a license to receive and
possess radioactive material for commercial waste disposal by land burial, or
for the conduct of any other activity the Agency determines will significantly
affect the quality of the environment, a license application shall be reviewed
and approved by the Agency before commencement of construction of the plant or
facility in which the activity will be conducted. If the Agency, after
considering the environmental, economic, technical and other benefits in
comparison with the environmental costs and available alternatives, concludes
that the action called for is the issuance of the proposed license, with any
appropriate conditions to protect environmental values, it shall issue the
license;
2) Commencement of construction prior to the Agency reaching the conclusion
required by subsection (b)(1) shall be grounds for denial of a license to
receive and possess radioactive material in the plant or facility. As used in
this subsection (b), "commencement of construction" is defined in 32
Ill. Adm. Code 310.20.
c) Licensees must satisfy applicable financial assurance
requirements specified in 32 Ill. Adm. Code 326.
d) Long-Term Care Requirements
1) A license application will be approved only if the Agency
determines that a long-term care fund for monitoring and maintenance has been
established by the waste handling applicant prior to the issuance of the
license; or
2) The waste handling applicants may choose, at the time of the
licensure, to provide a financial surety arrangement in lieu of a long-term
care fund.
AGENCY NOTE:
Long-term care funding may also be required for former U.S. Atomic Energy
Commission or U.S. Nuclear Regulatory Commission licensed facilities, or
persons whose activities cause situations that significantly affect health and
safety, or the environment by reason of exposure to radiation or radioactive
materials.
e) Emergency Plan
1) Except as exempted by subsection (e)(2), each application to
possess radioactive materials in excess of the quantities in Appendix C in
unsealed form or sealed in glass or on foils or plated sources shall contain
either:
A) An evaluation showing that the maximum dose to an individual
offsite due to a release of radioactive materials would not exceed 10 mSv (1
rem) total effective dose equivalent or 50 mSv (5 rem) effective dose
equivalent to the thyroid; or
B) An emergency plan, as described in Section 330.290, for
responding to a release of radioactive material.
2) The requirements of this subsection (e) do not apply to
licensees that possess only radioactive waste packaged in Type B containers.
3) In evaluating the maximum dose to an individual pursuant to subsection
(e)(1)(A), the applicant may take into account whether:
A) The radioactive material is physically separated so that only a
portion could be involved in an accident;
B) All or part of the radioactive material is not subject to
release during an accident due to the method of storage or packaging;
C) The release fraction in the respirable size range is predicted
to be lower than the release fraction shown in Appendix C due to the chemical
or physical form of the material;
D) The solubility of the radioactive material is predicted to
reduce the dose received;
E) Facility design or engineered safety features in the facility
are predicted to cause the release fraction to be lower than shown in Appendix
C; or
F) Operating restrictions or procedures are predicted to prevent
a release fraction as large or larger than that shown in Appendix C.
(Source: Amended at 38 Ill.
Reg. 21451, effective October 31, 2014)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.260 SPECIAL REQUIREMENTS FOR ISSUANCE OF CERTAIN SPECIFIC LICENSES FOR RADIOACTIVE MATERIALS
Section 330.260 Special
Requirements for Issuance of Certain Specific Licenses for Radioactive
Materials
a) Specific Licenses to Medical Institutions for Human Use of
Radioactive Material. A specific license allowing a medical institution to use
radioactive material for medical diagnosis, medical therapy, or medical
research involving humans shall be issued only if the applicant has met the
requirements of this Part and 32 Ill. Adm. Code 335.
b) Specific Licenses to Individual Physicians for Human Use of
Radioactive Material. An application by an individual physician or group of
physicians for a specific license for human use of radioactive material shall
be approved only if:
1) The applicant satisfies the general requirements specified in
this Part;
2) The application is for use in the applicant's practice in an
office outside a medical institution; and
3) The applicant has met the requirements of 32 Ill. Adm. Code
335.
c) Specific Licenses for Distribution or Transfer of
Radiopharmaceuticals. In addition to the requirements set forth in this Part,
persons licensed by the Agency for manufacture, preparation, or transfer for
commercial distribution of radiopharmaceuticals containing radioactive material
for medical use under 32 Ill. Adm. Code 335 shall meet the following additional
requirements:
1) The
applicant satisfies the general requirements specified in Section 330.250;
2) The
applicant submits evidence that the applicant is at least one of the following:
A) Compliant
with the U.S. Food and Drug Administration (FDA) registration requirements as
the owner or operator of a drug establishment that engages in the manufacture,
preparation, propagation, compounding, or processing of a drug under 21 CFR
Part 207;
B) Registered
or licensed with a state agency as a drug manufacturer;
C) Licensed
as a pharmacy by a state Board of Pharmacy;
D) Operating
as a nuclear pharmacy within a federal medical institution; or
E) A PET
drug production facility registered with a state agency;
3) The
applicant submits information showing that:
A) The radiopharmaceutical containing radioactive material will
be manufactured, labeled and packaged in accordance with the federal Food,
Drug, and Cosmetic Act, 21 U.S.C. 301-392 or the federal Public Health Service
Act, 42 U.S.C. 201-291; or
B) The manufacture and distribution of the radiopharmaceutical
containing radioactive material is not subject to the federal Food, Drug, and
Cosmetic Act and the federal Public Health Service Act;
4) The applicant submits information on the radionuclide; the
chemical and physical form; the maximum activity per vial, syringe, generator,
or other container of the radioactive drug; and the shielding provided by the
packaging to show it is appropriate for the safe handling and storage of the
radioactive drugs by medical use licensees;
5) The
applicant commits to the following labeling requirements:
A) A
label is affixed to each transport radiation shield, whether it is constructed
of lead, glass, plastic, or other material, of a radioactive drug to be
transferred for commercial distribution. The label shall include the radiation
symbol and the words "CAUTION, RADIOACTIVE MATERIAL" or "DANGER,
RADIOACTIVE MATERIAL"; the name of the radioactive drug or its
abbreviation; and the quantity of radioactivity at a specified date and time. For
radioactive drugs with a half-life greater than 100 days, the time may be
omitted.
B) A
label is affixed to each syringe, vial, or other container used to hold a
radioactive drug to be transferred for commercial distribution. The label shall
include the radiation symbol and the words "CAUTION, RADIOACTIVE
MATERIAL" or "DANGER, RADIOACTIVE MATERIAL" and an identifier
that ensures that the syringe, vial, or other container can be correlated with
the information on the transport radiation shield label;
6) A
licensee described by subsection (c)(2)(C) or (D):
A) May
prepare radioactive drugs for medical use, as defined in 32 Ill. Adm. Code
335.20, provided that the radioactive drug is prepared by either an authorized
nuclear pharmacist, as specified in subsections (c)(6)(B) and (C), or an
individual under the supervision of an authorized nuclear pharmacist as
specified in subsection (c)(15).
B) May
allow a pharmacist to work as an authorized nuclear pharmacist if the following
conditions are met:
i) The
individual qualifies as an authorized nuclear pharmacist as defined in Section 330.20;
ii) The
individual meets the requirements specified in subsections (c)(18)(B) and
(c)(21), and the licensee has received an approved license amendment
identifying the individual as an authorized nuclear pharmacist; or
iii) The
individual is designated as an authorized nuclear pharmacist in accordance with
subsection (c)(6)(C).
C) May
designate a pharmacist (as defined in 32 Ill. Adm. Code 310.20) as an
authorized nuclear pharmacist if:
i) The
individual was a nuclear pharmacist preparing only radioactive drugs containing
accelerator-produced radioactive material; and
ii) The
individual practiced at a pharmacy at a government agency or federally
recognized Indian Tribe before November 30, 2007 or at all other pharmacies
before August 8, 2009, or an earlier date as noticed by the U.S. Nuclear
Regulatory Commission.
D) Shall
provide to the Agency, no later than 30 days after the date a licensee allows
an individual to work as an authorized nuclear pharmacist under subsections
(c)(6)(B)(i), (c)(6)(B) (iii) or (c)(6)(C), a copy of the individual's State of
Illinois pharmacist license and:
i) A
copy of each individual's certification by a specialty board whose
certification process has been recognized by the U.S. Nuclear Regulatory
Commission or an Agreement State as specified in subsection (c)(18)(A); or
ii) U.S.
Nuclear Regulatory Commission or Agreement State license listing the individual
as an authorized nuclear pharmacist; or
iii) A
U.S. Nuclear Regulatory Commission master materials licensee permit listing the
individual as an authorized nuclear pharmacist; or
iv) A
permit issued by a licensee or U.S. Nuclear Regulatory Commission master material
permittee of broad scope or authorization from a commercial nuclear pharmacy
authorized to list its own authorized nuclear pharmacist; or
v) Documentation
that only accelerator-produced radioactive materials were used in the practice
of nuclear pharmacy at a government agency or federally recognized Indian Tribe
before November 30, 2007 or at all other locations of use before August 8,
2009, or an earlier date as noticed by the U.S. Nuclear Regulatory Commission;
E) Shall
provide notification to the Agency no later than 30 days after an authorized
user or an authorized nuclear pharmacist permanently discontinues performance
of duties under the license or has a name change;
7) A
licensee shall possess and use instrumentation to measure the radioactivity of
radioactive drugs. The licensee shall have procedures for use of the
instrumentation. The licensee shall measure, by direct measurement or by
combination of measurements and calculations, the amount of radioactivity in
dosages of alpha-, beta-, or photon-emitting radioactive drugs prior to
transfer for commercial distribution. In addition, the licensee shall:
A) Perform
tests, before initial use, periodically, and following repair, on each
instrument for accuracy, linearity, and geometry dependence as appropriate for
the use of the instrument and make adjustments when necessary; and
B) Check
each instrument for constancy and proper operation at the beginning of each day
of use;
8) Nothing
in this Section relieves the licensee from complying with applicable FDA or
other federal or State requirements governing radioactive drugs;
9) Radiopharmaceuticals
dispensed, distributed or transferred for human use shall be either:
A) Repackaged
from prepared radiopharmaceuticals that have been approved by the FDA for
medical use as defined in 32 Ill. Adm. Code 335.20; or
B) Prepared
from generators and reagent kits that have been approved by the FDA for medical
use, or are subject to the Illinois Food, Drug and Cosmetic Act [410 ILCS 620]
or the Pharmacy Practice Act of 1987 [225 ILCS 85];
10) Each
licensee preparing technetium-99m radiopharmaceuticals from
molybdenum-99/technetium-99m generators or rubidium-82 from strontium-82/rubidium-82
generators shall test the generator eluates for molybdenum-99 breakthrough or
strontium-82 and strontium-85 contamination, respectively, in accordance with 32
Ill. Adm. Code 335.4020. The licensee shall record the results of each test
and retain each record for three years after the record is made. The licensee
shall report the results of any test that exceeds the permissible concentration
listed in Section 335.4020(a) at the time of generator elution, in accordance
with Section 335.4020(d);
11) The
licensee may distribute in vitro test kits to customers but shall neither
remove any package insert nor violate the packaging;
12) The
licensee shall report to the Agency, within 10 days after occurrence, any
irregularities pertaining to identification, labeling, quality or assay of any radiopharmaceuticals
received under the authority of this license;
13) A
licensee such as a nuclear pharmacy that is authorized to distribute
radiopharmaceuticals shall ensure that radiopharmaceuticals are dispensed only
under the prescription of a physician who is authorized by 32 Ill. Adm. Code
335 to use the radiopharmaceuticals. The licensee shall verify that the
physician is authorized to receive the prescribed radiopharmaceutical prior to
transfer;
AGENCY NOTE: In accordance with
32 Ill. Adm. Code 335.40(b), licensees authorized for medical use of
radiopharmaceuticals may permit work as an authorized user in limited
circumstances without first obtaining an amendment. Therefore, possession of
the recipient's latest radioactive material license may not list all authorized
users.
14) A
licensee shall apply for and shall receive a license amendment before it
receives, prepares or uses radioactive material for a type of use that is
permitted under this Part but that is not authorized on the licensee's current
license issued under this Part;
15) Individuals
Under Supervision of an Authorized Nuclear Pharmacist
A) A
licensee that permits the preparation of radioactive material for medical use
by an individual under the supervision of an authorized nuclear pharmacist as
allowed by 32 Ill. Adm. Code 335.30(b)(2) shall:
i) In
addition to the requirements in 32 Ill. Adm. Code 400.120, instruct the
supervised individual in the preparation of radiopharmaceutical material for
medical use as appropriate to that individual's involvement with radioactive
material; and
ii) Require
the supervised individual to follow the instructions of the supervising
authorized user or authorized nuclear pharmacist regarding the preparation of
radioactive material for medical use, written radiation protection procedures
established by the licensee, the regulations of this Section, and license
conditions.
B) A
licensee that permits supervised activities under this subsection (c)(15) is
responsible for the acts and omissions of the supervised individual;
16) Authority
and responsibilities for the radiation protection program.
A) In
addition to the radiation protection program requirements in 32 Ill. Adm. Code
340.110, a licensee's management shall approve in writing:
i) Requests
for a license application, renewal, or amendment before submittal to the
Agency;
ii) Any
individual before allowing that individual to work as an authorized nuclear
pharmacist; and
iii) Radiation
protection program changes that do not require a license amendment.
B) A
licensee's management shall appoint a Radiation Safety Officer who agrees, in
writing, to be responsible for implementing the radiation protection program. The
licensee, through the Radiation Safety Officer, shall ensure that radiation
safety activities are being performed in accordance with licensee-approved
procedures and regulatory requirements. A licensee's management may appoint, in
writing, one or more Associate Radiation Safety Officers to support the
Radiation Safety Officer. The Radiation Safety Officer, with written agreement
of the licensee's management, must assign the specific duties and tasks to each
Associate Radiation Safety Officer. These duties and tasks are restricted to
the types of use for which the Associate Radiation Safety Officer is listed on
a license. The Radiation Safety Officer may delegate duties and tasks to the
Associate Radiation Safety Officer but shall not delegate the authority or
responsibilities for implementing the radiation protection program.
C) For up
to 60 days each year, a licensee may permit an individual qualified to be a
Radiation Safety Officer, under subsections (c)(17) and (c)(21), to function as
a temporary Radiation Safety Officer and to perform the functions of a
Radiation Safety Officer, as provided in subsection (c)(16)(E), if the licensee
takes the actions required in subsections (c)(16)(B), (D), (E), and (F) and
notifies the Agency no later than 30 days after allowing the individual to
function as a temporary Radiation Safety Officer.
D) A
licensee shall establish the authority, duties, and responsibilities of the
Radiation Safety Officer in writing.
E) A
licensee shall provide the Radiation Safety Officer sufficient authority,
organizational freedom, time, resources, and management prerogative, to:
i) Identify
radiation safety problems;
ii) Initiate,
recommend or provide corrective actions;
iii) Stop
unsafe operations; and
iv) Verify
implementation of corrective actions.
F) A
licensee shall retain a record of actions taken under subsections (c)(16)(A),
(B), and (D) as follows:
i) A
licensee shall retain a record of actions taken by the licensee's management in
accordance with subsection (c)(16)(A) for five years. The record must include a
summary of the actions taken and a signature of licensee management.
ii) The
licensee shall retain a copy of both authority, duties, and responsibilities of
the Radiation Safety Officer as required by subsection (c)(16)(E), and a signed
copy of each Radiation Safety Officer's agreement to be responsible for
implementing the radiation safety program, as required by subsection
(c)(16)(B), for the duration of the license. The records must include the
signature of the Radiation Safety Officer and licensee management.
iii) For
each Associate Radiation Safety Officer appointed under subsection (c)(16)(B),
the licensee shall retain, for five years after the Associate Radiation Safety
Officer is removed from the license, a copy of the written document appointing
the Associate Radiation Safety Officer signed by the licensee's management.
17) Training
for Radiation Safety Officer and Associate Radiation Safety Officer. Except as
provided in subsection (c)(20), the licensee shall require an individual
fulfilling the responsibilities of Radiation Safety Officer, or an individual
assigned duties and tasks as an Associate Radiation Safety Officer provided in
subsection (c)(16), at a nuclear pharmacy to be an individual who:
A) Is
certified by a specialty board whose certification process has been recognized
by the Agency, the U.S. Nuclear Regulatory Commission or an Agreement State and
who meets the requirements in subsection (c)(17)(D). To have its certification
process recognized, a specialty board shall require all candidates for
certification to:
i) Hold
a bachelor's or graduate degree from an accredited college or university in
physical science, engineering or biological science with a minimum of 20
college credits in physical science; and
• Have
five or more years of professional experience in health physics (graduate
training may be substituted for no more than two years of the required
experience), including at least three years in applied health physics; and
• Pass
an examination administered by diplomates of the specialty board that evaluates
knowledge and competence in radiation physics and instrumentation, radiation
protection, mathematics pertaining to the use and measurement of radioactivity,
radiation biology and radiation dosimetry; or
AGENCY NOTE: Specialty boards
whose certification processes have been recognized by the Agency, the U.S.
Nuclear Regulatory Commission or an Agreement State will be posted on the NRC's
website.
ii) Hold
a master's or doctor's degree in physics, medical physics, or other physical
science, engineering, or applied mathematics from an accredited college or
university;
• Have
two years of full-time practical training or supervised experience in medical
physics under the supervision of a medical physicist who is certified in
medical physics by a specialty board recognized by the Agency, the U.S. Nuclear
Regulatory Commission, or an Agreement State or in clinical nuclear medicine
facilities providing diagnostic or therapeutic services under the direction of
physicians who meet the requirements for authorized users in Section 335.9160,
335.9040, or 335.9050; and
• Pass
an examination, administered by diplomates of the specialty board, that
assesses knowledge and competence in clinical diagnostic radiological or
nuclear medicine physics and in radiation safety; or
B) Has
completed a structured educational program consisting of:
i) 200
hours of classroom and laboratory training in the following areas: radiation
physics and instrumentation, radiation protection, mathematics pertaining to
the use and measurement of radioactivity, radiation biology and radiation
dosimetry;
ii) One
year of full-time radiation safety experience under the supervision of the
individual identified as the Radiation Safety Officer on an Agency, U.S.
Nuclear Regulatory Commission, or Agreement State license or a permit issued by
a U.S. Nuclear Regulatory Commission master material licensee that authorizes
similar types and uses of radioactive material. An Associate Radiation Safety
Officer may provide supervision for those areas for which the Associate
Radiation Safety Officer is authorized on a U.S. Nuclear Regulatory Commission
or an Agreement State license or permit issued by a U.S. Nuclear Regulatory
Commission master material licensee. The full-time radiation safety experience
shall involve the following:
• Shipping,
receiving and performing related radiation surveys;
• Using
and performing checks for proper operation of instruments used to determine the
activity of dosages, survey meters, and instruments used to measure
radionuclides;
• Securing
and controlling radioactive material;
• Using
administrative controls to avoid mistakes in the administration of radioactive
material;
• Using
procedures to prevent or minimize radioactive contamination and using proper
decontamination procedures;
• Using
emergency procedures to control radioactive material; and
• Disposing
of radioactive material; and
iii) Written
attestation, signed by a preceptor Radiation Safety Officer or Associate
Radiation Safety Officer who has experience with the radiation safety aspects
of similar types of use of byproduct material for which the individual is
seeking approval as a Radiation Safety Officer. The written attestation must
state that the individual has satisfactorily completed the requirements in
subsections (c)(17)(B)(i), (B)(ii) and (D), and is able to independently
fulfill the radiation safety-related duties as a Radiation Safety Officer or
Associate Radiation Safety Officer for a nuclear pharmacy license; or
C) Meets
the training requirements in subsection (c)(17)(D); and
i) Is a
medical physicist who has been certified by a specialty board whose
certification process has been recognized by the Agency, the U.S. Nuclear
Regulatory Commission, or an Agreement State under 32 Ill. Adm. Code
335.9150(a), has experience with the radiation safety aspects of similar types
of use of radioactive material for which the licensee seeks the approval of the
individual as Radiation Safety Officer or an Associate Radiation Safety
Officer; or
ii) Is
an authorized nuclear pharmacist identified on a specific nuclear pharmacy
license issued by the Agency, the U.S. Nuclear Regulatory Commission, or an
Agreement State; a nuclear pharmacy use permit issued by a U.S. Nuclear
Regulatory Commission master material licensee; a permit issued by a U.S.
Nuclear Regulatory Commission or an Agreement State broad scope medical use
licensee; or a permit issued by a U.S. Nuclear Regulatory Commission master
material license broad scope medical use permittee; and has experience with the
radiation safety aspects of similar types of use of radioactive material for
which the licensee seeks the approval of the individual as the Radiation Safety
Officer or Associate Radiation Safety Officer; or
iii) Has
experience with the radiation safety aspects of the types of use of radioactive
material for which the individual is seeking simultaneous approval both as the
Radiation Safety Officer and the authorized user on the same new nuclear
pharmacy license.
D) Has
training in the radiation safety, regulatory issues, and emergency procedures
for the types of use for which a licensee seeks approval. This training
requirement may be satisfied by completing training that is supervised by a
Radiation Safety Officer, Associate Radiation Safety Officer, or authorized
nuclear pharmacist, as appropriate, who is authorized for the types of use for
which the licensee is seeking approval.
18) Training
for an authorized nuclear pharmacist. Except as provided in subsection
(c)(19), the licensee shall require the authorized nuclear pharmacist to be a
State of Illinois licensed pharmacist who:
A) Is
certified as a nuclear pharmacist by a specialty board whose certification
process has been recognized by the U.S. Nuclear Regulatory Commission or an
Agreement State. To be recognized, a specialty board shall require a candidate
for certification to:
i) Graduate
from a pharmacy program accredited by the Accreditation Council for Pharmacy
Education (ACPE) (previously named the American Council of Pharmaceutical Education)
or pass the Foreign Pharmacy Graduate Examination Committee (FPGEC)
examination;
ii) Hold a current,
active license to practice pharmacy;
iii) Provide
evidence of having acquired at least 4000 hours of training/experience in
nuclear pharmacy practice. Academic training may be substituted for no more
than 2,000 hours of the required training and experience; and
iv) Pass
an examination in nuclear pharmacy, administered by diplomate of the specialty
board, that evaluates knowledge and competency in procurement, compounding,
quality assurance, dispensing, distribution, health and safety, radiation
safety, provision of information and consultation, monitoring patient outcomes,
research, and development; or
B) Has
completed 700 hours in a structured educational program consisting of:
i) 200
hours of classroom and laboratory training in radiation physics and
instrumentation, radiation protection, mathematics pertaining to the use and
measurement of radioactivity, chemistry of radioactive material for medical use
and, radiation biology; and
ii) Supervised
practical experience in a nuclear pharmacy involving shipping, receiving and
performing related radiation surveys; using and performing checks for proper
operation of instruments used to determine the activity of dosages, survey
meters and, if appropriate, instruments used to measure alpha- or beta-emitting
radionuclides; calculating, assaying and safely preparing dosages for patients
or human research subjects; use of administrative controls to avoid medical
events in the administration of radioactive material; use of procedures to
prevent or minimize radioactive contamination and use of proper decontamination
procedures; and
iii) Has
obtained written attestation, signed by a preceptor authorized nuclear
pharmacist, that the individual has satisfactorily completed the requirements
in subsections (c)(18)(B)(i) and (ii) and is able to independently fulfill the
radiation safety-related duties as an authorized nuclear pharmacist;
19) An
individual identified as an authorized nuclear pharmacist on an Agency, U.S.
Nuclear Regulatory Commission, or Agreement State license or a permit issued by
an Agency, U.S. Nuclear Regulatory Commission or Agreement State broad scope
licensee or master materials license permit or by a master materials license
permittee of broad scope on or before January 14, 2022 need not comply with the
training requirements in subsection (c)(18);
20) Training
for Experienced Radiation Safety Officer, nuclear pharmacist, or authorized
nuclear pharmacist.
A) An
individual identified on an Agency, U.S. Nuclear Regulatory Commission, or an
Agreement State license or a permit issued by an Agency, U.S. Nuclear
Regulatory Commission, or an Agreement State broad scope licensee or master
material license permit or by a master material license permittee of broad
scope as a Radiation Safety Officer, a nuclear pharmacist or an authorized
nuclear pharmacist on or before January 14, 2022, need not comply with the
training requirements of 32 Ill. Adm. Code 335.9010, 335.9150, or subsection (c)(18),
respectively, except the Radiation Safety Officers identified in this
subsection shall meet the training requirements in 32 Ill. Adm. Code
335.9010(e) or 335.9150(d) for any material or uses for which they were not
authorized prior to this date.
B) Any
individual certified by the American Board of Health Physics in Comprehensive
Health Physics, American Board of Radiology, American Board of Nuclear
Medicine, American Board of Science in Nuclear Medicine, Board of
Pharmaceutical Specialties in Nuclear Pharmacy, American Board of Medical
Physics in radiation oncology physics, Royal College of Physicians and Surgeons
of Canada in nuclear medicine, American Osteopathic Board of Radiology, or
American Osteopathic Board of Nuclear Medicine on or before October 24, 2005,
need not comply with the training requirements of subsection (c)(17) to be
identified as a Radiation Safety Officer or as an Associate Radiation Safety
Officer on an Agency license for those materials and uses that these
individuals performed on or before October 24, 2005.
C) A
Radiation Safety Officer or a nuclear pharmacist, who used only
accelerator-produced radioactive materials, discrete sources of radium-226, or
both, for medical uses or in the practice of nuclear pharmacy at a government
agency or federally recognized Indian tribe before November 30, 2007, or at all
other locations of use before August 8, 2009, or an earlier date as recognized
by NRC, need not comply with the training requirements of subsection (c)(17) or
(c)(18), respectively, when performing the same uses. A nuclear pharmacist,
who only prepared radioactive drugs containing accelerator-produced radioactive
material at the locations and during the time period identified in this
subsection, qualifies as an authorized nuclear pharmacist for those materials
and uses performed before these dates, for the purposes of this Section.
D) Individuals
who need not comply with training requirements as described in this Section may
serve as preceptors for, and supervisors of, applicants seeking authorization
on Agency licenses for the same uses for which these individuals are
authorized.
21) Recentness
of Training. The training and experience specified in subsections (c)(17) and
(c)(18) shall have been obtained within the seven years preceding the date of
application or the individual shall have had related continuing education and
experience since the required training and experience was completed;
22) Resolution
of Conflicting Requirements During Transition Period. If this Part conflicts
with the licensee's radiation safety program as identified in its license, this
Part shall apply unless the statements, representations, conditions and
procedures in the license are more restrictive. However, if the licensee
exercises its privilege to amend its license, the portion amended must comply
with the requirements of this Part.
23) Licensing
the production of PET radioactive drugs for noncommercial distribution within a
consortium. An application from a medical facility or educational institution
to produce PET radioactive drugs for noncommercial distribution within its
consortium for use under 32 Ill. Adm. Code 335 or equivalent regulations of the
U.S. Nuclear Regulatory Commission or an Agreement State shall include:
A) A
request for authorization to produce PET radionuclides or evidence of an
existing license issued under this Part or equivalent regulations of the U.S.
Nuclear Regulatory Commission or an Agreement State; and
B) Evidence
that the applicant is qualified to produce radioactive drugs for medical use by
meeting one of the criteria in subsection (c)(2); and
C) If the
applicant is a nuclear pharmacy:
i) Verification
that the applicant satisfies the requirements of this Section that apply to
nuclear pharmacies; and
ii) Identification
of each individual authorized to prepare the PET radioactive drugs and documentation
that each meets the requirements of an authorized nuclear pharmacist; and
D) The
information required by subsection (c)(4) for each PET radioactive drug to be
noncommercially distributed within the consortium; and
E) Verification
that the applicant is in compliance with:
i) Applicable
FDA and other Federal and State requirements governing radioactive drugs; and
ii) The
labeling requirements of subsection (c)(5) for each PET radioactive drug
transport radiation shield and each syringe, vial or other container used to
hold a PET radioactive drug intended for noncommercial distribution to members
of its consortium; and
iii) The
requirements of subsections (c)(7), (12), (13), (14), (17), and (22).
AGENCY NOTE: Subsection (c)(7)
contains requirements for measuring the radioactivity of radioactive drugs.
24) A
licensee shall satisfy the labeling requirements in subsection (c)(5).
d) Use
of Sealed Sources in Industrial Radiography. A specific license for use of
sealed sources in industrial radiography shall be issued only if the applicant
has met the requirements of this Part and 32 Ill. Adm. Code 350 and 405.
e) Use of Radioactive Materials in Wireline Service Operations
and Subsurface Tracer Studies. A specific license for use of radioactive
material in wireline operations shall be issued only if the applicant has met
the requirements of this Part and 32 Ill. Adm. Code 351.
AGENCY NOTE: Specialty boards
whose certification processes have been recognized by the Agency, the U.S.
Nuclear Regulatory Commission or an Agreement State will be posted on NRC's website.
(Source: Amended at 48 Ill.
Reg. 13634, effective August 29, 2024)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.270 SPECIAL REQUIREMENTS FOR SPECIFIC LICENSES OF BROAD SCOPE
Section 330.270 Special
Requirements for Specific Licenses of Broad Scope
This Section prescribes
requirements for the issuance of specific licenses of broad scope for
radioactive material and certain regulations governing holders of those
licenses.
AGENCY NOTE: Authority to
transfer possession or control by the manufacturer, processor or producer of
any equipment, device, commodity or other product containing byproduct material
whose subsequent possession, use, transfer and disposal by all other persons
are exempted from regulatory requirements may be obtained only from the U.S.
Nuclear Regulatory Commission, Washington, D.C. 20555.
a) The different types of broad scope licenses are:
1) A "Type A specific license of broad scope" is a
specific license authorizing receipt, acquisition, ownership, possession, use
and transfer of any chemical or physical form of the radioactive material
specified in the license, but not exceeding quantities specified in the
license, for any authorized purpose. The quantities specified are usually in
multiples of gigabecquerels or curies.
2) A "Type B specific license of broad scope" is a
specific license authorizing receipt, acquisition, ownership, possession, use
and transfer of any chemical or physical form of radioactive material specified
in Appendix D, for any authorized purpose. The possession limit for a Type B
license of broad scope, if only one radionuclide is possessed thereunder, is
the quantity specified for that radionuclide in Column I of Appendix D. If two
or more radionuclides are possessed thereunder, the possession limit for each
is determined as follows: For each radionuclide, determine the ratio of the
quantity possessed to the applicable quantity specified in Column I of Appendix
D for that radionuclide. The sum of the ratios for all radionuclides possessed
under the license shall not exceed unity.
3) A "Type C specific license of broad scope" is a
specific license authorizing receipt, acquisition, ownership, possession, use
and transfer of any chemical or physical form of radioactive material specified
in Appendix D, for any authorized purpose. The possession limit for a Type C
license of broad scope, if only one radionuclide is possessed thereunder, is
the quantity specified for that radionuclide in Column II of Appendix D. If
two or more radionuclides are possessed thereunder, the possession limit is
determined for each as follows: For each radionuclide, determine the ratio of
the quantity possessed to the applicable quantity specified in Column II of
Appendix D for that radionuclide. The sum of the ratios for all radionuclides
possessed under the license shall not exceed unity.
b) An application for a Type A specific license of broad scope
will be approved if:
1) The applicant satisfies the general requirements specified in
Section 330.250;
2) The applicant has engaged in a reasonable number of activities
involving the use of radioactive material;
3) The applicant has established administrative controls and
provisions relating to organization and management, procedures, recordkeeping,
material control and accounting and management review that are necessary to
assure safe operations, including:
A) The establishment of a Radiation Safety Committee composed of
such persons as a Radiation Safety Officer, a representative of management and
persons trained and experienced in the safe use of radioactive material;
i) The Committee shall meet at least once each calendar
quarter.
ii) To
establish a quorum and to conduct business, at least one-half of the Committee
membership must be in attendance and shall include, at a minimum, the
management's representative, an authorized user and the Radiation Safety Officer.
However, no more than once per year, the Radiation Safety Officer's designee
may substitute for the Radiation Safety Officer, provided the designee has been
given a written report. The report shall include all information necessary for
that meeting, such as the minutes of the previous Committee meeting and reports
by the Radiation Safety Officer. Reports by the Radiation Safety Officer shall
include reports of investigations and information necessary for the reviews.
To maintain membership on the Committee, a member must attend at least one-half
of the meetings held in any year.
iii) The
minutes of each Radiation Safety Committee meeting shall include:
• The
date of the meeting;
• Members
in attendance;
• Members
absent;
• Summary
of deliberations and discussions;
• Recommended
actions and the results of all votes; and
• Documentation
of the radiation protection program review required by 32 Ill. Adm. Code
340.110(c).
iv) The Committee shall provide each member with a copy of the
meeting minutes before the next meeting and retain one copy for five years from
the meeting date.
B) The appointment of a Radiation Safety Officer who is qualified
by training and experience in radiation protection, and who is available for
advice and assistance on radiation safety matters.
C) The establishment of appropriate administrative procedures to
assure:
i) Control of procurement and use of radioactive material;
ii) Completion of safety evaluations of proposed uses of
radioactive material that take into consideration such matters as the adequacy
of facilities and equipment, training and experience of the user and the
operating or handling procedures; and
iii) Review, approval and recording by the Radiation Safety
Committee of safety evaluations of proposed uses prepared in accordance with
subsection (b)(3)(C)(ii) prior to use of the radioactive material; and
4) The applicant or its predecessor has been a specific licensee
of the Agency for five years.
c) An application for a Type B specific license of broad scope
will be approved if:
1) The applicant satisfies the general requirements specified in
Section 330.250; and
2) The applicant has established administrative controls and
provisions relating to organization and management, procedures, recordkeeping,
material control and accounting and management review that are necessary to
assure safe operations, including:
A) The nomination of a Radiation Safety Officer who is qualified
by training and experience in radiation protection, and who is available for
advice and assistance on radiation safety matters; and
B) The establishment of appropriate administrative procedures to
assure:
i) Control of procurement and use of radioactive material;
ii) Completion of safety evaluations of proposed uses of
radioactive material that take into consideration such matters as the adequacy
of facilities and equipment, training and experience of the user and the
operating or handling procedures; and
iii) Review, approval and recording by the Radiation Safety
Officer of safety evaluations of proposed uses prepared in accordance with
subsection (c)(2)(B)(ii) prior to use of the radioactive material.
d) An application for a Type C specific license of broad scope
will be approved if:
1) The applicant satisfies the general requirements specified in
Section 330.250;
2) The applicant submits a statement that radioactive material
will be used only by, or under the direct supervision of, individuals who have
received:
A) A college degree at the bachelor level, or equivalent training
and experience, in the physical, or biological sciences or in engineering; and
B) At least 40 hours of training and experience in the safe
handling of radioactive material, and in the characteristics of ionizing
radiation, units of radiation dose and quantities, radiation detection instrumentation
and biological hazards of exposure to radiation pertinent to the type and forms
of radioactive material to be used; and
3) The applicant has established administrative controls and
provisions relating to procurement of radioactive material, procedures,
recordkeeping, material control and accounting and management review necessary
to assure safe operations.
e) Specific licenses of broad scope are subject to the following
conditions:
1) Unless specifically authorized, persons licensed pursuant to
this Section shall not:
A) Conduct tracer studies in the environment involving direct
release of radioactive material;
B) Receive, acquire, own, possess, use or transfer devices
containing 3.7 PBq (100 kCi) or more of radioactive material in sealed sources
used for irradiation of materials;
C) Conduct activities for which a specific license issued by the
Agency under Section 330.260 or 330.280 is required; or
D) Add or cause the addition of radioactive material to any food,
beverage, cosmetic, drug or other product designed for ingestion or inhalation
by, or application to, a human being.
2) Each Type A specific license of broad scope issued under this
Part shall be subject to the condition that radioactive material possessed
under the license may only be used by, or under the direct supervision of,
individuals approved by the licensee's Radiation Safety Committee.
3) Each Type B specific license of broad scope issued under this
Part shall be subject to the condition that radioactive material possessed
under the license may only be used by, or under the direct supervision of,
individuals approved by the licensee's Radiation Safety Officer.
4) Each Type C specific license of broad scope issued under this
Part shall be subject to the condition that radioactive material possessed
under the license may only be used by, or under the direct supervision of,
individuals who satisfy the requirements of subsection (d)(2).
f) A
licensee possessing a Type A specific license of broad scope for medical use,
issued under this Part, is exempt from:
1) The provisions of 32
Ill. Adm. Code 335.40(b);
2) The
provisions of 32 Ill. Adm. Code 335.40(f) regarding additions to or changes in
the areas of use at the addresses identified in the application or on the
license;
3) The provisions of 32
Ill. Adm. Code 335.45(a);
4) The
provisions of 32 Ill. Adm. Code 335.45(b)(1) for an authorized user, an
authorized medical physicist, or an ophthalmic physicist; and
5) The provisions of 32
Ill. Adm. Code 335.45(b)(5).
g) A
licensee possessing a Type A specific license of broad scope for use described in
subsections 330.260(c)(2)(C) or (c)(2)(D) is exempt from the provisions of subsections
(c)(6)(B)(ii), (c)(6)(D), (c)(6)(E), and 330.340(b)(4).
(Source: Amended at 48 Ill.
Reg. 13634, effective August 29, 2024)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.280 SPECIAL REQUIREMENTS FOR A SPECIFIC LICENSE TO MANUFACTURE, ASSEMBLE, REPAIR, OR DISTRIBUTE COMMODITIES, PRODUCTS, OR DEVICES THAT CONTAIN RADIOACTIVE MATERIAL
Section 330.280Special Requirements for a
Specific License to Manufacture, Assemble, Repair, or Distribute Commodities,
Products, or Devices that Contain Radioactive Material
a) Licensing
the Introduction of Radioactive Material into Products in Exempt Concentrations
1) In
addition to the requirements set forth in Section 330.250, a specific license
authorizing the introduction of radioactive material into a product or material
owned by or in the possession of the licensee or another and the transfer of
ownership or possession of the product or material containing the radioactive
material to persons exempted from this Part pursuant to Section 330.30 or
330.40(a) will be issued if:
A) The
applicant submits:
i) a
description of the product or material into which the radioactive material will
be introduced;
ii) intended
use of the radioactive material and the product or material into which it is
introduced;
iii) method
of introduction;
iv) initial
concentration of the radioactive material in the product or material;
v) control
methods to assure that no more than the specified concentration is introduced
into the product or material;
vi) estimated
time interval between introduction and transfer of the product or material; and
vii) estimated
concentration of the radioactive material in the product or material at the
time of transfer; and
B) The
applicant provides reasonable assurance that the concentrations of radioactive
material at the time of transfer will not exceed the concentrations in Appendix
A, that reconcentration of the radioactive material in concentrations exceeding
those in Appendix A is not likely, that use of lower concentrations is not
feasible and that the product or material is not likely to be incorporated in
any food, beverage, cosmetic, drug or other commodity or product designed for
ingestion or inhalation by, or application to, a human being.
2) Each
person licensed under this subsection (a) is required to maintain records of
transfer of material and shall file a report with the Agency that shall
identify the following:
A) Type
and quantity of each product or material into which radioactive material has
been introduced during the reporting period;
B) Name
and address of the person who owned or possessed the product or material, into
which radioactive material has been introduced, at the time of introduction;
C) The
radionuclide, activity and activity assay date of radioactive material
introduced into each product or material; and
D) The
initial concentrations of the radionuclide in the product or material at time
of transfer of the radioactive material by the licensee.
3) The
licensee shall file the report within 30 days after any of the following events:
A) 5
years have passed since the preceding report was filed; or
B) The
licensee has:
i) Filed
an application for renewal of the license under Section 330.320; or
ii) Notified
the Agency under Section 330.325(c) that the licensee has ended activities
authorized under the license issued under this subsection (a).
4) The
report shall cover the period between the filing of the preceding report and an
occurrence specified in subsection (a)(3). If no transfers of radioactive
material have been made under this subsection (a) during the reporting period,
the report shall so indicate.
5) The
licensee shall maintain the record of a transfer for a period of one year after
the event has been included in a report to the Agency.
6) No
person may introduce radioactive material into a product or material knowing or
having reason to believe that it will be transferred to persons exempt under
Section 330.30 or 330.40(a) or the equivalent regulations of NRC (10 CFR 30.14)
or of an Agreement State, except in accordance with a specific license issued under
this subsection (a).
b) Licensing
the Distribution of Radioactive Material in Exempt Quantities
AGENCY NOTE: Authority to
transfer possession or control by the manufacturer, processor or producer of
any equipment, device, commodity or other product containing byproduct material
whose subsequent possession, use, transfer and disposal by all other persons are
exempted from regulatory requirements may be obtained only from the U.S.
Nuclear Regulatory Commission, Washington DC 20555.
c) Licensing
the Incorporation of Naturally Occurring and Accelerator-Produced Radioactive
Material into Gas and Aerosol Detectors.
AGENCY NOTE: Authority to
transfer possession or control by the manufacturer, processor or producer of
any equipment, device, commodity or other product containing byproduct material
whose subsequent possession, use, transfer and disposal by all other persons
are exempted from regulatory requirements may be obtained only from the U.S.
Nuclear Regulatory Commission, Washington DC 20555.
d) Licensing
the Manufacture and Distribution of Devices to Persons Generally Licensed Under
Section 330.220(a).
AGENCY NOTE: Subsection (p)
describes requirements for radioactive material transfer reports and records.
1) An
application for a specific license to manufacture or distribute devices
containing radioactive material, excluding special nuclear material, to persons
generally licensed under Section 330.220(a) or equivalent regulations of NRC or
an Agreement State will be approved if:
A) The
applicant satisfies the general requirements of Section 330.250.
B) The
applicant submits sufficient information relating to the design, manufacture,
prototype testing, quality control, labels, proposed uses, installation,
servicing, leak testing, operating and safety instructions and potential
hazards of the device to provide reasonable assurance that:
i) The
device can be safely operated by persons not having training in radiological
protection;
ii) Under
ordinary conditions of handling, storage and use of the device, the radioactive
material contained in the device will not be released or inadvertently removed
from the device and it is unlikely that any person will receive in one year a
dose in excess of 10 percent of the annual limits specified in 32 Ill. Adm.
Code 340.210(a); and
iii) Under
accident conditions such as fire and explosion associated with handling,
storage and use of the device, it is unlikely that any person would receive an
external radiation dose or dose commitment in excess of the following organ
doses:
Whole body;
head and trunk; active blood-forming organs; gonads or lens of eye .. 150 mSv
(15 rem)
Hands and
forearms; feet and ankles or localized areas of skin averaged over areas no
larger than one square centimeter.................................. 2 Sv (200
rem)
Other organs .......................................... 500
mSv (50 rem).
C) Each
device bears a durable, legible, clearly visible label or labels approved by
the Agency that contains in a clearly identified and separate statement:
i) Instructions
and precautions necessary to assure safe installation, operation and servicing
of the device. Documents such as operating and service manuals may be
identified on the label and used to provide this information;
ii) The
requirement, or lack of requirement, for testing for leakage or contamination,
or for testing any on-off mechanism and indicator, including the maximum time
interval for the testing, and the identification of radioactive material by
radionuclide, activity and activity assay date; and
iii) The
information called for in one of the following statements, as appropriate, in
the same or substantially similar form:
The receipt, possession, use and
transfer of this device, Model___, Serial No.____, are subject to a general
license or the equivalent and the regulations of the U.S. Nuclear Regulatory
Commission or a state with which the U.S. Nuclear Regulatory Commission has
entered into an agreement for the exercise of regulatory authority. This label
shall be maintained on the device in a legible condition. Removal of this label
is prohibited.
OR
CAUTION – RADIOACTIVE MATERIAL
Name of Manufacturer or
Distributor
AGENCY NOTE: The model, serial
number and name of the manufacturer or distributor may be omitted from this
label provided the information is elsewhere specified in labeling affixed to
the device.
D) Each
device having a separable source housing that provides the primary shielding
for the source also bears on the source housing a durable label displaying the
device model and serial number, the radionuclide and activity, the words
"Caution – Radioactive Material", the radiation symbol described in
32 Ill. Adm. Code 340.Illustration A and the name of the manufacturer or
distributor.
E) Each
device meeting the criteria of 10 CFR 31.5(c)(13)(i)(73 Fed. Reg. 42673, July
23, 2008) bears a permanent (e.g., embossed, etched, stamped or engraved) label
affixed to the source housing, if separable, or the device, if the source
housing is not separable, that includes the words "Caution – Radioactive
Material" and, if practicable, the radiation symbol described in 32 Ill.
Adm. Code 340.Illustration A.
F) The
device has been registered in the Sealed Source and Device Registry in
accordance with subsection (m)(2).
2) Except
as provided in this subsection (d)(2), the interval between tests for proper
operation of the on-off mechanism and indicator, if any, shall not exceed six
months. The interval between tests for contamination of the device or for
leakage of radioactive material from the device or for both shall not exceed three
months for devices containing sources designed to emit alpha particles and six
months for all other devices. In the event the applicant desires that the
device be required to be tested at longer intervals, the applicant shall
include in the application sufficient information to demonstrate that those
longer intervals are justified. The information shall include a description of
the performance characteristics of the device or similar devices and of design
features that have a significant bearing on the probability or consequences of
contamination of the device or leakage of radioactive material from the device
or failure of the on-off mechanism and indicator. In determining the
acceptable interval for the test for leakage of radioactive material or
contamination of the device, the Agency will consider information that
includes, but is not limited to:
A) Primary
containment or source capsule;
B) Protection
of primary containment;
C) Method
of sealing containment;
D) Containment
construction materials;
E) Form
of contained radioactive material;
F) Maximum
temperature withstood during prototype tests;
G) Maximum
pressure withstood during prototype tests;
H) Maximum
activity of contained radioactive material;
I) Radiotoxicity
of contained radioactive material; and
J) Operating
experience with identical devices or similarly designed and constructed
devices.
3) In
the event the applicant desires that the general licensee under Section 330.220(a),
or under equivalent regulations of NRC or an Agreement State, be authorized to
install the device, collect the sample to be analyzed by a specific licensee
for leakage of, or contamination by, radioactive material, service the device,
test the on-off mechanism and indicator or remove the device from installation,
the applicant shall include in the application written instructions to be
followed by the general licensee, estimated annual doses associated with the
activity or activities and bases for the estimates. The submitted information
shall demonstrate that performance of the activity or activities by an
individual untrained in radiological protection, in addition to other handling,
storage and use of devices under the general license, is unlikely to cause that
individual to receive an annual dose in excess of 10 percent of the limits
specified in 32 Ill. Adm. Code 340.210(a).
4) A
person licensed under this subsection (d) to distribute devices to generally
licensed persons shall provide the information in this subsection (d)(4) to
each person to whom a device is to be transferred for possession and use under
the general license in Section 330.220(a). This information shall be provided before
a device is transferred. In the case of a transfer through an intermediate
person, the information shall be provided to the intended user prior to
transfer to the intermediate person. The required information is:
A) A copy
of Section 330.220(a);
AGENCY NOTE: If
certain provisions of Section 330.220(a) do not apply to a particular device,
they may be omitted; e.g., tests for leakage or contamination or proper
operation of an on-off mechanism and indicator.
B) A copy
of 32 Ill. Adm. Code 310.40, 330.310 and 340.1210, 340.1220 and 340.1260;
C) A list
of the services that may only be performed by a specific licensee;
D) Information
on acceptable disposal options, including estimated costs of disposal; and
E) A
statement of the Agency's policy to take escalated enforcement action for
improper disposal.
5) A
person licensed under this subsection (d) to distribute devices to generally
licensed persons shall provide the information in this subsection (d)(5) to each
person to whom a device is to be transferred for possession and use under a
general license equivalent to Section 330.220(a) in the regulations of NRC or
an Agreement State. This information shall be provided before a device is
transferred. In the case of a transfer through an intermediate person, the
information shall be provided to the intended user prior to transfer to the
intermediate person. The required information is:
A) A copy
of the following regulations of NRC or the equivalent regulations of an
Agreement State. NRC regulations are 10 CFR 31.5(73 Fed. Reg. 42673, July 23,
2008), 10 CFR 31.2(65 Fed. Reg. 79187, December 18, 2000), 10 CFR 30.51(61 Fed.
Reg. 24673, May 16, 1996), 10 CFR 20.2201(67 Fed. Reg. 3585, January 25, 2002)
and 10 CFR 20.2202(63 Fed. Reg. 39483, July 23, 1998). If NRC regulations are
provided to a prospective general licensee in lieu of applicable Agreement
State regulations, they shall be accompanied by a note explaining that use of
the device is regulated by the Agreement State;
AGENCY NOTE: If certain
provisions of the regulations do not apply to a particular device, they may be
omitted; e.g., tests for leakage or contamination or proper operation of an
on-off mechanism and indicator.
B) A list
of the services that may only be performed by a specific licensee;
C) Information
on acceptable disposal options, including estimated costs of disposal;
D) A
statement of the policies of NRC and most Agreement States to take escalated
enforcement action for improper disposal; and
E) The
name or title, address and phone number of the contact at NRC or Agreement
State regulatory agency from whom additional information may be obtained.
6) A
person licensed under this subsection (d) may propose, for approval by the
Agency, an alternative method of informing customers.
7) Each transferred
device shall meet the labeling requirements of subsections (d)(1)(C), (D) and
(E).
8) If a
license is to be terminated or if notification of bankruptcy is required by Section
330.310(j), a person licensed under this subsection (d) shall, upon request,
provide to the Agency, NRC or an Agreement State the records of final
disposition required by subsection (p)(8).
e) Special
Requirements for the Manufacture, Assembly or Repair of Luminous Safety Devices
for Use in Aircraft
1) An
application for a specific license to manufacture, assemble or repair luminous
safety devices containing tritium or promethium-147 for use in aircraft, for
distribution to persons generally licensed under Section 330.220(b) will be
approved if:
A) The
applicant satisfies the general requirements specified in Section 330.250; and
B) The
applicant satisfies the requirements of the following regulations of NRC or
their equivalent. The regulations are 10 CFR 32.53 (77 Fed. Reg. 43693, July
25, 2012), 10 CFR 32.54 (63 Fed. Reg. 39483, July 23, 1998) and 10 CFR 32.55 (77
Fed. Reg. 43693, July 25, 2012).
2) Each
person licensed under this subsection (e) shall file an annual report with the
Agency that shall state the total activity of tritium or promethium‑147
transferred to persons generally licensed under Section 330.220(b) or
equivalent regulations of NRC or an Agreement State. The report shall identify
each general licensee by name and address, state the kinds and numbers of
luminous devices transferred and specify the activity of tritium or
promethium-147 in each kind of device. Each report shall cover the year ending
June 30 and shall be filed within 30 days thereafter. If no transfers have been
made to a particular Agreement State during the reporting period, this
information must be reported to the responsible Agreement State agency upon
request of the Agency.
3) Each
person licensed under this subsection (e) shall also file an annual report with
the Director, Office of Nuclear Material Safety and Safeguards, ATTN: Document
Control Desk/GLTS, U.S. Nuclear Regulatory Commission, Washington DC 20555 by
the appropriate method listed in 10 CFR 30.6, which must state the total
quantity of tritium or promethium-147 transferred to persons generally licensed
under Section 330.220(b). The report shall identify each general licensee by
name, state the kinds and numbers of luminous devices transferred, and specify
the quantity of tritium or promethium-147 in each kind of device. Each report shall
cover the year ending June 30 and shall be filed by July 30. If no transfers have
been made to persons generally licensed under Section 330.220(b) during the
reporting period, the report shall so indicate.
f) Special
Requirements for License to Manufacture Calibration Sources Containing
Americium-241, Plutonium or Radium-226 for Distribution to Persons Generally
Licensed Under Section 330.220(d). An application for a specific license to
manufacture calibration and reference sources containing americium-241,
plutonium or radium-226 for distribution to persons generally licensed under
Section 330.220(d) will be approved if:
1) The
applicant satisfies the general requirements of Section 330.250; and
2) The
applicant satisfies the requirements of 10 CFR 32.57 (77 Fed. Reg. 43693, July
25, 2012) and 10 CFR 70.39 (43 Fed. Reg. 6925, February 17, 1978). The
applicant shall also certify that it will satisfy, and subsequently satisfies,
the requirements of 10 CFR 32.58 and 32.59 (77 Fed. Reg. 43694, July 25, 2012).
g) Manufacture
and Distribution of Radioactive Material for Certain In Vitro Clinical or
Laboratory Testing Under General License. An application for a specific
license to manufacture or distribute radioactive material for use under the
general license of Section 330.220(e), or equivalent regulations of NRC or an Agreement
State, will be approved if:
1) The
applicant satisfies the general requirements specified in Section 330.250.
2) The
radioactive material is to be prepared for distribution in prepackaged units
of:
A) Carbon-14
in units not exceeding 370 kBq (10 µCi) each.
B) Cobalt-57
in units not exceeding 370 kBq (10 µCi) each.
C) Hydrogen-3
(tritium) in units not exceeding 1.85 MBq (50 µCi) each.
D) Iodine-125
in units not exceeding 370 kBq (10 µCi) each.
E) Mock
iodine-125 in units not exceeding 1.85 kBq (50 nCi) of iodine-129 and 185 Bq (5
nCi) of americium-241 each.
F) Iodine-131
in units not exceeding 370 kBq (10 µCi) each.
G) Iron-59
in units not exceeding 740 kBq (20 µCi) each.
H) Selenium-75
in units not exceeding 370 kBq (10 µCi) each.
3) Each
prepackaged unit bears a durable, clearly visible label:
A) Identifying
the radioactive contents as to chemical form and radionuclide, and indicating
that the amount of radioactivity does not exceed 370 kBq (10 µCi) of
iodine-125, iodine-131, carbon-14, cobalt-57 or selenium-75; 1.85 MBq (50 µCi)
of hydrogen-3 (tritium); 740 kBq (20 µCi) of iron-59; or mock iodine-125 in
units not exceeding 1.85 kBq (50 nCi) of iodine-129 and 185 Bq (5 nCi) of
americium-241 each; and
B) Displaying
the radiation caution symbol described in 32 Ill. Adm. Code 340.910(a) and the
words "CAUTION – RADIOACTIVE MATERIAL" and "Not for Internal or
External Use in Humans or Animals".
4) The
following statement, or a statement that contains the information called for in
the following statement, appears on a label affixed to each prepackaged unit or
appears in a leaflet or brochure that accompanies the package:
This radioactive material may be
received, acquired, possessed and used only by physicians, veterinarians,
clinical laboratories or hospitals and only for in vitro clinical or laboratory
tests not involving internal or external administration of the material, or the
radiation therefrom, to human beings or animals. Its receipt, acquisition,
possession, use and transfer are subject to the regulations and a general
license of NRC or of a state with which NRC has entered into an agreement for
the exercise of regulatory authority.
5) The
label affixed to the unit, or the leaflet or brochure that accompanies the
package, contains information about the precautions to be followed in handling
and storing that radioactive material. In the case of the mock iodine-125
reference or calibration source, the manufacturer shall state in the directions
that this item shall be disposed of in compliance with 32 Ill. Adm. Code
340.1010(a) or the equivalent regulations of NRC or an Agreement State.
h) Licensing
the Manufacture and Distribution of Ice Detection Devices. An application for
a specific license to manufacture and distribute ice detection devices to
persons generally licensed under Section 330.220(f) will be approved if:
1) The applicant
satisfies the general requirements of Section 330.250; and
2) The
criteria of 10 CFR 32.61 and 32.62(77 Fed. Reg. 43694, July 25, 2012) are met.
i) Manufacture
and Distribution of Radiopharmaceuticals Containing Radioactive Material for
Medical Use Under Specific Licenses. An application for a specific license to
manufacture and distribute radiopharmaceuticals containing radioactive material
for use by persons licensed pursuant to Section 330.260(a), (b) or (c) for the
uses described in 32 Ill. Adm. Code 335.3010, 335.4010 or 335.5010 will be
approved if:
1) The
applicant satisfies the general requirements specified in Section 330.250;
2) The
applicant submits information showing that:
A) The
radiopharmaceutical containing radioactive material will be manufactured,
labeled and packaged in accordance with the Federal Food, Drug, and Cosmetic
Act (21 USC 301) or the Public Health Service Act (42 USC 201 et seq.); or
B) The
manufacture and distribution of the radiopharmaceutical containing radioactive
material is not subject to the Federal Food, Drug, and Cosmetic Act and the
Public Health Service Act;
3) The
applicant submits information on the radionuclide; chemical and physical form;
maximum activity per vial, syringe, generator or other container of the
radioactive drug; and the shielding provided by the packaging to show the
packaging is appropriate for safe handling and storage of radiopharmaceuticals
by medical use licensees; and
4) The
label affixed to each package of the radiopharmaceutical contains information
on the radionuclide, activity and activity assay date and the label affixed to
each package, or the leaflet or brochure that accompanies each package, contains
a statement that the radiopharmaceutical is licensed by the Agency for
distribution to persons licensed pursuant to Section 330.260(a), (b) or (c) for
radioactive material specified in 32 Ill. Adm. Code 335.3010, 335.4010 or
335.5010, as appropriate, or under equivalent licenses of NRC or an Agreement
State. The labels, leaflets or brochures required by this subsection (i) are
in addition to the labeling required by the FDA and may be separate from, or,
with the approval of FDA, may be combined with the labeling required by FDA.
j) Manufacture
and Distribution of Generators or Reagent Kits for Preparation of
Radiopharmaceuticals Containing Radioactive Material
AGENCY NOTE: Although the Agency
does not regulate the manufacture and distribution of reagent kits that do not
contain radioactive material, it does regulate the use of those reagent kits
for the preparation of radiopharmaceuticals containing radioactive material as
part of its licensing and regulation of the users of radioactive material. Any
manufacturer of reagent kits that do not contain radioactive material who
desires to have those reagent kits approved by the Agency for use by persons
licensed pursuant to Section 330.260(a), (b) or (c) for generators or reagent
kits specified in 32 Ill. Adm. Code 335.4010 may submit the pertinent
information specified in this subsection (j).
An application for a specific
license to manufacture and distribute generators or reagent kits containing
radioactive material for preparation of radiopharmaceuticals by persons
licensed pursuant to Section 330.260(a), (b) or (c) for the uses specified in
32 Ill. Adm. Code 335.4010 will be approved if:
1) The
applicant satisfies the general requirements specified in Section 330.250;
2) The
applicant submits evidence that:
A) The
generator or reagent kit is to be manufactured, labeled and packaged in
accordance with the Federal Food, Drug, and Cosmetic Act or the Public Health
Service Act; or
B) The
manufacture and distribution of the generator or reagent kit are not subject to
the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act;
3) The
applicant submits information on the radionuclide, chemical and physical form,
packaging, including maximum activity per package, and shielding provided by
the packaging of the radioactive material contained in the generator or reagent
kit;
4) The
label affixed to the generator or reagent kit contains information on the
radionuclide, activity and activity assay date; and
5) The
label affixed to the generator or reagent kit, or the leaflet or brochure that
accompanies the generator or reagent kit, contains:
A) Adequate
information, from a radiation safety standpoint, on the procedures to be
followed and the equipment and shielding to be used in eluting the generator or
processing radioactive material with the reagent kit; and
B) A
statement that the generator or reagent kit, as appropriate, is approved for
use by persons licensed by the Agency pursuant to Section 330.260(a), (b) or
(c) and 32 Ill. Adm. Code 335.4010 or under equivalent licenses of NRC or an
Agreement State. The labels, leaflets or brochures required by this subsection
(j) are in addition to the labeling required by the FDA and they may be
separate from or, with the approval of FDA, may be combined with the labeling
required by FDA.
k) Manufacture
and Distribution of Sources or Devices Containing Radioactive Material for
Medical Use. An application for a specific license to manufacture and
distribute sources and devices containing radioactive material to persons
licensed pursuant to Section 330.260(a) or (b) for use as a calibration,
transmission or reference source in 32 Ill. Adm. Code 335.2040 or for the uses
listed in 32 Ill. Adm. Code 335.2140, 335.6010, 335.7010 and 335.8010 will be
approved if:
1) The
applicant satisfies the general requirements in Section 330.250;
2) The
applicant submits sufficient information regarding each type of source or
device pertinent to an evaluation of its radiation safety, including:
A) The radioactive
material contained and its chemical and physical form and activity;
B) Details
of design and construction of the source or device;
C) Procedures
for, and results of, prototype tests to demonstrate that the source or device
will maintain its integrity under stresses likely to be encountered in normal
use and accidents;
D) For
devices containing radioactive material, the radiation profile of a prototype
device;
E) Details
of quality control procedures to assure that production sources and devices
meet the standards of the design and prototype tests;
F) Procedures
and standards for calibrating sources and devices;
G) Legend
and methods for labeling sources and devices as to their radioactive content;
and
H) Instructions
for handling and storing sources or devices from the radiation safety
standpoint. These instructions shall be included on a durable label
attached to each source or device or attached to a permanent storage container
for the source or device; provided, that instructions that are too lengthy for the
label may be summarized on the label and printed in detail on a brochure that
is referenced on the label;
3) The
label affixed to the source or device, or to the permanent storage container
for the source or device, contains information on the radionuclide, activity
and activity assay date, radiation symbol and/or "CAUTION – RADIOACTIVE
MATERIAL", serial number, model, manufacturer name or logo, and a
statement that the source or device is licensed by the Agency for distribution
to persons licensed pursuant to Section 330.260(a), (b) or (c) and 32 Ill. Adm.
Code 335.2040, 335.2140, 335.6010, 335.7010 and 335.8010 or under equivalent
licenses of NRC or an Agreement State, provided that the labeling for sources
that do not require long-term storage may be on a leaflet or brochure that
accompanies the source;
4) In
the event the applicant desires that the source or device be required to be
tested for leakage of, or contamination by, radioactive material at intervals
longer than 6 months, the applicant shall include in the application sufficient
information to demonstrate that the longer interval is justified by performance
characteristics of the source or device or similar sources or devices and by
design features that have a significant bearing on the probability or
consequences of radioactive contamination or leakage of radioactive material
from the source;
5) In
determining the acceptable interval for tests of leakage of, or contamination
by, radioactive material, the Agency will consider information that includes,
but is not limited to:
A) Primary
containment or source capsule;
B) Protection
of primary containment;
C) Method
of sealing containment;
D) Containment
construction materials;
E) Form
of contained radioactive material;
F) Maximum
temperature withstood during prototype tests;
G) Maximum
pressure withstood during prototype tests;
H) Maximum
activity of contained radioactive material;
I) Radiotoxicity
of contained radioactive material;
J) Operating
experience with identical sources or devices or similarly designed and
constructed sources or devices; and
K) Proposed
use of source; and
6) The
source or device has been registered in the Sealed Source and Device Registry
in accordance with subsection (m)(2).
l) Requirements
for License to Manufacture and Distribute Industrial Products Containing
Depleted Uranium for Mass-Volume Applications. An application for a specific
license to manufacture industrial products and devices containing depleted
uranium for use pursuant to Section 330.210(g) or equivalent regulations of NRC
or an Agreement State will be approved if:
1) The
applicant satisfies the general requirements specified in Section 330.250.
2) The
applicant submits sufficient information relating to the design (including
blueprints), manufacture (construction materials and methods), prototype
testing (description of testing that will be done and the acceptance criteria),
quality control procedures, labeling or marking, proposed uses and potential
hazards of the industrial product or device to assure that possession, use or
transfer of the depleted uranium in the product or device will not cause any
individual to receive, in any period of one year, a radiation dose in excess of
10 percent of the limits specified in 32 Ill. Adm. Code 340.210(a).
3) The
applicant submits information assuring that the presence of depleted uranium
for a mass-volume application in the product or device will provide a unique benefit
to the public, i.e., a benefit that could not be achieved but for the use of
depleted uranium. The applicant's methods for use and handling of the product
or device will not result in uncontrolled disposal or dispersal of depleted
uranium into the environment.
4) The
Agency will deny any application for a specific license under this subsection (l)
if the end uses of the industrial product or device cannot be reasonably
foreseen.
5) Each
person licensed pursuant to this subsection (l) shall:
A) Maintain
the level of quality control required by the license in the manufacture of the
industrial product or device, and in the installation of the depleted uranium
into the product or device;
B) Label
or mark each unit to:
i) Identify
the manufacturer of the product or device and the number of the license under
which the product or device was manufactured, the fact that the product or
device contains depleted uranium and the activity of depleted uranium in each
product or device; and
ii) State
that the receipt, possession, use and transfer of the product or device are
subject to a general license or the equivalent and the regulations of NRC or an
Agreement State;
C) Assure
that the depleted uranium, before being installed in each product or device,
has been impressed with the following legend, clearly legible through any
plating or other covering: "Depleted Uranium";
D) Furnish:
i) A
copy of the general license contained in Section 330.210(g) and a copy of the
form "Registration Certificate – Use of Depleted Uranium Under General
License", to each person to whom the licensee transfers depleted uranium
in a product or device for use pursuant to the general license contained in
Section 330.210(g); or
ii) A
copy of the general license contained in NRC's or Agreement State's regulation
equivalent to Section 330.210(g) and a copy of NRC's or Agreement State's
certificate, or alternatively, furnish a copy of the general license contained
in Section 330.210(g) and a copy of the form "Registration Certificate –
Use of Depleted Uranium Under General License", to each person to whom he or
she transfers depleted uranium in a product or device for use pursuant to the
general license of NRC or an Agreement State, with a note explaining that use
of the product or device is regulated by NRC or an Agreement State under
requirements substantially the same as those in Section 330.210(g);
E) Report
to the Agency all transfers of industrial products or devices to persons for
use under the general license in Section 330.210(g). The report shall identify
each general licensee by name and address, an individual by name and/or
position who may constitute a point of contact between the Agency and the general
licensee, the type and model number of device transferred, and the activity of
depleted uranium contained in the product or device. The report shall be
submitted within 30 days after the end of each calendar quarter in which the
product or device is transferred to the generally licensed person. If no
transfers have been made to persons generally licensed under Section 330.210(g)
during the reporting period, the report shall so indicate;
F) File
a report that identifies each general licensee by name and address, an
individual by name and/or position who constitutes a point of contact between
the Agency and the general licensee, the type and model number of the device
transferred, and the activity of depleted uranium contained in the product or
device. The report shall be submitted within 30 days after the end of
each calendar quarter in which the product or device is transferred to the
generally licensed person. The licensee shall report:
i) To NRC,
all transfers of industrial products or devices to persons for use under NRC
general license in 10 CFR 40.25;
ii) To
the responsible state agency, all transfers of devices manufactured and
distributed pursuant to this subsection (l) for use under a general license in
that state's regulations equivalent to Section 330.210(g);
iii) To NRC,
if no transfers have been made by the licensees during the reporting period;
iv) To
the responsible Agreement State agency, upon the request of that agency, if no
transfers have been made to general licensees within a particular Agreement
State during the reporting period; and
G) Keep
records showing the name, address and point of contact for each general
licensee to whom the licensee transfers depleted uranium in industrial products
or devices for use pursuant to the general license provided in Section 330.210(g)
or equivalent regulations of NRC or an Agreement State. The records shall
be maintained for a period of 2 years and shall show the date of each transfer,
the activity of depleted uranium in each product or device transferred, and
compliance with the report requirements of this subsection (l).
m) Special
Requirements for License to Manufacture or Initially Distribute Sealed Sources
or Devices Containing Sealed Sources
1) An
application for license to manufacture or initially distribute sealed sources
or devices containing sealed sources for initial transfer to persons having a
specific license to receive those sealed sources or devices will be approved
subject to the following conditions:
A) The
applicant satisfies the general requirements specified in Section 330.250;
B) The
licensee subject to this subsection (m) shall not transfer a sealed source or
device containing a sealed source to any person, except in accordance with the
requirements of Section 330.400.
2) Any
manufacturer or initial distributor of a sealed source or device containing a
sealed source may submit a request to the Agency for evaluation of radiation
safety information about its product and for filing an evaluation sheet in the NRC
"Registry of Radioactive Sealed Sources and Devices".
3) The
request for review of a sealed source or a device must include sufficient
information about the design, manufacture, prototype testing, quality control
program, labeling, proposed uses and leak testing, and, for a device, the
request must also include sufficient information about installation, service
and maintenance, operating and safety instructions, and the device's potential
hazards to provide reasonable assurance that the radiation safety properties of
the source or device are adequate to protect health and minimize danger to life
and property.
4) The
Agency normally evaluates a sealed source or a device using radiation safety
criteria in accepted industry standards. If these standards and criteria do
not readily apply to a particular case, the Agency formulates reasonable standards
and criteria with the help of the manufacturer or distributor. The Agency
shall use criteria and standards sufficient to ensure that the radiation safety
properties of the device or sealed source are adequate to protect health and
minimize danger to life and property. Other subsections of this Section have
specific criteria that apply to certain products.
5) After
completion of the evaluation, the Agency issues a certificate of registration
to the person making the request. The certificate of registration acknowledges
the availability of the submitted information for inclusion in an application
for a specific license proposing use of the product, or concerning use under an
exemption from licensing or general license, as applicable, for the category of
certificate.
6) The
person submitting the request for evaluation and registration of safety
information about the product shall manufacture and distribute the product in
accordance with:
A) The
statements and representations, including quality control program, contained in
the request; and
B) The
provisions of the registration certificate.
7) Authority
to manufacture or initially distribute a sealed source or device to specific
licensees may be provided in the license without the issuance of a certificate
of registration in the following cases:
A) Calibration and
reference sources containing no more than:
i) 37
MBq (1 mCi), for beta and/or gamma emitting radionuclides; or
ii) 0.37
MBq (10 µCi), for alpha emitting radionuclides; or
B) The
intended recipients are qualified by training and experience, and have
sufficient facilities and equipment, to safely use and handle the requested
quantity of radioactive material in any form, in the case of unregistered
sources, or, for registered sealed sources contained in unregistered devices,
are qualified by training and experience and have sufficient facilities and
equipment, to safely use and handle the requested quantity of radioactive
material in unshielded form, as specified in their licenses; and
i) The
intended recipients are licensed under Section 330.270
or comparable provisions of NRC or
an Agreement State; or
ii) The recipients are
authorized for research and
development; or
iii) The sources and
devices are to be built to the unique
specifications of the particular
recipient and contain no more than 740 GBq (20 Ci) of tritium or 7.4 GBq (200
mCi) of any other radionuclide.
8) After the certificate
is issued, the Agency may conduct an additional
review as it determines is
necessary to ensure compliance with current regulatory standards. In
conducting its review, the Agency will complete its evaluation in accordance
with criteria specified in this Section. The Agency may request such
additional information as it considers necessary to conduct its review and the
certificate holder shall provide the information requested.
9) A
certificate holder who no longer manufactures or initially transfers any of the
sealed sources or devices covered by a particular certificate issued by the Agency
shall request inactivation of the registration certificate. The request must
be made to the Agency by an appropriate method listed in 32 Ill. Adm. Code
310.110 and must normally be made no later than two years after initial
distribution of all the sources or devices covered by the certificate has
ceased. However, if the certificate holder determines that an initial transfer
was in fact the last initial transfer more than 2 years after that transfer,
the certificate holder shall request inactivation of the certificate within 90
days after this determination and briefly describe the circumstances of the
delay.
10) If
a distribution license is to be terminated in accordance with Section 330.325,
the licensee shall request inactivation of its registration certificates
associated with that distribution license before the Agency will terminate the
license. A request for inactivation of certificates must indicate that the
license is being terminated and include the associated specific license
number.
11) A
specific license to manufacture or initially transfer a source or device
covered only by an inactivated
certificate no longer authorizes the licensee to initially transfer the sources
or devices for use. Servicing of devices must be in accordance with any
conditions in the certificate, including in the case of an inactive
certificate.
n) Manufacture
and Distribution of Radioactive Material for Medical Use Under General License.
A specific license authorizing the distribution of radioactive materials for
diagnostic medical use by a physician under a general license shall be issued
only if the applicant for the specific license satisfies the requirements of
Section 330.250 and:
1) The
applicant submits evidence that the radioactive material is to be manufactured,
labeled and packaged in accordance with an approval by the commissioner of Food
and Drugs, U.S. Food and Drug Administration, or in accordance with an approval
for a biologic product issued by the Secretary, U.S. Department of Health and
Human Services; and
2) The
following statement, or a statement that contains the information called for in
the following statement, appears on the label affixed to the container or appears
in the leaflet or brochure that accompanies the package:
This radiopharmaceutical may be
received, possessed and used only by physicians licensed to dispense drugs in
the practice of medicine. Its receipt, possession, use and transfer are
subject to the regulations and a general license or its equivalent of the NRC
or of a state with which NRC has entered into an agreement for the exercise of
regulatory authority.
o) Requirements
for License to Initially Transfer Source Material for Use Under the "Small
Quantities of Source Material" General License
1) An
application for a specific license to initially transfer source material for
use under Section 330.210 will be approved if:
A) The
applicant satisfies the general requirements specified in Section 330.250; and
B) The applicant submits adequate information on the methods to be used
for quality control, labeling and providing safety instructions to recipients.
2) Each
person licensed under this subsection (o) shall label the immediate container
of each quantity of source material with the type and quantity of source
material and the words "radioactive material".
3) Each
person licensed under this subsection (o) shall ensure that the quantities and
concentrations of source material are as labeled and indicated in any transfer
records.
4) Each
person licensed under this subsection (o) shall provide the information
specified in this subsection (o)(4) to each person to whom source material is
transferred for use under Section 330.210. This information shall be
transferred before the source material is transferred for the first time in
each calendar year to the particular recipient. The required information
includes:
A) A
copy of Sections 330.210 and 330.400; and
B) Appropriate
radiation safety precautions and instructions relating to handling, use,
storage and disposal of the material.
5) Each
person licensed under this subsection (o) shall report transfers as follows:
A) File
a report with the Agency that includes the following information:
i) The
name, address and license number of the person who transferred the source
material;
ii)For
each general licensee under Section 330.210 to whom greater than 50 grams (0.11
pounds) of source material has been transferred in a single calendar quarter,
the name and address of the general licensee to whom source material is
distributed; a responsible agent, by name and/or position and phone number, of
the general licensee to whom the material was sent; and the type, physical form
and quantity of source material transferred; and
iii) The
total quantity of each type and physical form of source material transferred in
the reporting period to all such generally licensed recipients.
B) File
a report with each responsible Agreement State or NRC, as appropriate, that
identifies all persons, operating under provisions equivalent to Section
330.210, to whom greater than 50 grams (0.11 pounds) of source material has
been transferred within a single calendar quarter. The report shall include the
following information specific to those transfers made to the Agreement State
or NRC licensees:
i) The
name, address and license number of the person who transferred the source
material;
ii) The
name and address of the general licensee to whom source material was
distributed; a responsible agent, by name and/or position and phone number, of
the general licensee to whom the material was sent; and the type, physical form
and quantity of source material transferred; and
iii) The
total quantity of each type and physical form of source material transferred in
the reporting period to all such generally licensed recipients within the Agreement
State or NRC jurisdictions.
C) Submit
each report by January 31 of each year covering all transfers for the previous
calendar year. If no transfers were made to persons generally licensed under
Section 330.210, or equivalent Agreement State or NRC provisions, during the
current period, a report shall be submitted to the Agency indicating so. If no
transfers have been made to general licensees in a particular Agreement State
during the reporting period, this information shall be reported to each
responsible Agreement State agency or NRC upon request.
6) Each
person licensed under this subsection (o) shall maintain all information that
supports the reports required by subsection (o)(5) concerning each transfer to
a general licensee for a period of one year after the event is included in a
report to the Agreement State agency or NRC.
p) Material Transfer
Reports and Records
Each person licensed under
subsection (d) to distribute devices to generally licensed persons shall comply
with the requirements of this subsection (p).
1) The person shall
report:
A) To the
Agency and to the responsible regulatory agency all transfers of devices to
persons for use under the general license in Section 330.220(a) or the
equivalent regulations of NRC or an Agreement State;
B) To the
Agency and to the responsible regulatory agency all receipts of devices from persons
generally licensed under Section 330.220(a) or the equivalent regulations of NRC
or an Agreement State;
C) To the
Agency if no transfers were made to or from general licensees during the
reporting period; and
D) To the
responsible regulatory agency upon the request of the agency if no transfers
during the reporting period were made to or from general licensees in the
agency's area of jurisdiction.
2) The
report shall be on NRC Form 653, "Transfers of Industrial Devices
Report", or in a clear and legible format containing all of the information
required by the form. The report shall cover each calendar quarter, shall be
filed within 30 days after the end of the calendar quarter, and shall clearly
indicate the period covered.
3) For a transfer
to a general licensee, the report shall provide:
A) The
identity of the general licensee by name and mailing address for the location
of use. If there is no mailing address for the location of use, an alternate
address for the general licensee shall be submitted, along with information on
the actual location of use;
B) The
name, title and phone number of the individual identified by the general
licensee as having knowledge of and authority to take required actions to
ensure compliance with the appropriate regulations and requirements;
C) The
date of transfer;
D) The
type, model and serial number of the device transferred; and
E) The
radionuclide and activity contained in the device.
4) If
one or more intermediate persons will temporarily possess a device at the
intended place of use before its possession by the user, the report shall
include the same information for both the intended user and each intermediate
person and shall clearly designate all intermediate persons.
5) For a
device received from a general licensee, the report shall provide the name and
address of the general licensee and the type, model and serial number of the device
and the date of receipt. For a device not initially transferred by the
reporting person, the report shall provide the name of the manufacturer or
distributor.
6) If
the person makes a change to a device possessed by a general licensee that
necessitates a change in the label, the report shall identify the general
licensee, the device and the changes to information on the device label.
7) The
report shall clearly identify the person licensed under subsection (d) that is
furnishing the report and shall include the person's specific license number.
8) The
person shall maintain all information concerning transfers and receipts of
devices that supports the reports required by this subsection (p). These
records shall be maintained for 5 years following the recorded event.
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY AND OFFICE OF HOMELAND SECURITY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.290 REQUIREMENTS FOR EMERGENCY PLANS
Section 330.290 Requirements
for Emergency Plans
a) An emergency plan for responding to a release of radioactive
material submitted under Section 330.250(e) of this Part shall include the
following information:
1) Facility Description. A brief description of the applicant's
facility and area near the site.
2) Types of Accidents. An identification of each type of
radioactive materials accident for which actions may be needed to protect
members of the public.
3) Classification of Accidents. A method for classifying
accidents as alerts or site area emergencies as defined below:
A) "Alert" means a condition in which events may occur,
are in progress, or have occurred that could lead to a release of radioactive
material but in which the release is not expected to require a response by
offsite response organizations to protect individuals offsite.
B) "Site area emergency" means a condition in which
events may occur, are in progress, or have occurred that could lead to a
significant release of radioactive material that could require a response by
offsite response organizations to protect individuals offsite.
4) Detection of Accidents. Identification of the means of
detecting each type of accident in a timely manner.
5) Mitigation of Consequences. A brief description of the means
and equipment for mitigating the consequences of each type of accident,
including those provided to protect workers onsite, and a description of the
program for maintaining the equipment.
6) Assessment of Releases. A brief description of the methods
and equipment to assess releases of radioactive materials.
7) Responsibilities
A) The names and titles of the applicant's personnel responsible
for developing, maintaining and updating the plan.
B) A brief description of the responsibilities of the applicant's
personnel should an accident occur, including identification of personnel responsible
for promptly notifying offsite response organizations, including the Agency.
C) A list of offsite response organizations and a description of
their responsibilities and anticipated actions.
8) Notification and Coordination
A) A brief description of the means, in the event of a classified
accident, of promptly notifying and, if necessary, requesting assistance from
the offsite response organizations listed pursuant to subsection (a)(7)(C) of
this Section. The assistance requested may include, but need not be limited
to, medical treatment of contaminated or injured onsite workers.
B) A description or drawing of locations designated as locations
from which control and assessment of an accident would be exercised (i.e.,
control points).
C) Provisions for arranging notification and coordination so that
unavailability of some personnel, parts of the facility, or some equipment will
not prevent notification and coordination.
9) Information to be Communicated. A brief description of the
information to be provided to offsite response organizations, including the Agency,
in the event of a classified accident. The types of information to be provided
shall include the status of the facility, a description of radioactive
releases, the names and telephone numbers of onsite personnel designated as
points of contact and recommendations for protective actions.
10) Training
A) A brief description of the performance objectives and plans for
annual training that the applicant will provide workers on how to respond to an
emergency, including any special instructions and orientation tours that the
applicant will provide for fire, police, medical and other emergency personnel.
B) Provisions for familiarizing personnel with site-specific
emergency procedures.
C) Provisions for preparing site personnel for their
responsibilities for a range of accident scenarios for the specific site,
including the use of drills, exercises and team training for such scenarios.
11) Safe Shutdown. A brief description of the means of restoring
the facility to a safe condition after an accident.
12) Exercises. Provisions for:
A) Conducting quarterly communications checks with offsite
response organizations that include the verification and updating of all
necessary phone numbers.
B) Inviting offsite response organizations to participate in
biennial exercises.
AGENCY NOTE: Participation of offsite
response organizations in biennial exercises, although recommended, is not
required.
C) Using accident scenarios postulated as most probable for the
specific site.
D) Ensuring that accident scenarios are not known to exercise
participants.
E) Providing critiques of each exercise by individuals who have no
direct implementation responsibility for the plan.
b) The applicant shall allow the offsite response organizations
expected to respond in case of an accident 60 days to comment on the
applicant's emergency plan before submitting it to the Agency. Significant
amendments to the plan should also be provided to offsite agencies for comment
before submission to the Agency. The applicant shall provide any comments
received within the 60 days to the Agency with the emergency plan.
c) Hazardous Chemicals. The applicant shall certify to the Agency
that it has met its responsibilities under the Emergency Planning and Community
Right-to-Know Act of 1986, title III, P.L. 99-499 (42 USC 11001 et seq.), if
applicable to the applicant's activities at the proposed place of use of the
radioactive material.
d) The licensee shall:
1) Comply with the provisions and descriptions of the emergency
plan submitted pursuant to this Section;
2) Review and update the emergency plan:
A) At
intervals not to exceed 1 year;
B) Whenever
the facility license is revised;
C) Whenever
the existing contingency plan fails when actually applied;
D) Whenever
the facility changes in a way that materially increases the potential for
fires, explosions or releases of waste or waste constituents (e.g., a change of
manufactured materials used, a change in facility design) or changes the
response necessary in the event of an emergency;
E) Whenever
the list of emergency coordinators changes; or
F) Whenever
the list of emergency equipment changes.
3) If
the contingency plan is amended to comply with subsection (d)(2)(A), (B), (C)
or (D) of this Section, the complete plan, as amended, shall be distributed to
those entities identified in subsection (d)(4) of this Section. If the plan is
amended to comply with subsection (d)(2)(E) or (F) of this Section, only the
revised lists need be distributed. Distribution shall be within 30 days after
the update is completed.
4) Ensure
copies of the contingency plan and all revisions to the plan are:
A) Maintained
at the facility;
B) Submitted
to the Agency; and
C) Submitted to all local police agencies, fire agencies,
hospitals and State and local emergency response teams that might be called
upon to provide emergency services.
5) Obtain Agency approval before implementing changes to the
plan, except for updates to names, titles and telephone numbers;
6) Provide training at intervals not to exceed 1 year for all
personnel with responsibilities for responding to accidents postulated as most
probable for the specific site;
7) Conduct biennial onsite exercises to test the response to
simulated emergencies;
8) Perform critiques of drills and exercises and ensure that such
critiques evaluate the appropriateness of the emergency plan, emergency procedures,
facilities, equipment, training of personnel and overall effectiveness of the
response;
9) Correct deficiencies noted in critiques of drills and
exercises; and
10) Notify offsite response organizations, including the Agency,
immediately after the licensee declares an alert or site area emergency.
AGENCY NOTE:
The reporting requirement of subsection (d)(10) of this Section does not
supersede or relieve licensees from complying with the requirements of the
Emergency Planning and Community Right-to-Know Act of 1986, Title III, P.L.
99-499 (42 USC 11001 et seq.) or other State or federal reporting requirements.
(Source: Amended at 32 Ill.
Reg. 6462, effective April 7, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.300 ISSUANCE OF SPECIFIC LICENSES
Section 330.300 Issuance of
Specific Licenses
a) Upon a determination that an application meets the
requirements of the Act and the regulations of the Agency, the Agency will
issue a specific license authorizing the proposed activity in such form and
containing such conditions and limitations as it deems appropriate or
necessary.
b) The Agency may incorporate in any license at the time of
issuance, or thereafter by appropriate rule, regulation or order, such
additional requirements and conditions with respect to the licensee's receipt,
possession, use and transfer of radioactive material subject to this Part as it
deems appropriate or necessary in order to:
1) Minimize danger to public health and safety or property;
2) Require such reports and the keeping of such records, and to
provide for such inspections of activities under the license as may be
appropriate or necessary; and
3) Prevent loss or theft of material subject to this Part.
(Source: Amended at 32 Ill.
Reg. 6462, effective April 7, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.310 TERMS AND CONDITIONS OF SPECIFIC AND GENERAL LICENSES
Section 330.310 Terms and
Conditions of Specific and General Licenses
a) Each specific or general license issued pursuant to this Part
shall be subject to all applicable license conditions, provisions of the Act,
and all applicable rules, regulations and orders of the Agency.
b) Each person granted a general license by this Part shall
provide information required by the Agency to track the location and use of
generally-licensed radioactive material. The information shall be in the
format prescribed by the Agency, shall be complete and accurate, and shall be
due within the time frame indicated on the notification. In accordance with 32
Ill. Adm. Code 310.50, the Agency may inspect and investigate premises,
operations or personnel and have access to or copy records:
1) Of a person who fails to provide information as required by
this subsection (b); or
2) For the purpose of evaluating past, current or potential
hazards to the public health, workers or the environment resulting from
radiation.
c) No specific license issued or granted to any person pursuant
to this Part and no right to possess or use radioactive material granted to any
person by any specific license issued pursuant to this Part shall be
transferred, assigned, or in any manner disposed of, either voluntarily or
involuntarily, directly or indirectly, through transfer of control of the
specific license to any other person unless the Agency:
1) Is
provided notification, including the identity and technical qualifications of
the proposed transferee, not later than 90 days prior to the transfer;
2) Finds that the proposed transfer, assignment or disposal is in
accordance with the provisions of the Act;
3) Consents in writing to the proposed transfer, assignment or
disposal; and
4) Finds the transferee, when applicable, to be compliant with
the requirements of 32 Ill. Adm. Code 326.
AGENCY NOTE:
Agency consent is required prior to any transfer or assignment of a specific
license. A purported transfer or assignment without prior written consent may
subject the purported transferor or assignor to penalties for violating this
Section. Likewise, a purported transferee or assignee may also be subject to
penalties if it does not have a valid specific license and possesses
radioactive material or performs activities requiring a valid specific license.
d) Upon approval from the Agency under subsection (c)(2) for
transfer, assignment or disposal of a specific license, the transferor shall
ensure the following information is provided to the transferee:
1) The radioactive material license and all documents referenced
in the license;
2) Records maintained in accordance with 32 Ill. Adm. Code 340,
Subpart L, inventory records, and any other records required by subsections (k)
and (l); and
3) Any other information required by the Agency pursuant to the
approval granted.
e) Each person licensed by the Agency pursuant to this Part shall
confine use and possession of the material licensed to the locations and
purposes authorized in the license and, to the extent practical, conduct
operations to minimize the introduction of residual radioactivity into the site
and/or facility of operation, including the subsurface.
f) Each person issued a specific license pursuant to this Part
shall maintain the license in accordance with the requirements of Section
330.320.
g) When temporary jobsites are authorized on a specific license,
radioactive material may be used at temporary jobsites, in areas not under
exclusive federal jurisdiction, throughout the State of Illinois.
AGENCY NOTE:
Authorization for use of byproduct radioactive materials at jobsites under
exclusive federal jurisdiction must be obtained from NRC, either by filing an
NRC Form-241 in accordance with 10 CFR 150.20(b), "Recognition of
Agreement State Licenses", or by applying for a specific license from
NRC. Also, specific licenses issued by the Agency do not authorize activities
in other states. Before radioactive materials can be used at a temporary
jobsite in another state, a license must be obtained from the appropriate state
or federal regulatory agency.
h) Each person issued a specific license pursuant to this Part
shall apply for an appropriate license amendment not later than 30 days after a
Radiation Safety Officer permanently discontinues performance of duties under
the license.
i) Notification
1) Each specific licensee shall notify the Agency in writing not
later than 60 days after principal activities involving the use of radioactive
materials, including sealed sources and devices, at the site or in a separate
building or outdoor area have not occurred for a period of 2 years, and the
licensee has not decontaminated the site or properly disposed of the sealed
sources or devices.
AGENCY NOTE:
Principal activities are those originally authorized on the license for that
site or location. For example, licensees could not store radioactive material
in an otherwise unused building to avoid end-of-use decommissioning, unless
storage was a principal activity for that building.
2) This notification shall include a description of the location
of the site, building or outdoor area and a plan for reclaiming or
decommissioning these facilities (including a proposed schedule) for release in
accordance with applicable regulations. The notification shall include an
evaluation of any changes, if required, to financial assurance arrangements
submitted in accordance with 32 Ill. Adm. Code 326. Upon approval of the plan
by the Agency, implementation shall begin within 6 months and be completed
within 24 months after approval (unless the Agency approves a different
schedule).
AGENCY NOTE:
32 Ill. Adm. Code 340.1310 requires licensees to notify the Agency no less than
30 days before vacating or relinquishing possession or control of premises that
may have been contaminated with radioactive material.
3) For a
device with a shutter that is not being used, the shutter shall be locked in
the closed position. Testing for proper operation of the on-off mechanism and
indicator is not required during the storage period. However, the on-off
mechanism and indicator shall be checked before the device is returned to
service if the device has not been tested within the required test interval.
Tests for leakage of, or contamination by, radioactive material, as applicable
to devices in storage, shall be conducted in accordance with 32 Ill. Adm. Code
340.410.
4) A
device kept in standby for future use is exempt from the 2-year storage limit
if the person performs a quarterly physical inventory of the device while it is
in standby. The requirements of subsection (i)(3) shall apply.
j) Notification of Bankruptcy
1) Each specific or general licensee shall notify the Agency, in
writing, immediately following the filing of a voluntary or involuntary
petition for bankruptcy under any chapter of Title 11 (Bankruptcy) of the United
States Code by or against:
A) The licensee;
B) An entity (as the term is defined in 11 USC 101(15))
controlling the licensee or listing the license or licensee as property of the
estate; or
C) An affiliate (as the term is defined in 11 USC 101(2)) of the
licensee.
2) This notification shall indicate:
A) The bankruptcy court in which the petition for bankruptcy was
filed;
B) The date of the filing of the petition;
C) The chapter under which the bankruptcy petition has been filed;
D) The name, address and phone number of the bankruptcy trustee
(if a trustee has been named at the time of the notification);
E) Whether the licensed radiation source remains in the possession
and control of the licensee and whether any change in possession or control is
expected or contemplated;
F) The name of the person in possession and control of the
licensed radiation source if the licensee no longer maintains possession or
control; and
G) Whether the Agency has been named in the bankruptcy petition
either as a creditor or in some other capacity.
k) Recordkeeping Requirements for Potentially Contaminated
Areas. Except for areas containing only sealed sources, provided the sources
have not leaked, or no contamination remains after any leakage, and except for
areas where only radioactive materials with half-lives less than 90 days were
used or stored, each specific licensee shall keep:
1) Records of spills or other unusual occurrences involving the
spread of contamination in and around the facility, equipment or site, when
contamination remains after any cleanup procedures or when there is reasonable
likelihood the contaminants may have spread to inaccessible areas (as in the
case of possible seepage into porous materials such as concrete). These
records must include the location and any known information on identification
of involved radionuclides, quantities, chemical and physical forms, and
concentrations.
2) Drawings and subsequent modifications of structures and
equipment in restricted areas where radioactive materials are used or stored,
and of locations of possible inaccessible contamination, such as buried or
enclosed pipes, that may be subject to contamination. If required drawings are
referenced, each relevant document need not be indexed individually. If
drawings are not available, the licensee shall substitute appropriate records
of available information concerning these areas and locations.
l) Each licensee shall maintain the following records, if
applicable:
1) Records of all areas where low-level radioactive wastes were
buried, including areas previously authorized by and documented pursuant to 10
CFR 20.2108.
2) Records of the Agency-approved cost estimate for the amount
certified for reclaiming and the associated reclamation plan, for licensees
required by 32 Ill. Adm. Code 326 to secure financial assurance arrangements.
3) All records required to be maintained pursuant to 32 Ill. Adm.
Code Chapter II, Subchapters b and d.
m) To lawfully obtain termination for a specific license, each
licensee shall meet the termination requirements of this Part.
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.320 RENEWAL REQUIREMENTS FOR SPECIFIC LICENSES
Section 330.320 Renewal
Requirements for Specific Licenses
a) Each
licensee issued a specific license shall maintain a valid specific license
until the licensee completes the license termination requirements of Section
330.325 and the Agency has notified the licensee in writing that the specific
license is terminated. Each specific license and any amendment to the license
issued by the Agency contains an expiration date. Unless the specific license
has been terminated in accordance with Section 330.325, the licensee shall, 30
days prior to the expiration date of the license, file with the Agency:
1) A
complete application, in proper format, for license renewal as provided in
Section 330.240; or
2) A
complete application, in proper format, for a license authorizing, at a
minimum, continued possession and storage of any radioactive materials
possessed under the expiring specific license.
b) In
any case in which a licensee, not less than 30 days prior to expiration of an
existing license, has filed an application in proper form for renewal or for a
new license authorizing the same activities, the existing license shall not
expire until final action has been taken by the Agency.
AGENCY NOTE:
Nothing in this subsection (b) is intended to limit the Agency's authority, if
circumstances warrant, to take emergency action in accordance with the Act [420
ILCS 40], or other appropriate action in regard to a specific license in
accordance with procedures in 32 Ill. Adm. Code 200.
c) A licensee who fails to comply with the requirements of
subsection (a) shall be subject to such civil penalties and sanctions as may be
appropriate to the circumstances, in accordance with the Radiation Protection Act
and 32 Ill. Adm. Code 310. In addition, if the expiration date passes without
license termination requirements having been met by the licensee and without a
timely renewal application having been filed by the licensee before the
expiration date, the authority of the licensee to engage in licensed activities
as specified in the specific license shall expire at the end of the specified expiration
date. The passing of the expiration date shall not relieve the licensee of the
duties and responsibilities of applying for and maintaining a valid specific
license, decommissioning, reclaiming, and meeting the license termination
requirements of Section 330.325. Immediately upon the passing of the
expiration date, a licensee that has neither met license termination
requirements nor filed a timely application under subsection (a) shall:
1) Cease
use of radioactive material;
2) Store all radioactive material in a secure
location and limit activities involving radioactive material to those necessary
for shipping, transferring and disposing of the radioactive material;
3) File either a new application for a specific
license or provide information equivalent to that required on Agency Form
KLM.007 (Certificate Termination and Disposition or Radioactive Material);
4) Comply
with all applicable Agency regulations;
5) Comply with the license conditions of the
expired license until either a new license is issued or the termination
requirements of Section 330.325 are met; and
6) Comply
with any orders issued by the Agency in accordance with the Act and 32 Ill.
Adm. Code 200 that result from violation of subsection (a) or any other
applicable provisions of Agency regulations or the Act.
(Source: Amended at 35 Ill.
Reg. 2931, effective February 7, 2011)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.325 TERMINATION REQUIREMENTS FOR SPECIFIC LICENSES AND LOCATIONS OF USE
Section 330.325 Termination
Requirements for Specific Licenses and Locations of Use
a) To
lawfully obtain termination of a specific license or a location of use, each
licensee shall meet the requirements of this Section no later than the end of
the expiration date on the specific license or on any applicable amendment to
the specific license unless the licensee has filed an application for renewal
in accordance with Section 330.320(a) of this Part prior to the expiration
date.
AGENCY NOTE: If the licensee has
filed a renewal application in accordance with Section 330.320(a) of this Part
and the Agency subsequently denies the application, the Agency shall, in an
order issued to the licensee in accordance with the Act, the Illinois
Administrative Procedure Act [5 ILCS 100] and 32 Ill. Adm. Code 200, specify
the time by which the licensee must meet the requirements of this Section.
b) Requirements
for Obtaining Termination of a Specific License, Removal of a Site or Location
of Use from a Specific License
1) The
licensee shall:
A) Cease
use of radioactive material;
B) Remove
radioactive contamination to levels considered acceptable for unrestricted
use. A site will be considered acceptable for unrestricted use when:
i) Radioactive
contamination is removed to levels outlined in 32 Ill. Adm. Code 340.Appendix
A; or
ii) The
residual radioactivity, excluding radon, thoron and their progeny, that is
distinguishable from background radiation does not result in a total effective
dose equivalent (TDE) to an average member of the critical group that exceeds
25 mrem (0.25 mSv) per year, including that from groundwater sources of
drinking water, and the residual radioactivity has been reduced to levels that
are as low as reasonably achievable (ALARA). Determination of the levels that
are ALARA must take into account consideration of any detriments, such as
deaths from transportation accidents, expected to potentially result from
decontamination and waste disposal;
C) Properly
transfer and/or dispose of radioactive material;
D) Submit
a completed Agency Form KLM.007 (Certificate Termination and Disposition of
Radioactive Material) or provide equivalent information;
E) For
licensees authorized to possess sealed sources, submit evidence of transfer
and/or disposal of all sealed sources authorized on the license and a copy of
the most recent leak test; and
F) For
licensees authorized to possess radioactive material in forms other than sealed
sources, submit a radiation survey report to confirm the absence of radioactive
materials or to establish the levels of residual radioactive contamination,
unless the licensee demonstrates the absence of residual radioactive
contamination in some other manner. The radiation survey report shall specify
the date of the survey and the instrumentation used and shall certify that each
instrument was properly calibrated and tested. The licensee shall, as
applicable, report levels or quantities of:
i) Beta
and gamma radiation at 1 centimeter from surfaces in units, multiples, or
subunits of Sieverts or rem per hour;
ii) Gamma
radiation at 1 meter from surfaces in units, multiples, or subunits of Sieverts
or rem per hour;
iii) Removable
radioactivity on surfaces in units, multiples, or subunits of Becquerels or Curies
per 100 square centimeters of surface area, or in disintegrations (transformations)
per minute per 100 square centimeters of surface area;
iv) Fixed
radioactivity on surfaces in units, multiples, or subunits of Becquerels or Curies
per 100 square centimeters of surface areas or in disintegrations
(transformations) per minute per 100 square centimeters of surface area;
v) Radioactivity
in contaminated liquids, such as water, oils or solvents, in units, multiples,
or subunits of Becquerels or Curies per milliliter of volume; and
vi) Radioactivity
in contaminated solids, such as soils or concrete, in units, multiples, or
subunits of Becquerels or Curies per gram of solid.
2) If no
residual radioactive contamination attributable to activities conducted under
the license is detected, the licensee shall submit a certification that no
detectable radioactive contamination was found.
3) If
detectable levels or residual radioactive contamination attributable to
activities conducted under the license are found, the licensee shall:
A) In
addition to the information submitted under subsections (b)(1)(D) and (b)(1)(F)
of this Section, submit for Agency approval a plan for reclaiming the facility,
including decontamination and removal of residual radioactive contamination;
B) Limit
actions involving radioactive material to those approved under the
decontamination plan in subsection (b)(3)(A) of this Section;
C) Continue
to control entry to restricted areas until they are suitable for release for
unrestricted use; and
D) Implement
and complete the plan approved under subsection (b)(3)(A) of this Section.
c) When
a licensee ends activities authorized under a specific license and has met the
termination requirements of subsection (b) of this Section, the licensee shall
immediately notify the Agency in writing and request that the license be
terminated. This notification and request for termination shall include the
documents required by subsection (b) of this Section and shall otherwise
substantiate that the licensee has met all of the requirements in subsection (b)
of this Section.
d) After
receiving a request for license termination pursuant to subsection (c) of this
Section, the Agency shall confirm, through such inspections and record reviews
as may be necessary, that the licensee has met the requirements of subsection
(b) of this Section. Upon confirmation, the Agency shall issue an amendment to
terminate the licensee. Until issued the termination amendment, the licensee
shall maintain a valid specific license in accordance with Section 330.320 of
this Part.
e) A
licensee who fails to comply with the pertinent requirements of this Section
shall be subject to such civil penalties and sanctions as may be appropriate in
accordance with the Act and 32 Ill. Adm. Code 310. The passing of the
expiration date shall not relieve the licensee of the duties and
responsibilities of applying for and maintaining a valid specific license in
accordance with Section 330.320 of this Part, decommissioning, reclaiming, and
meeting the license termination requirements of this Section. Immediately upon
the passing of the expiration date, a licensee that fails to comply with
subsection (a) of this Section shall comply with the requirements of Section
330.320(c) of this Part.
(Source: Added at 30 Ill.
Reg. 8928, effective April 28, 2006)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.330 RENEWAL OF LICENSES (REPEALED)
Section 330.330 Renewal of
Licenses(Repealed)
(Source: Repealed at 35 Ill.
Reg. 2931, effective February 7, 2011)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.340 AMENDMENT OF LICENSES AT REQUEST OF LICENSEE
Section 330.340 Amendment of
Licenses at Request of Licensee
a) Applications for amendment of a license shall be filed in
accordance with Section 330.240 and shall specify the purpose for which the
licensee desires the license to be amended and the grounds for the amendment.
b) Except
as otherwise authorized by the Agency, the licensee shall receive an amendment
before the licensee:
1) Receives,
uses, or transfers radioactive material for a type of use not authorized on the
licensee's current license.
2) Adds
or changes the Radiation Safety Officer.
3) Receives
radioactive material in excess of the license possession limits or in a form
not stated on the current license.
4) Adds
to or changes areas of use or storage locations, including change of address.
5) Revises
procedures identified in the current license.
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.350 AGENCY ACTION ON APPLICATION TO RENEW AND AMEND
Section 330.350 Agency
Action on Application to Renew and Amend
In considering an application by
a licensee to renew or amend the license, the Agency will apply the criteria
set forth in this Part and 32 Ill. Adm. Code: Chapter II, Subchapters b and d,
as applicable.
(Source: Amended at 32 Ill.
Reg. 6462, effective April 7, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.360 PERSONS POSSESSING A LICENSE FOR SOURCE, BYPRODUCT, OR SPECIAL NUCLEAR MATERIAL IN QUANTITIES NOT SUFFICIENT TO FORM A CRITICAL MASS ON EFFECTIVE DATE OF THIS PART (REPEALED)
Section 330.360 Persons
Possessing a License for Source, Byproduct, or Special Nuclear Material in
Quantities Not Sufficient to Form a Critical Mass on Effective Date of This
Part (Repealed)
(Source: Repealed at 24 Ill. Reg. 8042, effective June 1, 2000)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.370 PERSONS POSSESSING ACCELERATOR-PRODUCED OR NATURALLY-OCCURRING RADIOACTIVE MATERIAL ON EFFECTIVE DATE OF THIS PART (REPEALED)
Section 330.370 Persons
Possessing Accelerator-Produced or Naturally-Occurring Radioactive Material on
Effective Date of This Part (Repealed)
(Source: Repealed at 10 Ill. Reg. 17315, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.400 TRANSFER OF MATERIAL
Section 330.400 Transfer of
Material
a) No licensee shall transfer radioactive material except as
authorized pursuant to this Section.
b) Except
as otherwise provided for in the license and subject to the provisions of
subsections (c) and (d), any licensee may transfer radioactive material:
1) To the Agency if prior approval has been granted by the Agency;
2) To the U.S. Department of Energy;
3) To any person exempt from the regulations in this Part to the
extent permitted under the exemption;
4) To any person authorized to receive the material under terms
of a general license or its equivalent, or a specific license or equivalent
licensing document, issued by the Agency, the U.S. Nuclear Regulatory
Commission or an Agreement State, or to any person otherwise authorized to
receive the material by the Federal Government or any agency thereof, the Agency,
or an Agreement State; or
5) As otherwise authorized by the Agency in writing.
c) Before transferring radioactive material to a specific
licensee of the Agency, the NRC, or an Agreement State or to a general licensee
who is required to register with the Agency, the U.S. Nuclear Regulatory
Commission or an Agreement State prior to receipt of the radioactive material,
the licensee transferring the material shall verify that the transferee's
license authorizes the receipt of the radionuclide, form and activity of
radioactive material to be transferred.
d) The following methods for the verification required by
subsection (c) are acceptable:
1) The transferor may possess a current copy of the transferee's
specific license or registration certificate authorizing the transferee to
receive the radionuclide, form and activity of radioactive material to be
transferred;
2) The transferor may possess a written certification by the
transferee that the transferee is authorized by license or registration
certificate to receive the radionuclide, form and activity of radioactive
material to be transferred, specifying the license or registration certificate number,
issuing agency and expiration date;
3) For emergency shipments, the transferor may accept oral
certification by the transferee that the transferee is authorized by license or
registration certificate to receive the radionuclide, form and activity of
radioactive material to be transferred, specifying the license or registration
certificate number, issuing agency and expiration date; provided, that the oral
certification is confirmed in writing within 10 days;
4) The transferor may obtain other information compiled by a
reporting service from official records of the Agency, the U.S. Nuclear
Regulatory Commission or an Agreement State regarding the identity of licensees
and the scope and expiration dates of licenses and registration; or
5) When none of the methods of verification described in
subsections (d)(1) through (4) are readily available or when a transferor
desires to verify that information received by one of the methods is correct or
up-to-date, the transferor may obtain and record confirmation from the Agency,
the U.S. Nuclear Regulatory Commission or an Agreement State that the
transferee is licensed to receive the radioactive material.
e) Shipment and transport of radioactive material shall be in
accordance with the provisions of 32 Ill. Adm. Code 341.
(Source: Amended at 48 Ill.
Reg. 13634, effective August 29, 2024)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.500 MODIFICATION AND REVOCATION OF LICENSES
Section 330.500 Modification
and Revocation of Licenses
a) The terms and conditions of all licenses shall be subject to
amendment, revision, or modification or the license may be suspended or revoked
by reason of amendments to the Act, or by reason of rules, regulations, and
orders issued by the Agency in accordance with 32 Ill. Adm. Code 200.
b) In accordance with 32 Ill. Adm. Code 200, any license may be
revoked, suspended, or modified, in whole or in part, for any material false
statement in the application or any statement of fact required under provisions
of the Act, or because of conditions revealed by such application or statement
of fact or any report, record, or inspection or other means that would warrant
the Agency to refuse to grant a license on an original application, or for
violation of, or failure to observe any of the terms and conditions of the Act,
or of the license, or of any rule, regulation, or order of the Agency.
(Source: Amended at 32 Ill.
Reg. 6462, effective April 7, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.900 RECIPROCAL RECOGNITION OF LICENSES
Section 330.900 Reciprocal
Recognition of Licenses
a) Subject to this Part, any person who holds a specific license
from the U.S. Nuclear Regulatory Commission or an Agreement State is hereby
granted a general license to conduct the activities authorized in such
licensing document within this State, in areas not under exclusive federal
jurisdiction, for a period not in excess of 180 days in any 12-month period,
provided that:
1) A current copy of the licensing document is on file with the Agency
and activities authorized by the document are not limited to specified
installations or locations.
2) The out-of-state licensee notifies the Agency by telephone,
facsimile, or as otherwise provided in 32 Ill. Adm. Code 310.110 prior to
engaging in such activities. Notification shall indicate the following:
A) Contact
person
B) Phone
number of contact
C) Company
name and address
D) Company
contact person on-site
E) License
number of applicant or registrant
F) Licensing
authority
G) Expiration
date of applicant's or registrant's license
H) Dates
of work at temporary job site
I) Client
or facility name and address
K) Client
or facility contact person and phone number
L) Proposed
use and names of authorized users, their unique identification that can be
independently verified (e.g., driver's license number, employee ID, work permit
number, etc.), or if no other identification is available, the social security
number of the individual; and
M) Device manufacturer, model, radionuclide, source model, and
activity.
3) If initial notification was by telephone, the out-of-state
licensee shall submit to the Agency, within 10 days following notification, a
letter containing the information as specified in subsection (a)(2). Upon
receipt from the out-of-state licensee of a written request containing a
schedule of activities to be conducted within Illinois, the Agency shall waive
the requirement for additional notifications of activities on that schedule
during the 12-month period following the receipt of the initial notification
from a person engaging in activities under the general license provided in this
Section.
4) The out-of-state licensee complies with 32 Ill. Adm. Code: Chapter
II and with all the terms and conditions of the licensing document, except any
terms and conditions that may be inconsistent with 32 Ill. Adm. Code: Chapter
II.
5) The out-of-state licensee supplies other information as the
Agency may request to show compliance with 32 Ill. Adm. Code: Chapter II.
6) The out-of-state licensee shall not transfer or dispose of
radioactive material possessed or used under the general license provided in
this Section, except by transfer to a person:
A) Specifically
licensed by the Agency, the U.S. Nuclear Regulatory Commission or another state
to receive such material; or
B) Exempt
from the requirements for a license for such material under Section 330.40(a).
b) In addition to the provisions of subsection (a), any person
who holds a specific license issued by the U.S. Nuclear Regulatory Commission
or an Agreement State authorizing the holder to manufacture, transfer, install
or service a device described in Section 330.220(a) within areas subject to the
jurisdiction of the licensing body is hereby granted a general license to
install, transfer, demonstrate or service the device in this State, provided
that:
1) The device has been manufactured, labeled, installed and
serviced in accordance with applicable provisions of the specific license
issued to such person by the U.S. Nuclear Regulatory Commission or another
state;
2) The person shall assure that any labels required to be affixed
to the device under regulations of the authority that licensed manufacture of
the device bear a statement that "Removal of this label is
prohibited".
c) The Agency may withdraw, limit or qualify its acceptance of
any specific license issued by the U.S. Nuclear Regulatory Commission or
another state, or any product distributed pursuant to the license, if the Agency
determines that had the person been licensed in Illinois by the Agency, the
license would have been subject to action under Section 330.500.
(Source: Amended at 46 Ill.
Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.950 NATIONALLY TRACKED SOURCES
Section 330.950 Nationally
Tracked Sources
a) Each
licensee who manufactures a nationally tracked source after April 1, 2008 shall
assign a unique serial number to each nationally tracked source. Serial
numbers shall be composed only of alpha-numeric characters.
b) Each
licensee who manufactures a nationally tracked source shall complete and submit
a National Source Tracking Transaction Report. The report shall include the
following information:
1) The
name, address and license number of the reporting licensee;
2) The
name of the individual preparing the report;
3) The
manufacturer, model and serial number of the source;
4) The
radioactive material in the source;
5) The
initial source strength in becquerels (curies) at the time of manufacture; and
6) The
manufacture date of the source.
c) Each
licensee who transfers a nationally tracked source to another person shall
complete and submit a National Source Tracking Transaction Report. The report
shall include the following information:
1) The
name, address and license number of the reporting licensee;
2) The
name of the individual preparing the report;
3) The
name and license number of the recipient facility and the shipping address;
4) The
manufacturer, model and serial number of the source or, if not available, other
information to uniquely identify the source;
5) The
radioactive material in the source;
6) The
initial or current source strength in becquerels (curies);
7) The
date for which the source strength is reported;
8) The
shipping date;
9) The estimated arrival date; and
10) For
nationally tracked sources transferred as waste under a Uniform Low-Level
Radioactive Waste Manifest, the waste manifest number and the container
identification with the nationally tracked source.
d) Each
licensee who receives a nationally tracked source shall complete and submit a
National Source Tracking Transaction Report. The report shall include the
following information:
1) The
name, address and license number of the reporting licensee;
2) The
name of the individual preparing the report;
3) The
name, address and license number of the person who provided the source;
4) The
manufacturer, model and serial number of the source or, if not available, other
information to uniquely identify the source;
5) The
radioactive material in the source;
6) The
initial or current source strength in becquerels (curies);
7) The
date for which the source strength is reported;
8) The
date of receipt; and
9) For
material received under a Uniform Low-Level Radioactive Waste Manifest, the
waste manifest number and the container identification with the nationally
tracked source.
e) Each
licensee who disassembles a nationally tracked source shall complete and submit
a National Source Tracking Transaction Report. The report shall include the
following information:
1) The
name, address and license number of the reporting licensee;
2) The
name of the individual preparing the report;
3) The
manufacturer, model and serial number of the source or, if not available, other
information to uniquely identify the source;
4) The
radioactive material in the source;
5) The
initial or current source strength in becquerels (curies);
6) The date for which the source strength is reported; and
7) The disassembly date of the source.
f) Each
licensee who disposes of a nationally tracked source shall complete and submit
a National Source Tracking Transaction Report. The report shall include the
following information:
1) The
name, address and license number of the reporting licensee;
2) The
name of the individual preparing the report;
3) The
waste manifest number;
4) The
container identification with the nationally tracked source;
5) The
date of disposal; and
6) The
method of disposal.
g) The
reports discussed in subsections (b) through (f) shall be submitted by the
close of the next business day after the transaction. A single report may be
submitted for multiple sources and transactions. The reports shall be
submitted to the National Source Tracking System by using:
1) The
on-line National Source Tracking System;
2) Electronic
submission in a computer-readable format;
3) Facsimile;
4) Mail
to the address on the National Source Tracking Transaction Report Form (NRC
Form 748); or
5) Telephone
with follow up by facsimile or mail.
h) Each
licensee shall correct any error in previously filed reports or file a new
report for any missed transaction within 5 business days after discovery of the
error or missed transaction. Such errors may be detected by a variety of
methods, such as administrative reviews or physical inventories required by
regulation. In addition, each licensee shall reconcile the inventory of
nationally tracked sources possessed by the licensee against that licensee's
data in the National Source Tracking System. The reconciliation shall be
conducted during January of each year. The reconciliation process shall
include resolving any discrepancies between the National Source Tracking System
and the actual inventory by filing the reports identified by subsections (b)
through (f). By January 31 of each year, each licensee shall submit to the
National Source Tracking System confirmation that the data in the National
Source Tracking System is correct.
(Source: Amended at 48 Ill.
Reg. 13634, effective August 29, 2024)
SUBPART D: TRANSPORTATION (Repealed)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.1000 TRANSPORTATION OF RADIOACTIVE MATERIAL (REPEALED)
Section 330.1000
Transportation of Radioactive Material (Repealed)
(Source: Repealed at 10 Ill. Reg. 17315, effective September 25, 1986)
Section 330.APPENDIX A Exempt Concentrations
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX A EXEMPT CONCENTRATIONS
Section 330.APPENDIX A Exempt Concentrations
Element
(atomic
number)
Isotope
Column I
Gas Concentration1
Column II
Liquid and Solid Concentration2
Bg/ml
microCi/ml
Bg/ml
microCi/ml
Antimony
(51)
Sb-122
1.11x101
3x10-4
Sb-124
7.40x100
2x10-4
Sb-125
3.70x101
1x10-3
Argon
(18)
Ar-37
3.70x101
1x10-3
Ar-41
1.48x10-2
4x10-7
Arsenic
(33)
As-73
1.85x102
5x10-3
As-74
1.85x101
5x10-4
As-76
7.40x100
2x10-4
As-77
2.96x101
8x10-4
Barium
(56)
Ba-131
7.40x101
2x10-3
Ba-140
1.11x101
3x10-4
Beryllium
(4)
Be-7
7.40x102
2x10-2
Bismuth
(83)
Bi-206
1.48x101
4x10-4
Bromine
(35)
Br-82
1.48x10-2
4x10-7
1.11x102
3x10-3
Cadmium
(48)
Cd-109
7.40x101
2x10-3
Cd-115m
1.11x101
3x10-4
Cd-115
1.11x101
3x10-4
Calcium
(20)
Ca-45
3.33x100
9x10-5
Ca-47
1.85x101
5x10-4
Carbon
(6)
C-14
3.70x10-2
1x10-6
2.96x102
8x10-3
Cerium
(58)
Ce-141
3.33x101
9x10-4
Ce-143
1.48x101
4x10-4
Ce-144
3.70x100
1x10-4
Cesium
(55)
Cs-131
7.40x102
2x10-2
Cs-134m
2.22x103
6x10-2
Cs-134
3.3x100
9x10-5
Chlorine
(17)
Cl-38
3.33x10-2
9x10-7
1.48x102
4x10-3
Chromium
(24)
Cr-51
7.40x102
2x10-2
Cobalt
(27)
Co-57
1.85x102
5x10-3
Co-58
3.70x101
1x10-3
Co-60
1.85x101
5x10-4
Copper
(29)
Cu-64
1.11x102
3x10-3
Element
(atomic
number)
Isotope
Column I
Gas Concentration1
Column II
Liquid and Solid Concentration2
Bg/ml
microCi/ml
Bg/ml
microCi/ml
Dysprosium
(66)
Dy-165
1.48x102
4x10-3
Dy-166
1.48x101
4x10-4
Erbium
(68)
Er-169
3.33x101
9x10-4
Er-171
3.70x101
1x10-3
Europium
(63)
Eu-152
2.22x101
6x10-4
(9.2h)
Eu-155
7.40x101
2x10-3
Fluorine
(9)
F-18
7.40x10-2
2x10-6
2.96x102
8x10-3
Gadolinium
(64)
Gd-153
7.40x101
2x10-3
Gd-159
2.96x101
8x10-4
Gallium
(31)
Ga-72
1.48x101
4x10-4
Germanium
(32)
Ge-71
7.40x102
2x10-2
Gold
(79)
Au-196
7.40x101
2x10-3
Au-198
1.85x101
5x10-4
Au-199
7.40x101
2x10-3
Hafnium
(72)
Hf-181
2.59x101
7x10-4
Hydrogen
(1)
H-3
1.85x10-1
5x10-6
1.11x103
3x10-2
Indium
(49)
In-113m
3.70x102
1x10-2
In-114m
7.40x100
2x10-4
Iodine
(53)
I-126
1.11x10-4
3x10-9
7.40x10-1
2x10-5
I-131
1.11x10-4
3x10-9
7.40x10-1
2x10-5
I-132
2.96x10-3
8x10-8
2.22x101
6x10-4
I-133
3.70x10-4
1x10-8
2.59x100
7x10-5
I-134
7.40x10-3
2x10-7
3.70x101
1x10-3
Iridium
(77)
Ir-190
7.40x101
2x10-3
Ir-192
1.48x101
4x10-4
Ir-194
1.11x101
3x10-4
Iron
(26)
Fe-55
2.96x102
8x10-3
Fe-59
2.22x101
6x10-4
Krypton
(36)
Kr-85m
3.70x10-2
1x10-6
Kr-85
1.11x10-1
3x10-6
Lanthanum
(57)
La-140
7.40x100
2x10-4
Lead
(82)
Pb-203
1.48x102
4x10-3
Element
(atomic
number)
Isotope
Column I
Gas Concentration1
Column II
Liquid and Solid Concentration2
Bg/ml
microCi/ml
Bg/ml
microCi/ml
Lutetium
(71)
Lu-177
3.70x101
1x10-3
Manganese
(25)
Mn-52
1.11x101
3x10-4
Mn-54
3.70x101
1x10-3
Mn-56
3.70x101
1x10-3
Mercury
(80)
Hg-197m
7.40x101
2x10-3
Hg-197
1.11x102
3x10-3
Hg-203
7.40x100
2x10-4
Molybdenum
(42)
Mo-99
7.40x101
2x10-3
Neodymium
(60)
Nd-147
2.22x101
6x10-4
Nd-149
1.11x102
3x10-3
Nickel
(28)
Ni-65
3.70x101
1x10-3
Niobium
3.70x101
1x10-3
(Columbium)
Nb-95
(41)
Nb-97
3.33x102
9x10-3
Osmium
(76)
Os-185
2.59x101
7x10-4
Os-191m
1.11x103
3x10-2
Os-191
7.40x101
2x10-3
Os-193
2.22x101
6x10-4
Palladium
(46)
Pd-103
1.11x102
3x10-3
Pd-109
3.33x101
9x10-4
Phosphorus
(15)
P-32
7.40x100
2x10-4
Platinum
(78)
Pt-191
3.70x101
1x10-3
Pt-193m
3.70x102
1x10-2
Pt-197m
3.70x102
1x10-2
Pt-197
3.70x101
1x10-3
Potassium
(19)
K-42
1.11x102
3x10-3
Praseodymium
(59)
Pr-142
1.11x101
3x10-4
Pr-143
1.85x101
5x10-4
Promethium
(61)
Pm-147
7.40x101
2x10-3
Pm-149
1.48x101
4x10-4
Rhenium
(75)
Re-183
2.22x102
6x10-3
Re-186
3.33x101
9x10-4
Re-188
2.22x101
1x10-4
Rhodium
(45)
Rh-103m
3.70x103
1x10-1
Rh-105
3.70x101
1x10-3
Element
(atomic
number)
Isotope
Column I
Gas Concentration1
Column II
Liquid and Solid Concentration2
Bg/ml
microCi/ml
Bg/ml
microCi/ml
Rubidium
(37)
Rb-86
2.59x101
7x10-4
Ruthenium
(44)
Ru-97
1.48x102
4x10-3
Ru-103
2.96x101
8x10-4
Ru-105
3.70x101
1x10-3
Ru-106
3.70x100
1x10-4
Samarium
(62)
Sm-153
2.96x101
8x10-4
Scandium
(21)
Sc-46
1.48x101
4x10-4
Sc-47
3.33x101
9x10-4
Sc-48
1.11x101
3x10-4
Selenium
(34)
Se-75
1.11x102
3x10-3
Silicon
(14)
Si-31
3.33x102
9x10-3
Silver
(47)
Ag-105
3.70x101
1x10-3
Ag-110m
1.11x101
3x10-4
Ag-111
1.48x101
4x10-4
Sodium
(11)
Na-24
7.40x101
2x10-3
Strontium
(38)
Sr-85
3.70x101
1x10-3
Sr-89
3.70x100
1x10-4
Sr-91
2.59x101
7x10-4
Sr-92
2.59x101
7x10-4
Sulfur
(16)
S-35
2.22x101
6x10-4
Tantalum
(73)
Ta-182
1.48x101
4x10-4
Technetium
(43)
Tc-96m
3.70x103
1x10-1
Tc-96
3.70x101
1x10-3
Tellurium
(52)
Te-125m
7.40x101
2x10-3
Te-127m
2.22x101
6x10-4
Te-127
1.11x102
3x10-3
Te-129m
1.11x101
3x10-4
Te-131m
2.22x101
6x10-4
Te-132
1.11x101
3x10-4
Terbium
(65)
Tb-160
1.48x101
4x10-4
Thallium
(81)
Tl-200
1.48x101
4x10-3
Tl-201
1.11x102
3x10-3
Tl-202
3.70x101
1x10-3
Tl-204
3.70x101
1x10-3
Element
(atomic
number)
Isotope
Column I
Gas Concentration1
Column II
Liquid and Solid Concentration2
Bg/ml
microCi/ml
Bg/ml
microCi/ml
Thulium
(69)
Tm-170
1.85x101
5x10-4
Tm-171
1.85x102
5x10-3
Tin
(50)
Sn-113
3.33x101
9x10-4
Sn-125
7.40x100
2x10-4
Tungsten
W-181
1.48x102
4x10-3
(Wolfram)
(74)
W-187
2.59x101
7x10-4
Vanadium
(23)
V-48
1.11x101
3x10-4
Xenon
(54)
Xe-131m
1.48x10-1
4x10-6
Xe-133
1.11x10-1
3x10-6
X3-135
3.70x10-2
1x10-6
Ytterbium
(70)
Yb-175
3.70x101
1x10-3
Yttrium
(39)
Y-90
7.40x100
2x10-4
Y-91m
1.11x103
3x10-2
Y-91
1.11x101
3x10-4
Y-92
2.22x101
6x10-4
Y-93
1.11x101
3x10-4
Zinc
(30)
Zn-65
3.70x101
1x10-3
Zn-69m
2.59x101
7x10-4
Zn-69
7.40x102
2x10-2
Zirconium
(40)
Zr-95
2.22x101
6x10-4
Zr-97
7.40x100
2x10-4
Beta-and/or
gamma-emitting radioactive material not listed above with half-life of less
than 3 years.
3.70x10-6
1x10-10
3.70x102
1x10-6
1 Values are given in
Column I only for those materials normally used as gases.
2 Bq or microCi/g for
solids.
NOTE 1: Many radionuclides
transform into nuclides that are also radioactive. In expressing the
concentrations in this Appendix, the activity stated is that of the parent radionuclide
and takes into account the daughters.
NOTE 2: For purposes of Section
330.40 where there is involved a combination of radionuclides, the limit for
the combination should be derived as follows: Determine for each radionuclide
in the product the ratio between the radioactivity concentration present in the
product and the exempt radioactivity concentration established in this Appendix
for the radionuclide when not in combination. The sum of such ratios may not
exceed "1".
EXAMPLE:
Concentration of Nuclide A in Product
+
Concentration of Nuclide B in Product
≤ 1
Exempt Concentration of Nuclide A
Exempt Concentration of Nuclide B
(Source: Amended at 35 Ill.
Reg. 2931, effective February 7, 2011)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX B EXEMPT QUANTITIES
Section 330.APPENDIX B
Exempt Quantities
Radioactive
Material
kBq
microCi
Antimony-122
(Sb-122)
3,700
100
Antimony-124
(Sb-124)
370
10
Antimony-125
(Sb-125)
370
10
Arsenic-73
(As-73)
3,700
100
Arsenic-74
(As-74)
370
10
Arsenic-76
(As-76)
370
10
Arsenic-77
(As-77)
3,700
100
Barium-131
(Ba-131)
370
10
Barium-133
(Ba-133)
370
10
Barium-140
(Ba-140)
370
10
Bismuth-210
(Bi-210)
37
1
Bromine-82
(Br-82)
370
10
Cadmium-109
(Cd-109)
370
10
Cadmium-115m
(Cd-115m)
370
10
Cadmium-115
(Cd-115)
3,700
100
Calcium-45
(Ca-45)
370
10
Calcium-47
(Ca-47)
370
10
Carbon-14
(C-14)
3,700
100
Cerium-141
(Ce-141)
3,700
100
Cerium-143
(Ce-143)
3,700
100
Cerium-144
(Ce-144)
37
1
Cesium-129
(Cs-129)
3,700
100
Cesium-131
(Cs-131)
37,000
1,000
Cesium-134m
(Cs-134m)
3,700
100
Cesium-134
(Cs-134)
37
1
Cesium-135
(Cs-135)
370
10
Cesium-136
(Cs-136)
370
10
Cesium-137
(Cs-137)
370
10
Chlorine-36
(Cl-36)
370
10
Chlorine-38
(Cl-38)
370
10
Chromium-51
(Cr-51)
37,000
1,000
Cobalt-57
(Co-57)
3,700
100
Cobalt-58m
(Co-58m)
370
10
Cobalt-58
(Co-58)
370
10
Cobalt-60
(Co-60)
37
1
Copper-64
(Cu-64)
3,700
100
Dysprosium-165
(Dy-165)
370
10
Dysprosium-166
(Dy-166)
3,700
100
Erbium-169
(Er-169)
3,700
100
Erbium-171
(Er-171)
3,700
100
Europium-152
(Eu-152)(9.2h)
3,700
100
Europium-152
(Eu-152)(13 yr)
37
1
Radioactive
Material
kBq
microCi
Europium-154
(Eu-154)
37
1
Europium-155
(Eu-155)
370
10
Fluorine-18
(F-18)
37,000
1,000
Gadolinium-153
(Gd-153)
370
10
Gadolinium-159
(Gd-159)
3,700
100
Gallium-67
(Ga-67)
3,700
100
Gallium-72
(Ga-72)
370
10
Germanium-68
(Ge-68)
370
10
Germanium-71
(Ge-71)
3,700
100
Gold-195
(Au-195)
370
10
Gold-198
(Au-198)
3,700
100
Gold-199
(Au-199)
3,700
100
Hafnium-181
(Hf-181)
370
10
Holmium-166
(Ho-166)
3,700
100
Hydrogen-3
(H-3)
37,000
1,000
Indium-111
(In-111)
3,700
100
Indium-113m
(In-113m)
3,700
100
Indium-114m
(In-114m)
370
10
Indium-115m
(In-115m)
3,700
100
Indium-115
(In-115)
370
10
Iodine-123
(I-123)
3,700
100
Iodiue-125
(I-125)
37
1
Iodine-126
(I-126)
37
1
Iodine-129
(I-129)
3.7
0.1
Iodine-131
(I-131)
37
1
Iodine-132
(I-132)
370
10
Iodine-133
(I-133)
37
1
Iodine-134
(I-134)
370
10
Iodine-135
(I-135)
370
10
Iridium-192
(Ir-192)
370
10
Iridium-194
(Ir-194)
3,700
100
Iron-52
(Fe-52)
370
10
Iron-55
(Fe-55)
3,700
100
Iron-59
(Fe-59)
370
10
Krypton-85
(Kr-85)
3,700
100
Krypton-87
(Kr-87)
370
10
Lanthanum-140
(La-140)
370
10
Lutetium-177
(Lu-177)
3,700
100
Manganese-52
(Mn-52)
370
10
Manganese-54
(Mn-54)
370
10
Manganese-56
(Mn-56)
370
10
Mercury-197m
(Hg-197m)
3,700
100
Mercury-197
(Hg-197)
3,700
100
Mercury-203
(Hg-203)
370
10
Radioactive
Material
kBq
microCi
Molybdenum-99
(Mo-99)
3,700
100
Neodymium-147
(Nd-147)
3,700
100
Neodymium-149
(Nd-149)
3,700
100
Nickel-59
(Ni-59)
3,700
100
Nickel-63
(Ni-63)
370
10
Nickel-65
(Ni-65)
3,700
100
Niobium-93m
(Nb-93m)
370
10
Niobium-95
(Nb-95)
370
10
Niobium-97
(Nb-97)
370
10
Osmium-185
(Os-185)
370
10
Osmium-191m
(Os-191m)
3,700
100
Osmium-191
(Os-191)
3,700
100
Osmium-193
(Os-193)
3,700
100
Palladium-103
(Pd-103)
3,700
100
Palladium-109
(Pd-109)
3,700
100
Phosphorus-32
(P-32)
370
10
Platinum-191
(Pt-191)
3,700
100
Platinum-193m
(Pt-193m)
3,700
100
Platinum-193
(Pt-193)
3,700
100
Platinum-197m
(Pt-197m)
3,700
100
Platinum-197
(Pt-197)
3,700
100
Polonium-210
(Po-210)
3.7
0.1
Potassium-42
(K-42)
370
10
Potassium-43
(K-43)
370
10
Praseodymium-142
(Pr-142)
3,700
100
Praseodymium-143
(Pr-143)
3,700
100
Promethium-147
(Pm-147)
370
10
Promethium-149
(Pm-149)
370
10
Rhenium-186
(Re-186)
3,700
100
Rhenium-188
(Re-188)
3,700
100
Rhodium-103m
(Rh-103m)
3,700
100
Rhodium-105
(Rh-105)
3,700
100
Rubidium-81
(Rb-81)
370
10
Rubidium-86
(Rb-86)
370
10
Rubidium-87
(Rb-87)
370
10
Ruthenium-97
(Ru-97)
3,700
100
Ruthenium-103
(Ru-103)
370
10
Ruthenium-105
(Ru-105)
370
10
Ruthenium-106
(Ru-106)
37
1
Samarium-151
(Sm-151)
370
10
Samarium-153
(Sm-153)
3,700
100
Scandium-46
(Sc-46)
370
10
Scandium-47
(Sc-47)
3,700
100
Scandium-48
(Sc-48)
370
10
Radioactive
Material
kBq
microCi
Selenium-75
(Se-75)
370
10
Silicon-31
(Si-31)
3,700
100
Silver-105
(Ag-105)
370
10
Silver-110m
(Ag-110m)
37
1
Silver-111
(Ag-111)
3,700
100
Sodium-22
(Na-22)
370
10
Sodium-24
(Na-24)
370
10
Strontium-85
(Sr-85)
370
10
Strontium-89
(Sr-89)
37
1
Strontium-90
(Sr-90)
3.7
0.1
Strontium-91
(Sr-91)
370
10
Strontium-92
(Sr-92)
370
10
Sulfur-35
(S-35)
3,700
100
Tantalum-182
(Ta-182)
370
10
Technetium-96
(Tc-96)
370
10
Technetium-97m
(Tc-97m)
3,700
100
Technetium-97
(Tc-97)
3,700
100
Technetium-99m
(Tc-99m)
3,700
100
Technetium-99
(Tc-99)
370
10
Tellurium-125m
(Te-125m)
370
10
Tellurium-127m
(Te-127m)
370
10
Tellurium-127
(Te-127)
3,700
100
Tellurium-129m
(Te-129m)
370
10
Tellurium-129
(Te-129)
3,700
100
Tellurium-131m
(Te-131m)
370
10
Tellurium-132
(Te-132)
370
10
Terbium-160
(Tb-160)
370
10
Thallium-200
(Tl-200)
3,700
100
Thallium-201
(Tl-201)
3,700
100
Thallium-202
(Tl-202)
3,700
100
Thallium-204
(Tl-204)
370
10
Thulium-170
(Tm-170)
370
10
Thulium-171
(Tm-171)
370
10
Tin-113
(Sn-113)
370
10
Tin-125
(Sn-125)
370
10
Tungsten-181
(W-181)
370
10
Tungsten-185
(W-185)
370
10
Tungsten-187
(W-187)
3,700
100
Vanadium-48
(V-48)
370
10
Xenon-131m
(Xe-131m)
37,000
1,000
Xenon-133
(Xe-133)
3,700
100
Xenon-135
(Xe-135)
3,700
100
Ytterbium-175
(Yb-175)
3,700
100
Yttrium-87
(Y-87)
370
10
Radioactive
Material
kBq
microCi
Yttrium-88
(Y-88)
370
10
Yttrium-90
(Y-90)
370
10
Yttrium-91
(Y-91)
370
10
Yttrium-92
(Y-92)
3,700
100
Yttrium-93
(Y-93)
3,700
100
Zinc-65
(Zn-65)
370
10
Zinc-69m
(Zn-69m)
3,700
100
Zinc-69
(Zn-69)
37,000
1,000
Zirconium-93
(Zr-93)
370
10
Zirconium-95
(Zr-95)
370
10
Zirconium-97
(Zr-97)
370
10
Any
radioactive material not listed above other than alpha-emitting radioactive
material
3.7
0.1
(Source: Amended at 18 Ill. Reg.
5553, effective March 29, 1994)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C
Quantities of Radioactive Materials Requiring Consideration of the Need for an
Emergency Plan for Responding to a Release
Radioactive
Material1
Release
Fraction
Quantity
(GBq)
Quantity
(Ci)
Actinium-228
0.001
148,000
4,000
Americium-241
0.001
74
2
Americium-242
0.001
74
2
Americium-243
0.001
74
2
Antimony-124
0.01
148,000
4,000
Antimony-126
0.01
222,000
6,000
Barium-133
0.01
370,000
10,000
Barium-140
0.01
1,110,000
30,000
Bismuth-207
0.01
185,000
5,000
Bismuth-210
0.01
22,200
600
Cadmium-109
0.01
37,000
1,000
Cadmium-113
0.01
2,960
80
Calcium-45
0.01
740,000
20,000
Californium-252
0.001
333
9 (20mg)
Carbon-14
(Non-CO2)
0.01
1,850,000
50,000
Cerium-141
0.01
370,000
10,000
Cerium-144
0.01
11,100
300
Cesium-134
0.01
74,000
2,000
Cesium-137
0.01
111,000
3,000
Chlorine-36
0.5
3,700
100
Chromium-51
0.01
11,100,000
300,000
Cobalt-60
0.001
185,000
5,000
Copper-64
0.01
7,400,000
200,000
Curium-242
0.001
2,220
60
Curium-243
0.001
110
3
Curium-244
0.001
148
4
Curium-245
0.001
74
2
Europium-152
0.01
18,500
500
Europium-154
0.01
14,800
400
Europium-155
0.01
111,000
3,000
Gadolinium-153
0.01
185,000
5,000
Germanium-68
0.01
74,000
2,000
Gold-198
0.01
1,110,000
30,000
Hafnium-172
0.01
14,800
400
Hafnium-181
0.01
259,000
7,000
Holmium-166m
0.01
3,700
100
Hydrogen-3
0.5
740,000
20,000
Indium-114m
0.01
37,000
1,000
Iodine-125
0.5
370
10
Iodine-131
0.5
370
10
Iridium-192
0.001
1,480,000
40,000
Iron-55
0.01
1,480,000
40,000
Iron-59
0.01
259,000
7,000
Krypton-85
1.0
222,000,000
6,000,000
Lead-210
0.01
296
8
Manganese-56
0.01
2,220,000
60,000
Mercury-203
0.01
370,000
10,000
Molybdenum-99
0.01
1,110,000
30,000
Neptunium-237
0.001
74
2
Nickel-63
0.01
740,000
20,000
Niobium-94
0.01
11,100
300
Phosphorus-32
0.5
3,700
100
Phosphorus-33
0.5
37,000
1,000
Polonium-210
0.01
370
10
Potassium-42
0.01
333,000
9,000
Promethium-145
0.01
148,000
4,000
Promethium-147
0.01
148,000
4,000
Radium-226
0.001
3,700
100
Ruthenium-106
0.01
7,400
200
Samarium-151
0.01
148,000
4,000
Scandium-46
0.01
111,000
3,000
Selenium-75
0.01
370,000
10,000
Silver-110m
0.01
37,000
1,000
Sodium-22
0.01
333,000
9,000
Sodium-24
0.01
370,000
10,000
Strontium-89
0.01
111,000
3,000
Strontium-90
0.01
3,330
90
Sulfur-35
0.5
33,300
900
Technetium-99
0.01
370,000
10,000
Technetium-99m
0.01
14,800,000
400,000
Tellurium-127m
0.01
185,000
5,000
Tellurium-129m
0.01
185,000
5,000
Terbium-160
0.01
148,000
4,000
Thulium-170
0.01
148,000
4,000
Tin-113
0.01
370,000
10,000
Tin-123
0.01
111,000
3,000
Tin-126
0.01
37,000
1,000
Titanium-44
0.01
3,700
100
Vanadium-48
0.01
259,000
7,000
Xenon-133
1.0
33,300,000
900,000
Yttrium-91
0.01
74,000
2,000
Zinc-65
0.01
185,000
5,000
Zirconium-93
0.01
14,800
400
Zirconium-95
0.01
185,000
5,000
Any other
beta-gamma emitter
0.01
370,000
10,000
Mixed
fission products
0.01
37,000
1,000
Mixed
corrosion products
0.01
370,000
10,000
Contaminated
equipment, beta-gamma
0.001
370,000
10,000
Irradiated
material, any form other than
solid noncombustible
0.01
37,000
1,000
Irradiated
material, solid noncombustible
0.001
370,000
10,000
Mixed
radioactive waste,2 beta-gamma
0.01
37,000
1,000
Packaged
mixed waste, 2 beta-gamma
0.001
370,000
10,000
Any other
alpha emitter
0.001
74
2
Contaminated
equipment, Alpha
0.0001
740
20
Packaged
waste, alpha2
0.0001
740
20
1 For combinations of radioactive materials, the licensee
is required to consider whether an emergency plan is needed if the sum of the
ratios of the quantity of each radioactive material authorized to the
quantity listed for that material above exceeds one.
2 Waste packaged in Type B containers does not require an
emergency plan.
(Source: Amended at 35 Ill.
Reg. 2931, effective February 7, 2011)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE A Group I
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE B Group II
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE C Group III
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE D Group IV
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE E Group V
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX C QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN FOR RESPONDING TO A RELEASE
Section 330.APPENDIX C Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency
Plan for Responding to a Release
Section 330.TABLE F Group VI
(Repealed)
(Source: Repealed
at 10 Ill. Reg. 1511, effective September 25, 1986)
Section 330.APPENDIX D Limits for Licenses of Broad Scope (Section 330.270)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX D LIMITS FOR LICENSES OF BROAD SCOPE (SECTION 330.270)
Section 330.APPENDIX D
Limits for Licenses of Broad Scope (Section 330.270)
Column I
Column II
Radioactive Material
GBq
Ci
GBq
Ci
Antimony-122
37
1
0.37
0.01
Antimony-124
37
1
0.37
0.01
Antimony-125
37
1
0.37
0.01
Arsenic-73
370
10
3.7
0.1
Arsenic-74
37
1
0.37
0.01
Arsenic-76
37
1
0.37
0.01
Arsenic-77
370
10
3.7
0.1
Barium-131
370
10
3.7
0.1
Barium-140
37
1
0.37
0.01
Beryllium-7
370
10
3.7
0.1
Bismuth-210
3.7
0.1
0.037
0.001
Bromine-82
370
10
3.7
0.1
Cadmium-109
37
1
0.37
0.01
Cadmium-115m
37
1
0.37
0.01
Cadmium-115
370
10
3.7
0.1
Calcium-45
37
1
0.37
0.01
Calcium-47
370
10
3.7
0.1
Carbon-14
3,700
100
37
1.
Cerium-141
370
10
3.7
0.1
Cerium-143
370
10
3.7
0.1
Cerium-144
3.7
0.1
0.037
0.001
Cesium-131
3,700
100
37
1
Cesium-134m
3,700
100
37
1
Cesium-134
3.7
0.1
0.037
0.001
Cesium-135
37
1
0.37
0.01
Cesium-136
370
10
3.7
0.1
Cesium-137
3.7
0.1
0.037
0.001
Chlorine-36
37
1
0.37
0.01
Chlorine-38
3,700
100
37
1.
Chromium-51
3,700
100
37
1.
Cobalt-57
370
10
3.7
0.1
Cobalt-58m
3,700
100
37
1.
Cobalt-58
37
1
0.37
0.01
Cobalt-60
3.7
0.1
0.037
0.001
Copper-64
370
10
3.7
0.1
Dysprosium-165
3,700
100
37
1.
Dysprosium-166
370
10
3.7
0.1
Erbium-169
370
10
3.7
0.1
Erbium-171
370
10
3.7
0.1
Europium-152 (9.2 h)
370
10
3.7
0.1
Europium-152 (13 y)
3.7
0.1
0.037
0.001
Europium-154
3.7
0.1
0.037
0.001
Europium-155
37
1
0.37
0.01
Fluorine-18
3,700
100
37
1.
Gadolinium-153
37
1
0.37
0.01
Gadolinium-159
370
10
3.7
0.1
Gallium-72
370
10
3.7
0.1
Germanium-71
3,700
100
37
1.
Gold-198
370
10
3.7
0.1
Gold-199
370
10
3.7
0.1
Hafnium-181
37
1
0.37
0.01
Holmium-166
370
10
3.7
0.1
Hydrogen-3
3,700
100
37
1.
Indium-113m
3,700
100
37
1.
Indium-114m
37
1
0.37
0.01
Indium-115m
3,700
100
37
1.
Indium-115
37
1
0.37
0.01
Iodine-125
3.7
0.1
0.037
0.001
Iodine-126
3.7
0.1
0.037
0.001
Iodine-129
3.7
0.1
0.037
0.001
Iodine-131
3.7
0.1
0.037
0.001
Iodine-132
370
10
3.7
0.1
Iodine-133
37
1
0.37
0.01
Iodine-134
370
10
3.7
0.1
Iodine-135
37
1
0.37
0.01
Iridium-192
37
1
0.37
0.01
Iridium-194
370
10
3.7
0.1
Iron-55
370
10
3.7
0.1
Iron-59
37
1
0.37
0.01
Krypton-85
3,700
100
37
1.
Krypton-87
370
10
3.7
0.1
Lanthanum-140
37
1
0.37
0.01
Lutetium-177
370
10
3.7
0.1
Manganese-52
37
1
0.37
0.01
Manganese-54
37
1
0.37
0.01
Manganese-56
370
10
3.7
0.1
Mercury-197m
370
10
3.7
0.1
Mercury-197
370
10
3.7
0.1
Mercury-203
37
1
0.37
0.01
Molybdenum-99
370
10
3.7
0.1
Neodymium-147
370
10
3.7
0.1
Neodymium-149
370
10
3.7
0.1
Nickel-59
370
10
3.7
0.1
Nickel-63
37
1
0.37
0.01
Nickel-65
370
10
3.7
0.1
Niobium-93m
37
1
0.37
0.01
Niobium-95
37
1
0.37
0.01
Niobium-97
3,700
100
37
1.
Osmium-185
37
1
0.37
0.01
Osmium-191m
3,700
100
37
1.
Osmium-191
370
10
3.7
0.1
Osmium-193
370
10
3.7
0.1
Palladium-103
370
10
3.7
0.1
Palladium-109
370
10
3.7
0.1
Phosphorus-32
37
1
0.37
0.01
Platinum-191
370
10
3.7
0.1
Platinum-193m
3,700
100
37
1.
Platinum-193
370
10
3.7
0.1
Platinum-197m
3,700
100
37
1.
Platinum-197
370
10
3.7
0.1
Polonium-210
0.37
0.01
0.0037
0.0001
Potassium-42
37
1
0.37
0.01
Praseodymium-142
370
10
3.7
0.1
Praseodymium-143
370
10
3.7
0.1
Promethium-147
37
1
0.37
0.01
Promethium-149
370
10
3.7
0.1
Radium-226
0.37
0.01
0.0037
0.0001
Rhenium-186
370
10
3.7
0.1
Rhenium-188
370
10
3.7
0.1
Rhodium-103m
37,000
1,000
370
10.
Rhodium-105
370
10
3.7
0.1
Rubidium-86
37
1
0.37
0.01
Rubidium-87
37
1
0.37
0.01
Ruthenium-97
3,700
100
37
1.
Ruthenium-103
37
1
0.37
0.01
Ruthenium-105
370
10
3.7
0.1
Ruthenium-106
3.7
0.1
0.037
0.001
Samarium-151
37
1
0.37
0.01
Samarium-153
370
10
3.7
0.1
Scandium-46
37
1
0.37
0.01
Scandium-47
370
10
3.7
0.1
Scandium-48
37
1
0.37
0.01
Selenium-75
37
1
0.37
0.01
Silicon-31
370
10
3.7
0.1
Silver-105
37
1
0.37
0.01
Silver-110m
3.7
0.1
0.037
0.001
Silver-111
370
10
3.7
0.1
Sodium-22
3.7
0.1
0.037
0.001
Sodium-24
37
1
0.37
0.01
Strontium-85m
37,000
1,000
370
10
Strontium-85
37
1
0.37
0.01
Strontium-89
37
1
0.37
0.01
Strontium-90
0.37
0.01
0.0037
0.0001
Strontium-91
370
10
3.7
0.1
Strontium-92
370
10
3.7
0.1
Sulfur-35
370
10
3.7
0.1
Tantalum-182
37
1
0.37
0.01
Technetium-96
370
10
3.7
0.1
Technetium-97m
370
10
3.7
0.1
Technetium-97
370
10
3.7
0.1
Technetium-99m
3,700
100
37
1.
Technetium-99
37
1
0.37
0.01
Tellurium-125m
37
1
0.37
0.01
Tellurium-127m
37
1
0.37
0.01
Tellurium-127
370
10
3.7
0.1
Tellurium-129m
37
1
0.37
0.01
Tellurium-129
3,700
100
37
1.
Tellurium-131m
370
10
3.7
0.1
Tellurium-132
37
1
0.37
0.01
Terbium-160
37
1
0.37
0.01
Thallium-200
370
10
3.7
0.1
Thallium-201
370
10
3.7
0.1
Thallium-202
370
10
3.7
0.1
Thallium-204
37
1
0.37
0.01
Thulium-170
37
1
0.37
0.01
Thulium-171
37
1
0.37
0.01
Tin-113
37
1
0.37
0.01
Tin-125
37
1
0.37
0.01
Tungsten-181
37
1
0.37
0.01
Tungsten-185
37
1
0.37
0.01
Tungsten-187
370
10
3.7
0.1
Vanadium-48
37
1
0.37
0.01
Xenon-131m
37,000
1,000
370
10.
Xenon-133
3,700
100
37
1.
Xenon-135
3,700
100
37
1.
Ytterbium-175
370
10
3.7
0.1
Yttrium-90
37
1
0.37
0.01
Yttrium-91
37
1
0.37
0.01
Yttrium-92
370
10
3.7
0.1
Yttrium-93
37
1
0.37
0.01
Zinc-65
37
1
0.37
0.01
Zinc-69m
370
10
3.7
0.1
Zinc-69
3,700
100
37
1.
Zirconium-93
37
1
0.37
0.01
Zirconium-95
37
1
0.37
0.01
Zirconium-97
37
1
0.37
0.01
Any radioactive material other
than source material, special nuclear material, or alpha emitting radioactive
material not listed above.
3.7
0.1
0.037
0.001
(Source: Amended at 46 Ill. Reg. 866, effective December 21, 2021)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX E LIST OF SPECIALTY BOARD CERTIFICATIONS RECOGNIZED BY THE AGENCY UNTIL OCTOBER 24, 2007 (REPEALED)
Section 330.APPENDIX E List
of Specialty Board Certifications Recognized by the Agency Until October 24,
2007(Repealed)
(Source: Repealed at 32 Ill.
Reg. 9199, effective June 13, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX F NATIONALLY TRACKED SOURCE THRESHOLDS
Section 330.APPENDIX F Nationally
Tracked Source Thresholds
The terabecquerel (TBq) values
are the regulatory standard. The curie (Ci) values specified are obtained by
converting from the TBq value. The curie values are provided for practical
usefulness only and are rounded after conversion.
Radioactive material
Category 1
Category 1
Category 2
Category 2
(TBq)
(Ci)
(TBq)
(Ci)
Actinium-227
20
540
0.2
5.4
Americium-241
60
1,600
0.6
16
Americium-241/Be
60
1,600
0.6
16
Californium-252
20
540
0.2
5.4
Cobalt-60
30
810
0.3
8.1
Curium-244
50
1,400
0.5
14
Cesium-137
100
2,700
1
27
Gadolinium-153
1,000
27,000
10
270
Iridium-192
80
2,200
0.8
22
Plutonium-238
60
1,600
0.6
16
Plutonium-239/Be
60
1,600
0.6
16
Polonium-210
60
1,600
0.6
16
Promethium-147
40,000
1,100,000
400
11,000
Radium-226
40
1,100
0.4
11
Selenium-75
200
5,400
2
54
Strontium-90
1,000
27,000
10
270
Thorium-228
20
540
0.2
5.4
Thorium-229
20
540
0.2
5.4
Thulium-170
20,000
540,000
200
5,400
Ytterbium-169
300
8,100
3
81
(Source: Added at 32 Ill.
Reg. 6462, effective April 7, 2008)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX G FINANCIAL SURETY ARRANGEMENTS (SECTION 330.250(C)(1)(D)) (REPEALED)
Section
330.APPENDIX G Financial Surety Arrangements (Section 330.250(c)(1)(D))
(Repealed)
(Source: Repealed at 24 Ill. Reg. 8042, effective June 1, 2000)
TITLE 32: ENERGY
CHAPTER II: ILLINOIS EMERGENCY MANAGEMENT AGENCY SUBCHAPTER b: RADIATION PROTECTION
PART 330
LICENSING OF RADIOACTIVE MATERIAL
SECTION 330.APPENDIX H WORDING OF FINANCIAL SURETY ARRANGEMENTS (SECTION 330.250(C)(1)(E)) (REPEALED)
Section 330.APPENDIX H Wording
of Financial Surety Arrangements (Section 330.250(c)(1)(E)) (Repealed)
(Source: Repealed at 24 Ill. Reg. 8042, effective June 1, 2000)